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Abstract 
Cholesterol-rich membrane microdomains, also known as lipid rafts, are specialized 
assemblies of membrane lipids and proteins that regulate diverse cellular events. Distinct 
physicochemical properties of cholesterol and sphingolipids facilitate partitioning of 
membrane associated proteins producing heterogeneity in the membrane bilayer. The lipid 
rafts are considered as signalling and sorting platforms on the cell surface that mediates 
clustering of signalling machinery including receptors, serine tyrosine kinases, GPI 
anchored and acetylated proteins. Lipid rafts are also regarded as membrane organizers 
that control myriads of cellular processes like endocytosis, cell adhesion and migration. 
Interestingly, their dysfunction has been implicated in a range of cancers, cardiovascular, 
and neurodegenerative diseases. Due to their apparent biological importance, various 
biochemical and microscopic techniques have been implemented to characterise protein 
constituents of cellular raft fractions along with high throughput proteomics approaches. 
Mass-spectrometry based proteomics profiling of lipid rafts has been pivotal in 
understanding the composition and spatiotemporal dynamics within these microdomains. 
Despite extensive proteomics research, the global protein landscape and subsequent 
function of lipid raft still remained elusive.  
In an effort to determine and understand potential lipid raft proteome profiled by multiple 
proteomic investigations in physiological and disease conditions this thesis describes a 
systematic computational approach. To achieve this, I propose and sought to fulfil three 
main aims (1) To develop an open source resource to characterise mammalian lipid raft 
proteome (2) In depth in silico characterisation of structural features and functional 
significance of human lipid raft associated proteins (3) To understand raft associated 
mechanism of tumor progression by integrative analysis of quantitative proteomics studies. 
In Chapter 2, I present a database for mammalian lipid raft proteome “RaftProt” 
(http://lipid-raft-database.di.uq.edu.au/). This online public resource is the first repository 
hosting a comprehensive collection lipid raft associated proteins detected through high 
throughput lipid raft proteomics studies. I have developed a user-friendly web platform, 
including number of online features, to assist searching, browsing and downloading large 
scale proteomics datasets. Furthermore, implementing an ontology at the backend of the 
RaftProt I provided a novel approach to organise and represent proteomic datasets based 
on anatomical features. A subset of bona-fide high confidence lipid raft proteins was 
proposed by applying experimental evidence based filtering criteria. Taken together, this 
database is a valuable resource to decipher the biological and disease specific 
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organization of mammalian lipid raft proteome. Importantly, this collection effort also led 
the foundation for systems level characterisation of functional lipid rafts later in this project. 
Chapter 3 presents a systematic bioinformatics workflow to characterise human lipid raft 
proteome. Computational methods were used to classify human lipid raft proteins into 
intrinsic, extrinsic and raft dependent proteins based on diverse mechanism of targeting 
proteins to the raft. Three broad structural features: post-translational lipid modifications, 
cholesterol binding and presence of transmembrane signature in the protein sequence, 
were considered to define intrinsic component of the lipid raft. In contrast, potential of lipid 
raft proteins to undergo protein-protein interactions was exploited to derive a group of 
extrinsic raft proteins. A detailed functional and pathway enrichment analysis uncovered 
potential enrichment of receptors and transporter molecules in the intrinsic lipid raft 
proteome was also carried out. This analysis also showed presence of kinases and 
cytoskeletal proteins in the extrinsic raft component together with some raft specific 
pathways. This detailed computational analysis of the largest dataset of human lipid raft 
proteins, therefore provided valuable insights about mechanisms of raft targeting and 
functional characteristics of human raft proteins. 
Alterations in cholesterol-rich membrane microdomains have been shown in number of 
different cancer types. In Chapter 4, I performed an integrative analysis of quantitative 
lipid raft proteomics datasets on five different cancer types to determine unifying raft 
mechanisms during neoplastic progression. An interrogation of published raft proteomics 
datasets modelling cancer progression in renal cancer, breast cancer and melanoma 
revealed increased association of cytoskeletal proteins with the lipid raft in aggressive 
tumours. Previous results of ectopic expression of tumour suppressor PTRF in prostate 
cancer showed attenuation of raft-cytoskeleton interactions. In this thesis, my analysis of 
quantitative lipid raft proteomics datasets of unrelated tumor suppressor OPCML in 
ovarian cancer showed that the presence of the tumor suppressors in the lipid raft 
compartment leads to depletion of cytoskeletal components. These results strongly 
indicate that the unifying interplay of membrane raft and cytoskeleton assembly occur 
during neoplastic progression and is a reversible phenomenon. This chapter therefore 
demonstrates the utility of the integrative computational analysis of proteomics studies to 
characterise protein expression signatures in the lipid raft common across different cancer.  
In conclusion, the research work presented in this thesis made substantial contribution 
towards characterising and understanding lipid raft proteome in physiological and cancer 
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progression and provided foundation for further computational and experimental analysis 
of protein components in these fascinating membrane microdomains. 
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1. Chapter 1: Introduction 
1.1 Biological membranes 
Biological membranes are ubiquitous and one of the most fascinating features of the life 
on earth. All living beings, except some viruses, depend in one way or another on 
membranes. In fact, the term “cells”, coined by the famous microscopist Robert Hooke in 
1665, was based on his observation of tiny box-shaped compartments (cell walls) of cork 
tissue under the microscope. It took almost two centuries for a Swiss botanist Karl Nageli 
(1855) to call the thin cellular boundary as “plasma membrane”. These complex structures 
of lipids, carbohydrates and proteins surround cells and separate cellular contents from the 
external environment. In early 20th century the function of cell walls to transport material 
and response to external osmosis was began to unravel. During the same period, 
researchers have also proposed number of different theoretical models explaining 
formation, structure and functions of the cell membrane. Gorter and Grendel (1925), 
discovered the barrier surrounding the cell was in the form of a bilayer lipids. A decade 
later, Davson and Danielli proposed a rather less convincing theory that bilayer of lipids 
were coated by the layer of globular proteins that assists the cellular adsorption. However, 
in 1972, Singer and Nicolson proposed a well-accepted fluid mosaic model for defining 
membrane structure in which like a mosaic; globular proteins are floating on the sea of 
lipid bilayer. They described cell membrane as a matrix of a phospholipids bilayer with 
embedded integral membrane proteins and glycoproteins undergoing dynamic 
rearrangements via Brownian motion1. This membrane hypothesis proved to be a very 
useful in explaining many, but not all, processes occurring in the membrane2. Research in 
the past four decades has produced a substantial amount of evidences that improved our 
understanding of the structural organization and functioning of bio-membranes. Emphasis 
has now shifted from fluidity to mosaicism, i.e. formation of both small as well as large-
scale clusters due to segregation of specific repertoire of membrane proteins and lipids2. 
At the same time, information from observations of live cells and model membranes 
indicated the existence of heterogeneity in the membrane in the form of liquid-disordered 
and liquid-ordered phases3-4.  
In the late 20th and throughout the 21st century, many different roles of lipid bilayer have 
emerged. Apart from their implication in providing structural rigidity to cell, membranes 
also have impact on cellular communication, transport of diverse micro and 
macromolecules, creating physical barrier, maintenance of cellular homeostasis and many 
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more cellular processes. In higher life forms, besides plasma membrane, internal 
membranes are also present in cells. These internal membranes give rise to 
compartments in the cell, which we now know as organelles. Intracellular membranes of 
subcellular organelles like mitochondria, nucleus, Golgi bodies & endoplasmic reticulum 
encase distinct protein entities and assist specific organelle related functions. This 
separation distinguishes organelles from cytoplasmic fluid and is particularly advantageous 
in fine tuning of several cellular processes. Interestingly, a pioneer work of Simons, Van 
Meer, and Ikonen5-6 revealed the existence of sub-compartments on the cell surface, 
organised by cholesterol and sphingolipids that led to conceptualisation of functional 
microdomains called lipid rafts.   
1.2 Lipid rafts concept: size, life span and shape 
The observation of asymmetric distribution of certain lipid entities in the membrane bilayer, 
forming a specialised lipid domains, served as a foundation of lipid raft hypothesis more 
than fifteen years ago7. Later, these of dynamic cell surface assemblies were reported to 
be enriched with sphingolipids and cholesterol5. The phenomenon of membrane 
organisation came into light during studies focused on understanding epithelial cell polarity 
where apical surface was enriched with glycol-sphingolipids compared to lateral cell 
surface5. Lateral segregations of lipids offers membrane capacity to undergo phase 
separation into densely packed liquid ordered (Lo) and loosely packed liquid disorder (Ld) 
phase. A substantial fraction of cell membrane consists of phospholipids made from 
unsaturated fatty acyl chains is more fluid, resembling the Ld phase
8. On the other hand, 
lipid micro-domains arise due to higher affinity of cholesterol towards saturated lipids like 
sphingomyelin, belong to Lo phase and given a descriptive name “lipid rafts”. Importantly, a 
number of integral and peripheral proteins are believed to be targeted and house in these 
microdomains.  
Results from in vivo studies on lipid rafts indicate the existence of lateral membrane 
heterogeneity, which eventually led to a notion that these are fluctuating nanoscale 
assemblies of sphingolipids, cholesterol, and proteins. The size and life span of lipid raft 
varies in plasma membrane and the stability is directly proportional to size. These 
structures can be stabilized to form as specialized cargoes that coordinate biological 
processes like membrane trafficking and cell signalling. Raft stability is thought to be 
regulated by complex lipid-lipid, protein-lipid and protein-protein interactions between the 
raft proteins and the saturated lipid anchors9.  
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The resting state rafts are nanoscale regions of sterol- and sphingolipid together with GPI-
anchored proteins, certain transmembrane proteins, acylated cytosolic effectors, and 
cortical actin molecules (Figure 1.1a). In response to external or internal signals, these 
nanoscale structures can be merge into more ordered assemblage called raft platforms 
that are difficult to visualize under optical microscope (Figure 1.1b). However, these 
platforms could still mediate processes like membrane trafficking and cell signalling. 
Protein post-translational modifications such as phosphorylation may trigger protein–
protein interactions, aggregation of raft lipids leading to the integration of raft platforms into 
raft phases (Figure 1.1c) which can be easily visualized under the microscope10-11. 
 
Figure 1.1: Lipid raft membrane heterogeneity and shape (a) Nanoscale plasma 
membrane compartments of cholesterol, sphingolipids and proteins (b) Formation of raft 
platforms in response to external stimulus or internal triggers (c) Equilibration of number of 
raft platforms can induce raft phases which are micrometre in size (d) The structure of 
planar raft with cholesterol, sphingolipids and an adaptor protein Flotillin. (e) A flask 
shaped membrane invagination called caveolae formed by a cholesterol binding protein 
caveolin-1. Adapted from Simons et al.12 and Lisanti et al.13 
Direct evidence for the existence of dynamic raft-based membrane heterogeneity in the 
plasma membrane was demonstrated from investigations on T-cells. Upon T-cell 
activation, lipid raft components are selectively immobilized in nanoscale clusters together 
with specific receptors, indicating heterogeneity of lipid rafts14-15. Enrichment with 
sphingolipid-cholesterol provides membranes a potential to undergo lateral segregation. 
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(Figure 1.1c). This cholesterol-dependent coalescence is considered vital for selectively 
partition proteins and lipids to the lipid rafts according to their raftophilic potential. This 
underscores inherent capability of the plasma membrane to be selectively stimulated to 
generate heterogeneity in the membrane structure and function by preferential interactions 
between proteins and lipids to form lipid rafts16.  
Morphologically lipid rafts can be divided into two distinct subtypes: (i) linear rafts (Figure 
1.1d) and (ii) a flask shape membrane invagination called caveolae (Figure 1.1e). 
Caveolae are 60-80nm wide plasma membrane pits rich in sphingolipids and cholesterol 
and are often considered as an important subclass of lipid rafts17-18. The formation of 
caveolae is regulated by proteins of the caveolin and cavin families19-20. They can respond 
to plasma membrane stresses and external stimuli and therefore considered as sensors of 
plasma membrane. A close association is found between caveolae dysfunction and 
diseases, such as muscular dystrophies and cancer. This highlights the significance of 
caveolae as a protector and organizer of plasma membrane. Collectively, both caveolae 
and non-caveolar rafts are involved in myriad of physiological and pathological conditions, 
which are discussed in detail in the section 1.5 of this chapter. 
1.3 Lipid raft composition 
Distinct physical and chemical composition of lipid and protein molecules in the lipid rafts 
contributes to lateral selection in bilayer and likely bestow specific lipid-lipid and protein-
lipid interactions. Lipid rafts are predominantly enriched with the discrete class of lipid 
species: sphingolipids and cholesterol. In contrast to most membrane lipids that have a 
polar head and two fatty acid chains; cholesterol has a unique four-ring structure that 
offers special biophysical properties (Figure 1.2 a, b). Cholesterol helps in separating 
phospholipid molecules, decreases stearic hindrance between fatty acid chains and 
prevent their crystalisation21. At the same time, the rigid sterol backbone of cholesterol 
favourably orient itself adjacent to longer hydrocarbon chains of saturated phospholipids 
with its polar hydroxyl group positioned near polar head of phospholipids (Figure 1.2c). 
This preferential phospholipid-cholesterol interaction reduces membrane permeability of 
small polar molecules and in turn adds firmness to the membrane. As fatty acid side 
chains are longer for saturated (straight-chain) phospholipids, their clustering with the help 
of cholesterol makes the part of membrane thicker compared to surrounding, giving rise to 
specialised cholesterol-rich sub-compartments i.e. “lipid-rafts”. 
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Figure 1.2: The structure and interaction of cholesterol with membrane lipids. (A) 
The unique chemical structure of cholesterol with hydrophilic and hydrophobic regions. (B) 
The asymmetric cis-conformation of endogenous cholesterol with a smooth alpha face and 
a 'rough' face due the projection of methyl groups at carbon number 10 and 13. (C) The 
interaction of cholesterol (Chol) with sphingomyelin (SM), catalysed by the formation of a 
hydrogen bond (H bond) between the hydroxy group (OH) of cholesterol and the amino 
group (NH) of the sphingolipid. The H bond restricts cholesterol movement with the alpha 
face towards aliphatic fatty acid chain of lipid molecule and the β face remains available for 
binding to transmembrane domains of protein. Partly adopted from Fantini et al. 22  
Interaction of saturated acyl chains of sphingolipids, which are predominantly found on 
outer leaflet, with cholesterol is thermodynamically favourable over unsaturated 
analogues23. This is highlighted by similar arrangements seen with the liquid-ordered state 
in the synthetic model membranes24. Composition of the inner leaflet is not as well 
characterised and how inner and outer leaflets cross-talk with each other is unclear. It 
might be possible that long acyl chains of sphingolipids in the outer leaflet as well as 
transmembrane proteins could stabilize coupling of both leaflets8. Similarly, at the cell 
surface, cholesterol interacts with other membrane lipids as well as with specific 
membrane proteins. Cholesterol binds with certain proteins and assist in stabilising their 
membrane conformation and proper functioning. Moreover, after partitioning to the rafts, 
proteins might undergo conformational changes that modify their activity, which is critical 
to precisely orchestrate various cellular processes.  
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Lipid rafts dynamically harbour specialized proteins with varying degree of affinity to assist 
number of cellular processes. The association of proteins to the lipid rafts is speculated to 
have a varying degree of kinetics and partition coefficient25. Lipid raft associated proteins 
include glycosylphosphatidylinositol (GPI)-anchored proteins26-27, protein kinases of Src-
family, transmembrane subunits of G-proteins28, palmitoylated proteins and cholesterol 
binding proteins such as Hedgehog29. Proteins with hydrophobic modifications as well as 
GPI-anchors predominantly associated with the rafts, potentially due to hydrophobic 
attractions. Although molecular mechanism driving transmembrane protein partitioning to 
rafts is not yet clear, mutational analysis suggested importance of specific patterns of 
amino acid residues in the alpha helix closer to the exoplasmic leaflet30. Also lipid rafts are 
thought to be thicker, compared to its surrounding non-raft cell surface; owing to 
partitioning of proteins with larger transmembrane domains to the rafts30. Post-translational 
lipid modifications like palmitoylation were considered as one of the important 
determinants of protein’s raft localisation31. Similarly, monomeric and oligomeric state of 
proteins can also affect their raft localization32. It is likely that the separate rafts can cluster 
together to trigger signalling events, rendering proteins to a distinct environment, enriched 
in molecules of signalling machinery. Additionally, it is observed that small alterations in 
protein composition of lipid raft could lead to initialization and/or amplification of signalling 
cascades. This advocates the involvement of protein molecules as a key player in 
regulating functions of lipid rafts. Figure 1.3 describes proposed cartoon representation of 
lipid raft (along with protein and lipid components) on the cell membrane.  
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Figure 1.3: Stylized diagram describing the proposed structure and composition of 
lipid raft. Selective enrichment of cholesterol and sphingolipids in the lipid rafts imparts 
firmness and thickness to these membrane regions, crucial for portioning of 
transmembrane, GPI anchored and acylated proteins.  
1.4 Raft dependent cellular functions 
Many diverse roles of the cholesterol-rich membrane microdomains have emerged over 
the years as our understanding regarding these domains became clearer and are 
highlighted in Table 1.1. A most widely studied function of lipid rafts is to offer a discrete 
environment for signalling molecules such as receptors, members of the Src family 
tyrosine kinases, G-proteins, small GTPases and therefore regulate downstream 
pathways. Activation of many receptors is not only regulated by binding of specific ligand 
but also influenced by their spatial confinement to the membrane micro-domains. 
Observations from T-cell signalling suggested that, for raft association is critical for 
receptors and many signalling molecules to perform their function33-34. Likewise, Irwin and 
colleagues showed that, raft localization of EGFR is essential for activation of Akt 
signalling in the absence of EGFR kinase activity35. Raft invaginations caveolae and planar 
lipid rafts are considered to be membrane organisers in cancer signalling and their role 
has been extensively reviewed recently36. A family of seven transmembrane helix 
containing G-protein coupled receptors, a target of around 70% of all pharmaceutical 
agents, is also localised and function through lipid raft microdomains37. 
Occurrence of several transporter proteins in lipid raft brought to fore a role for lipid rafts in 
the uptake of essential nutrients, such as glucose38 via glucose transporter GLUT4 and 
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long chain fatty acids39-40, inside the cell. Cellular transporter proteins play essential part in 
the elimination of drug molecules. ABC transporter family multi drug resistant proteins P-
glycoprotein (Pgp)41 and multidrug resistant related protein 1 (MRP1)42 show preferential 
association with lipid rafts. Therefore, lipid raft could also regulate drug efflux and could be 
crucial for multi-drug resistant cells. Growing evidences indicate the clustering of some ion 
channels within lipid rafts in neurons, and thereby able to orchestrate their function. These 
channels include, voltage gated sodium43, potassium44 and calcium channels45, ligand-
gated ion channels as well as several Transient Receptor Potential (TRP) Channels46.  
Lipid rafts are considered as a sorting platforms involved in targeted membrane trafficking 
of various proteins. A recent review by Diaz-Rohrer and colleagues47, summarises how 
this sorting machinery utilise number of organelles. Earlier evidences came from studies 
on apical sorting signals such as GPI anchoring26. More recent findings suggest that the 
oligomerization and apical sorting GPI-anchored proteins mediated by a lipid raft-
associated glycosylate moieties and not just depend on their N- or O-glycosylation48. 
Klemm et al.49, demonstrated that rafts are directly involved in transfer of newly 
synthesized proteins from the Trans-Golgi network to the cell surface. The presence of 
raft-like membranes on secreted extracellular vesicles called exosomes, indicate the 
involvement of rafts in sorting and release of exosomes from cell surface50. Disruption of 
protein molecules like MYC1 has been associated with impaired lipid raft integrity and lead 
to subsequent activation of the autophagy pathway51. Another intriguing observation, is the 
sorting of lipid and proteins via lipid raft associated endocytic pathways52. Raft mediated 
endocytosis is considered as a common mechanism for pathogen entry53 and recycling of 
receptor bound surface ligands53-54. These clathrin-independent endocytic pathways were 
thought to be regulated by caveolae and by non-caveolar lipid raft carriers55. 
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Table 1.1 Lipid raft regulated cellular processes and related implication in diseases after 
raft disruption 
Cellular process Involving Protein Consequences 
Signalling EGFR Prostate cancer56 and 
Breast cancer35 
H-RAS Nanocluster formation57-58 
Integrin Hyper motility of 
Fibrobrast59 and Blood flow 
sensing by endothelial 
cells60. 
eNOS Vascular dilation and 
constriction regulation61 
Insulin Receptor Diabetese62 
T-cell receptor Immune response63 
B-cell receptor Immune response64 
Ephrin receptors Cancer65 
Hedgehog Embryonic development66 
Bacterial or viral entry Gag protein  HIV Infection67 
Annexin A2  Hepatitis C Infection68 
JEV glycoprotein Encephalitis Infection69 
HA protein  Influenza Infection70 
PIP 2 protein Malaria Infection71 
Receptor recycling and 
membrane trafficking  
FGFR Ligand receptor complex 
confinement72 
EGFR Prevent degradation73 
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HER2/ERBB2 Promote degradation 
Endocytosis Caveoline-1 Exosome uptake74 
Adenylyl cyclase TLR4 signalling75 
Cell Adhesion OPCML Tumor suppression and 
receptor recyclling76 
FAK and integrin beta 1 Integrin signalling77 
CD44 Glioma cell adhesion78 
Drug efflux MRP1/ P-glycoprotein Drug efflux79 
BCRP/ABCG2 Xenobiotic efflux80 
Ion transport Sodium channels Axon fuctioning43 
Kv1, Kv2 and Kv4 potassium 
channels 
Heart functioning81 
Voltage gated calcium 
channels 
Neuronal function45 
1.5 Role of lipid rafts in health and diseases 
The year 2015 marked the hundredth anniversary of discovery of cholesterol by the 
French chemist Michel Chevreul from human gallstones82. Since its discovery, substantial 
evidences linked cholesterol with pathogenesis of variety of disorders including a well-
established involvement in cardiovascular complications83-84. An elevated level of 
cholesterol in blood stream in multiple clinical studies has been found in people with 
obesity85-87. Obesity is considered as a lifestyle disorder that currently has ever-increasing 
incidences in the world. Cholesterol is one of the major components of lipoprotein particles 
in serum: low density lipoprotein (LDL) and high density lipoprotein (HDL). Since last three 
decades a number of studies have associated higher level of LDL cholesterol in serum as 
a risk factors for heart diseases88-89, stroke90 and type-2 diabetes91. Recently neurological 
disorders like Parkinson’s disease92 and cerebral amyloidosis93 have been associated with 
increased serum cholesterol level. Increased concentrations of body cholesterol gets 
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deposited in various tissue compartments and ultimately in the cells. The irregular 
accumulation cholesterol subsequently in membrane rafts creates abnormalities in protein 
or lipid composition of rafts. Alterations in membrane microdomains have been reported in 
many disorders over the years. Due to their apparent importance as a signalling and 
sorting platform, membrane rafts have been studied in several tumours, including 
prostate56, 94-95, breast96-97, lung98 and colon cancer99-100. Likewise, these specialized 
membrane domains are implicated in pathological conditions such as Alzheimer’s, 
Parkinson’s, prion and cardiovascular disorders and HIV etc. As a result, rafts are 
proposed to be an interesting target to cure or prevent these disorders. In the following 
sections, I summarised some recent findings advocating involvement of membrane rafts in 
different diseases, but the main focus of this thesis is to evaluate the role of membrane 
microdomains in various cancers. 
1.5.1 Lipid rafts and cancer 
Cancer is a group of diseases, characterized by dysregulated balance between survival 
and cell death, having cellular population with characteristic invasiveness, proliferation & 
differentiation rate, adhesiveness and in some cases metastatic potential101. Several 
factors contribute to tight synchronization of these processes in tumor cells. Aberrant 
signalling and membrane trafficking events are some of the factors that results in tumor 
progression and oncogenesis102. 
Evidences from in vivo studies have emphasized the involvement of cholesterol in tumor 
development and proliferation. The use of cholesterol-lowering drugs such as statins have 
demonstrated clinical benefits in prolonging survival rate of cancer patients103. Animals fed 
with high-fat diet exhibited increased angiogenesis that accelerated growth of breast 
tumours104. A mevalonate pathway inhibitor Simvastatin have shown to reduce tumor 
burden and metastasis in ovarian cancer mouse model105. Similarly, diet-induced 
hypocholesteremia in mice have shown to promote androgen independent prostate tumor 
metastasis potentially via modulating composition of lipid rafts106.  
In the past few decades, researchers have reported functional association of several 
growth and death receptors, adhesion molecules and signalling proteins to the lipid rafts of 
various tumor types. Zhuang and colleagues have demonstrated ligand mediated 
activation of EGFR signalling pathway functions through lipid rafts in caveolin-1-/- prostate 
cancer cell line56. Increased levels of EGFR in raft fraction were associated with 
development of genfitinib resistance by breast cancer cells. Subsequent lipid raft 
disruption with lovastatin, sensitized resistant tumor cells to EGFR kinase inhibition35. Irwin 
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et al. further reported the co-localization of c-Src kinase with EGFR in the lipid rafts of 
breast cancer cells indicating the presence of signalling complex at raft domain107. Lipid 
raft plays an important role in controlling distribution and abundance of different receptor 
tyrosine kinases (RTKs) such as EPHB2 and FGFR. This spatial alteration of RTKs may 
affect the response of cancer cells to RTK inhibitors and likely to promote 
tumorigenicity108.  
Invasiveness and metastatic potential of tumor cells were also indicated to be raft 
dependent. In breast cancer cells, raft associated GPI anchored protein CD24 can induce 
c-Src signalling promoting the formation of focal adhesion complexes, integrin-dependent 
cell- adhesion and tumor invasion109. Lipid raft promotes interaction between CD44 and 
Ezrin and thereby influence cell migration in breast cancer97. The lipid raft proteins uPAR 
and MMP-9, play critical roles in tumor invasion, migration and angiogenesis. These 
proteins have been reported to be highly expressed in high-grade tumor samples of 
breast, prostate and astrocytomas110-112. Lipid raft promote formation of SK3–Orai1 
complex, which is essential for migratory phenotype in breast cancer cells. The treatment 
with alkyl-lipid ohmline impairs lipid raft localization of SK3–Orai1complex and 
subsequently migration and bone metastasis of cancer cells113. 
Membrane raft can modulate both pro- or anti-apoptotic signalling pathways. 
Pharmacological activation of liver X receptor (LXR), a cellular cholesterol modulator, 
induces apoptosis in LNCaP cells by raft disruption and thereby inhibition of Akt dependent 
survival pathway114. Moreover, data from quantitative proteomic experiments suggested 
that, anti-leukemic activity of alkyl-phospholipids and arsenic trioxide to be raft dependent 
and mediated by linker for activation of T-cell family member 2 (LAT2) by modulating Akt 
signalling115. In contrast, raft stabilization is essential for recruitment of death receptors on 
the cell. Antitumor lipids such edelfosine and perifosine have shown to act by interacting 
with membrane raft to trigger apoptosis, mainly by recruiting death receptors like 
Fas/CD95 to raft that forms the death-inducing signalling complex (DISC) and activates 
caspase-8 in multiple myloma116. Hence, the use of antitumor lipids has been proposed as 
an alternative strategy for therapeutic intervention in cancer117-118.  
Lipid rafts have portrayed as a membrane cargoes that bear various tumor suppressing or 
tumor promoter proteins. An ovarian cancer tumor suppressor Opioid-binding Protein/Cell-
adhesion Molecule (OPCML) was found to be associated with lipid rafts119. OPCML was 
reported to negatively regulate a subset of RTKS by promoting the ubiquitin-mediated 
degradation by sequestering them to lipid rafts119. Similarly, a raft associated tumor 
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suppressor PTRF has been shown to reduce the in vitro and in vivo tumor growth of 
prostate cancer19-20. On the other hand, prostate cancer oncogenes caveolin-1 was shown 
to promote neoplastic progression through planar lipid rafts120. Collectively, substantial 
evidences, presented here, indicate key role of lipid rafts in several cancer related 
processes. 
1.5.2 Lipid rafts and other diseases 
Apart from cancer, membrane microdomains are extensively studied for their role 
neurodegenerative disorders. For instance, in Alzheimer’s disease, abrupt changes in lipid 
raft content of cholesterol and ganglioside contributes to the formation the neurotoxic form 
the amyloid-beta protein (Aβ), one of the major etiological factors of disease progression. 
These amyloid fibrils further reported to induce abnormal stabilization of GM1-rafts121-122. 
Composition of lipid rafts is significantly affected at an early and incidental stage of 
Parkinson’s disease123. Rafts also provide a favourable environment for surface 
localization and transformation of cellular prion protein into its pathological isoform in prion 
diseases124-126. Growing evidence indicates that the host cell membrane lipid rafts can be 
targeted by different pathogens, including viruses, bacteria, or parasites. Pathogens use 
lipid and/or protein component of rafts to bind and to enter the host cell. Lipid rafts serve 
as a platform for bacterial adhesion to cell surface, and in turn facilitate their entry inside 
the cell. Moreover, activation of signalling cascade by bacterial toxins such as cholera 
toxin beta subunit was supposed to be mediated through lipid rafts127. Some viruses, for 
example HIV-1 and influenza use lipid rafts for harbouring the host membrane. They can 
also acquire lipid raft domain as their membrane envelop at the time of budding out of host 
cell124-125, 128-129. The infection of human erythrocytes by malaria parasite Plasmodium 
falciparum is dependent on protein associated with lipid-rafts130-131. Several potassium 
channels like Kv1, Kv2 and Kv4 are associate with caveolae and non-caveolae rafts that 
regulate membrane potential of heart, and their disruption could lead to hypertension, 
ischemia and heart failure81. Furthermore, Lipid raft can be involve in formation of redox 
signalling platform to amplify oxidative stress signal and thus involved in development of 
cardiovascular disorders132-133. 
1.6 Controversies surrounding the raft hypothesis 
After emergence of lipid raft concept, several theories for formation, function, structure and 
organization of rafts were postulated based on reports from both model membrane as well 
as living cells. Broadly, there are two schools of thoughts supporting either a lipid-driven or 
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a protein-driven mechanism for formation and stabilisation of lipid raft assemblies. Early 
model was proposed by the Anderson and Jacobson134 called lipid shell model, suggesting 
the role of lipid shells, a complex assembly of protein, carbohydrates and raftophilic lipids 
in the formation of caveolae and planar rafts. However, this model was criticized24 because 
it was unable to demonstrate strong association required between the shell lipids and the 
anchor of membrane protein. Moreover, the concept of lipid shells as a solvable shell 
around the raft protein contradicts with their ability to associate with pre-existing larger lipid 
domains. Next, the actively generated raft model was suggested by the work of Mayor et 
al.135-136 while studying nanoscale GPI-anchored protein assemblies on the cell surface. 
These cholesterol-dependent GPI-protein clusters bring diverse protein molecules together 
in a close proximity to serve as membrane sorting and signalling zones. These small 
membrane structures have an ability to actively converge into larger domains to induce 
discrete raft functions. The critical examination of diffusion behaviour of transmembrane 
proteins indicated the existence of control cytoskeletal system that imposes a non-specific 
barrier, which latter called as a cytoskeletal fence model137. This protein-centric model of 
lipid raft formation was first postulated by Kususmi et al.138-139, where sub-
compartmentalisation within the cell surface as a consequence of anchoring of 
transmembrane proteins to the cytoskeleton network like a picket fence. This picked fence 
restricts long-range diffusion of lipid molecules and imparts special physicochemical 
properties to this compartment, distinct from surrounding membranes. This model hints at 
the possible existence of lipid rafts in the cytoplasmic leaflet and probable cross-talk 
between outer and inner leaflet-rafts. A refined lipid raft model, now well-accepted in the 
scientific community, is conceptualisation of lipid raft as dynamic nanoscale structures 
(Figure 1.1 a, b, c) that I explained in the previous section 1.2 of this chapter.  
Despite the logical advantages of lipid raft mediated compartmentalisation to many cellular 
processes, the basic hypothesis of occurrence of stable lipid raft has been under 
scrutiny140. The debate about whether rafts are elusive or illusive is mostly due to lack of 
methodologies, which will directly assess these assemblies. Although cellular cholesterol 
and sphingolipid levels clearly influence protein function, the argument relates to the 
proposed lipid-modulated protein function with the absence of raftophilic lipid-rich domains 
in fibroblasts141. Resistance of sphingolipid, cholesterol, and some membrane proteins to 
extraction with non-ionic detergents142 or mechanical disruption143 has been widely used 
as an index to illustrate raft association. But these detergent extraction procedures were 
considered to produce artefactual observations141. Though the acquire resistance and 
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cholesterol dependence illustrates physiological properties of lipid rafts but composition of 
native rafts on living cell was questionable in early days144. Another key issue revolved 
around the direct visualization of lipid rafts on intact cells. Specialized membrane domains 
(very large assemblies) like lipid raft phases (Figure 1.1c), after cross-linking with 
exogenous ligand and caveolae have been studied using various imaging techniques. 
However, the resolution range of light microscopy made it difficult to visualize structures 
such as resting rafts (Figure 1.1a) and lipid raft platforms (Figure 1.1b)145. Moreover, 
technologies like fluorescence recovery after photo-bleaching (FRAP) and Förster 
resonance energy transfer (FRET), reported ambiguous results causing scepticism about 
the raft concept. These studies also highlighted the issue surrounding constituents to be 
called as universal raft markers. All these scrutinies have stimulated the research 
community for newer approaches to study the behaviour of small-scale raft domains. 
Because of that, in past few years, number of specialised microscopic techniques146-150 
enabled visualisation of membrane microdomains in biological context provided very 
strong evidence of the existence of lipid rafts.  
1.7 Methods to study rafts 
1.7.1 Microscopic techniques 
Based on experimental evidences, rafts are defined as small (10–200 nm), 
heterogeneous, highly dynamic, sterol- and sphingolipid-enriched domains that 
compartmentalize cellular processes151. Through complex protein-lipid interplay, smaller 
rafts sometimes stabilised to induce larger platforms. There was a long concern about 
visualization of rafts on the living cell. Earlier, the limited resolution of optical microscopy 
was not capable to visualise lipid rafts. But recent advances in microscopic techniques 
now provide an opportunity to explore regions below 200 nm. A number of high-resolution 
techniques have now been applied to characterise nanoscale rearrangements within cell 
membrane. Some notable methods reporting existence of lipid domains by live cell 
imaging include immune-electron microscopy152 photo activated localized microscopy 
(PALM), stimulated emission depletion (STED), direct stochastic optical reconstruction 
microscopy (dSTORM)150, structured illumination microscopy (SIM)153, single molecule 
microscopy154-155. During the same time, new fluorescent probes for membrane raft 
research have been generated. Molecular probes make it possible to visualize lipid 
nanostructures under optical microscope. These probes can broadly be classified in of the 
three main classes. The first class consists of probes that specifically label lipid 
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components of the membrane, including gangliosides or cholesterol. Probes that rely on 
the selective partitioning of the dyes to either Lo or Ld phases forms the second class. 
Finally, environment-sensitive probes which can directly distinguish Lo and Ld phases due 
to differences in their intrinsic properties. However, all of the probes described so far have 
some limitations to their use156.  
1.7.2 Biochemical extraction 
Owing to their simplicity and relatively easy procedures, biochemical methods are popular 
to study raft association of proteins by harnessing their property to resist solubilisation in 
non-ionic detergents142. These fractions are therefore called Detergent-resistant 
membranes (DRM). Raft constituents (protein and lipids) remain insoluble after detergent 
treatment at cold condition and purified using the density gradient created by sucrose 
solution as floating fractions. Non-ionic detergent Triton-X-100 has been extensively used 
for the raft purification, but the use of other detergents like Brij96, Brij35, CHAPS and 
Triton-X-114 has also been mentioned in the literature. However, different detergent and 
experimental conditions have shown to identify slightly different raft proteins. Latter, 
detergent free methods were proposed that used mechanical disruption143 or pH/carbonate 
resistance157. Additionally, affinity purification is also utilised to characterise raft 
components. Targeting putative raft lipids like GM1 or toxins like Cholera toxin B were 
used to purify raft fraction158. Manipulation of raft lipid structure by chemical agents that 
modulate either cellular cholesterol or sphingolipid has proven to be useful in raft research 
field159. Extraction of raft specific lipids, disrupts association of proteins from raft and been 
considered as a ‘gold standard method’ to detect native raft proteins. The pros and cons of 
individual bio-analytical methods have been summarised in Table 1.2.  
Table 1.2 A summary of biochemical techniques to identify raft components adopted from 
Simons et al. 8 
Method Characterisation Live 
Cells 
Remarks References 
DRM fractionation 
and density 
gradient 
Detection of 
putative raft 
proteins and their 
potential raft 
association 
No  Most common method 
to characterised raft 
components 
  Ease of use 
 Artefactual in nature 
160 
Affinity purification Isolation of 
putative raft-
No  Ease of use 
 Relatively common 
158 
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localised proteins  Capable to detect 
weak raft association 
 Cell-cell variability 
makes quantitation 
difficult 
Chemical 
perturbation 
Native lipid raft 
proteins 
identification 
Yes  Variable findings with 
change in condition 
and/or suitable agent 
 Straightforward  
157 
1.7.3 High-throughput mass spectrometry based proteomics 
Over the years, lipid rafts have been the focus of research to understand the 
spatiotemporal dynamics of raft proteins and their underlined functions. Raft-resident 
proteins are key players to maintain the structure, activities and interactions in these 
domains. Identification, characterization and quantitation of all or most of the proteins 
therefore considered as critical in understanding functional organization of this complex 
biological system. A comprehensive proteome could guide us about the probable higher 
dimensional (systems-wide) function of the domain in physiological or disease conditions.  
Proteomics is a branch of ‘omics’ that examines proteins within systems. Characterisation 
of spectrum of proteins provide a systemic context to underline biology, rather the looking 
at single protein component161. Proteomics methods are routinely employed to identify 
protein components in a cell, an organelle, or an isolated complex system. Furthermore, it 
is also been utilised to capture protein expression, localization(s), interaction(s), and 
modification(s) and sometimes structural features of proteins. There are number of 
proteomic methodologies like 2D gel electrophoresis, protein microarrays, two hybrid 
analysis and mass spectrometry. Among them, mass-spectrometry has emerged as the 
indispensable tool in analysing the presence and/or function of proteins in biological 
system of interest and widely accepted as a hypothesis-generating platform.  
Lipid rafts have been interrogated in number of different ways using mass-spectrometry 
based proteomics methods. Earlier studies have focused on elucidating protein 
constituents of lipid rafts in different cell types. But in recent years, the field of quantitative 
proteomics has started gaining popularity162 with the ability to detect small changes in 
protein or peptide abundances in response to altered state. It allows differential analysis of 
system of interest, with the use of either metabolic or isotopic labelling of amino acids or 
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label-free approaches. With the application of such methodologies, the complex protein 
landscape of the membrane microdomains along with underlined raft specific 
functionalities has started to be explored163. These proteomics studies tried to understand 
raft associated spatial and temporal dynamics164-166, along with some specialised work 
aimed at characterising post translational modifications of these membrane structures.167 
This highlights enormous potential to uncover novel raft associated functions with careful 
examination of accelerated accumulation large scale proteomics datasets.  
The last two decades have seen tremendous advancements in the mass spectrometric 
based proteomic characterisation. While working on my PhD, in 2014, couple of seminal 
papers came out in Nature describing mass-spectrometry based drafts of human 
proteome. Kim and co-workers168 carried out proteomics profiling of 30 normal tissue type 
and provided a comprehensive map of human proteome by identifying of 17,294 proteins 
(84% of the human protein coding gene) using furrier transformed mass spectrometry. On 
the other hand, Wilhelm et al.169, reported LC-MS/MS evidence for 18,097 human proteins 
covering 92% of SwissProt human proteome. Their efforts also led to detection of sixteen 
thousand isoforms. Later on, a global analysis of tissue-based profiling of human proteome 
by antibody approach demonstrated protein localisation and their expression profiles of 
90% of protein coding genes in the various tissues of the body170. Interestingly, all these 
investigations are supported by the state of the art computational architectures like 
ProteomeDB, http://www.humanproteomemap.org and Human protein Atlas that enabled 
sharing, analysis, visualisation and re-use of this massive scale of proteomics data to the 
global scientific community. Similar efforts have also been made by the initiatives like 
human protein reference database171, plasma proteome database172, nextProt173, Peptide 
atlas174, PRIDE175 etc. to store, organise, share and provide access to targeted and short-
gun proteomics datasets. All the above examples signify the importance of computational 
architecture and downstream analysis of proteomics data to provide valuable insights 
about underlyned biology.  
1.8 Databases in biomedical research 
In this big-data era, the amount to biological data generated by genomics, proteomics and 
other –“omics” tools is growing faster than our capability to analyse them. Organizing this 
large scale data in a structured framework is therefore crucial in modern biology and has 
great impact in biomedical research. This is where public databases come in picture to fill 
this gap. These online repositories store, organise and make the molecular data 
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accessible to global life scientist community. Databases offer a mean to automate complex 
search and analysis tasks of organized molecular data and help to create a wider 
realisation of future research. Two main objectives fulfil by databases and related services 
are: verification of existing results and discovery new knowledge. The wealth of 
information provided by the databases permits users to verify or compare their hypothesis 
or results with already existing knowledge base. They can also offer an opportunity to 
discover novel patterns in the data and add value if the existing data is re-analysed in the 
light of new knowledge. Plethora of biological databases provided useful contributions in 
annotation, structural modelling, functional characterization and analysis of disease 
phenotype in biomedical area. They are also good source of information about 
heterogeneity of data source, complexity of the biological data and experimental 
procedures used to generate the results. A recent report suggests that the molecular data 
and services hosted at EMBL-European Bioinformatics Institute alone contribute to future 
research impacts worth £920 million every year underscoring the value and impact of open 
data in the life sciences176. 
It came to my realisation, at the start of this project, that though there were more than 100 
subcellular proteomics studies carried out, the molecular data characterising raft-resident 
proteins is dispersed among heterogeneous scientific literature. At that time, there was no 
dedicated infrastructure where one could find all this wealth of information. I presumed a 
single database that consolidates the lipid raft proteomics data and integrates it to a 
powerful query, annotation and analysis platform would greatly facilitate lipid raft research. 
Therefore, as a first step, I proposed to build a dedicated, well-curated online resource for 
lipid raft proteomics studies for the increasingly data-driven scientific community. One of 
the goals of my thesis is to come up with the resource that could permit researcher to 
interrogate complex datasets efficiently saving both time and efforts to search entire 
literature space. This effort of careful data mining and organization of proteomics datasets 
was worth and provided the starting point for more sophisticated downstream in silico 
systems analysis of microdomains.  
1.9 From proteomics datasets to functional proteome 
Proteins, a polymer of amino acids, are central players in almost all the processes 
precisely regulated by the lipid raft. Therefore, understanding the protein constituents that 
regulate spatial and temporal dynamics of microdomains in different cellular events is 
important. Often researchers explore only single or few cell or tissue types during 
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proteomics experiments. We have to remember that, higher organisms including human, 
rely on a co-ordinated system of organs, tissues, cells and molecules to survive. But most 
of the times results from one cell type are extrapolated to infer overall function of the 
system. An integrative analysis combining molecular data with phenotype information is 
therefore critical to uncover hidden pattern in large scale biological datasets. Similar to 
genomics, the field comparative analysis of proteomics data is also gaining popularity168-
169, 177-178 and useful to examine different aspects of proteome of interest. Various 
computational and statistical frameworks allowed us to perform simultaneous analysis of 
multiple proteomics datasets179-182. Furthermore, data-driven research from The Cancer 
Proteome Atlas (TCPA)183 initiative has been aimed to characterised proteomic differences 
among multiple patient tumor samples of breast cancer, colon cancer, ovarian cancer and 
could be utilised as a resource for biomarker discovery184. Clinical utility of proteomics data 
analysis was shown by Rosenberg et al.185 by performing meta-analysis of proteomics 
results of prostate and colon tumours suggested common molecular signatures across 
multiple patient samples. Integrative analysis permits to assess variability and similarities 
between two or more individual experiments. Importantly, statistical toolkits186 and 
computational considerations187 have been proposed for analysing relatively small-scale of 
sub-cellular proteomics datasets are gaining popularity among scientific community.  
Incorporating prior knowledge available in various bioinformatics resources is critical in 
order to capture global consequences of lipid rafts protein composition. Furthermore, 
alterations on cellular function cab be studied using a systems analysis approach. My 
initial finding suggested that many microdomain proteomics studies were either restricted 
to manual interpretation of their results or carried out very preliminary computational 
analysis. At the same time, focused modelling approach considering few molecular 
components has been carried out to gain mechanistic understanding of lipid raft protein 
sorting and dynamics, which is surveyed in the next section. 
1.9.1 Computational studies on lipid rafts 
Dynamic yet highly regulated membrane compartmentalization in the form of lipid rafts 
attracted many researchers to uncover their biological as well as pathological function in 
cells. Although there is a wealth of experimental data ranging from model membranes to in 
vitro and in vivo work is available about lipid rafts; only a handful of computational studies 
were focused on these specialized regions. The in silico work done so far can roughly be 
categorised into two major classes. First class includes the work focused to get 
mechanistic insights into raft functioning with the help of mathematical modelling. Till date, 
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most of the computational studies involving lipid rafts belong to this class. These models 
rely on few experimental observations that were used to build a predictive model of 
underlying biological concept. Iyangar et al. used differential equations to model a spatially 
restricted signalling events taking place at the microdomains188. On the other hand, 
molecular dynamic simulation models looked at the thermodynamic/atomistic changes 
associated with lipid rafts stabilisation with particular focused heavily on lipid-lipid 
interactions189 with inclusion of a single molecule of protein138. Haack et al.190 developed a 
spatial membrane dynamics model to characterise the role of lipid rafts in the binding of 
protein receptor to the lipid bilayer membrane which then extended to Wnt signalling191. 
This mathematical model was concerned with understanding the influence of lipid raft to 
slow down lateral diffusion of transmembrane proteins. Their team also developed a Lipid 
Raft Modelling and simulation tool (LiRAM) plug-in for the modelling and simulation tool 
JAMES II.  
A second class of computational approach involves the use of biological networks to 
understand communications among between a numbers of proteins identified through high 
throughput proteomics. The outcome of this type of analysis provides a systemic overview 
of a system under investigation along with the hypothesis about underlying biology, which 
then can be tested in experimental setup. The only interaction network analysis approach 
used to infer lipid raft function was carried out by Zhang and colleagues192. In this work, 
they overlaid protein annotation of raft localization over the human interactome and 
analysed topological properties of the network. Systematic network characterization of lipid 
raft associated proteins showed that these proteins were central to multiple biological 
functions and concerned with disease development. However, the method used to identify 
localization of proteins is lipid rafts and thereby annotation of the dataset at first place was 
not clear, which raises questions about inference of these results. The question still 
remains about what are all the proteins ever reported to be localised to lipid rafts of human 
origin? Thus, a detailed computational approach coupled with network analysis of large 
lipid raft proteomics datasets could offer substantial possibilities to uncover novel raft 
functions. A typical workflow (Figure 1.4) that can be implemented for systemic analysis of 
proteomics datasets is presented below. 
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Figure 1.4 A workflow of mass spectrometry based data-driven systems analysis. Adapted 
from Inder et al.163 
1.9.2 Need for systems biology 
Comprehensive and large-scale datasets are being generated by emerging high-
throughput techniques nowadays. This poses a new challenge of integration of these 
datasets in order to provide a meaningful biological context to the system under study. 
Currently, many functional proteomics experiments that assess micro-domain functions 
mostly count on manual data interpretation164-165. Even though the work has produced 
important outcomes, they were alone not sufficient to provide systems-wide picture. Some 
of the studies have implemented preliminary bioinformatics approach like pathways193 or 
gene sets194 enrichment analysis. These approaches highlight functions of either over-
represented or under-represented pathways in the experimental results set against the 
relevant background dataset, but still lack the global perspective. Therefore, in this thesis I 
propose application of a detailed systems biology approach to uncover structure and 
function of lipid raft assemblies. Systems biology revolves around capturing fundamental 
understanding of biological system based on underlying network interaction among the 
components. Biological processes are orchestrated through complex networks of 
molecular cross-talks and biochemical reactions which are difficult to infer from current 
molecular biology or biochemistry methods that consider perturbation of single or very few 
components at a time. Omics experiments are capable of capturing hundreds and 
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thousands of data points for molecular signatures, thus network-based methods are 
proposed to estimate the systems-wide impact of perturbations by overlaying molecular 
attributes onto the underlying networks of molecular and biochemical interactions. In this 
thesis, I focused mainly on protein–protein interactions (PPIs) and signalling or metabolic 
pathways, as they are highly appropriate for a systems analysis of functional datasets 
generated by lipid raft proteomics studies.  
Significance of connections among biological molecules at macroscopic level has long 
been recognised in biology and now being formularized at molecular level in post-genomic 
era. The traditional thinking of one gene one disease or phenotype has rapidly being 
turned down by many experimental evidences. A comprehensive understanding of about 
how lipid rafts modulate the cellular processes could be obtained by systematic 
assessment of several cellular proteins in parallel. PPI networks analysis approach could 
be useful to obtain a global representation of heterogeneous lipid raft proteomics in a 
functional context. PPI networks are represented as graphs with proteins as nodes 
interconnected by edges corresponding to direct physical interactions between them. 
Recent reviews in the literature195-196 provides extensive details about best practices in PPI 
network construction and subsequent analysis. Dedicated PPI databases197-200 were built 
to store interaction information emerging from experimental results or mentioned in peer-
reviewed publications. To get a maximum coverage, most of the times information from 
these PPI databases are integrated to build a meta-database using specialized 
bioinformatics platforms201. PPI networks proved to be a valuable tool in characterise 
system-wide effects of molecular or functional perturbation202-203. Network centric 
approaches play a key role in analysing and inferring experimental results to generate 
testable hypothesis. As biological networks are a graphical representation of protein 
interactions, it has number of topological properties. The topographic characterization of 
PPI networks may be used to infer important biological information including the inference 
of protein complexes through the identification of highly connected components or 
modules within networks204-205, dynamic modularity of system206. PPI networks can also be 
integrated with results from high throughput genetic screening to generate signed 
interactions to understand network relationship with phenotype207. In many PPI-based 
network analyses, microarray expression data is overlaid on the network208-209. However, 
the use of protein expression data from quantitative proteomics profiling provides a far 
more accurate representation of underlying biology.  
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In literature, a number of open source as well as commercial tools are available for PPI 
analysis. These resources can be broadly categorized either as knowledge bases, or as 
analytical tools (described in details in Table 1.3).  
Table 1.3 Network analysis resources in systems biology. 
Categories Description Tools 
Knowledge 
based 
resources 
Protein-Protein interaction 
databases 
IntAct200, MINT199, DIP197, STRING210, 
Ingenuity pathway analysis (IPA)211, 
MetaCoreTM and BioGRID198 
Gene regulation database JASPAR212, UniPROBE213 and 
Transfac214 
Pathway databases KEGG215, Reactome216, BioCyc217, 
WikiPathways218, IPA and MetaCoreTM 
Analytical 
tools 
Network analysis Cytoscape219, Pajek220, iGraph221 and 
MATLAB 
Pathway analysis David193, GeneSpring (Agilent 
Technologies), IPA and MetaCoreTM 
In the context to this thesis, I believe powerful proteomic techniques have just started to 
explore the complex dynamics and functions of membrane microdomains. Employing a 
systematic bioinformatics and network analysis approach to lipid raft proteomics datasets 
could decipher global protein landscape and its impact on cellular behaviour. This 
approach is therefore important to understand the effects of lipid rafts on cellular signalling 
and other downstream pathways regulated by membrane microdomains, could provide 
valuable insight into membrane organization, and will be helpful for the future biomedical 
research. 
1.10 Thesis aims and significance  
Cholesterol-rich membrane micro-domains, also known as lipid rafts, are specialized 
assemblies of membrane lipids and proteins that regulate diverse cellular processes. 
Growing evidence suggest their role as signalling and sorting platforms, with specific 
proteins found to be clustered in this compartment. Furthermore, their dysfunction has 
  
 26 
 
been implicated in a range of diseases including cancers, cardiovascular, and 
neurodegenerative diseases. Despite intensive research towards characterising raft 
partitioned proteins and their dynamics at the cell surface, the comprehensive picture 
about raft localised proteins, their molecular function and regulation is still not clear. 
Therefore, this thesis takes a step towards characterising a lipid raft proteome. I 
hypothesize that the utilising a detailed bioinformatics and systems biology approach in 
conjunction with existing wealth of mass-spectrometry bases proteomics data will assist to 
unravel functions of these amazing cholesterol-rich membrane regions in health and 
disease. Based on this working hypothesis, this thesis has following aims. 
(i) To create an open source database for mammalian lipid raft proteome. 
(ii) To gain a detailed structural and functional understanding of the human lipid raft 
proteome using an in silico approach. 
(iii) To uncover lipid raft associated mechanisms during cancer progression by 
performing an integrated analysis of quantitative lipid raft proteomics datasets.  
To characterise a global composition of mammalian lipid raft proteome in multiple cell and 
tissue types, I developed a public resource called “RaftProt” (http://lipid-raft-
database.di.uq.edu.au/) a mammalian lipid raft proteome database (Chapter 2). 
The human raft proteins identified in Aim 1 were utilised to derive intrinsic and extrinsic 
lipid raft proteins based on a number of structural features using a detailed bioinformatics 
analysis. This work was followed by functional enrichment analysis of human lipid raft 
proteome (Chapter 3).  
Chapter 4 is demonstrates the integrative analysis of lipid raft proteome alterations in 
multiple tumor progression and tumor suppression model systems. Analysing in-house and 
published quantitative lipid proteomics datasets (identified through RaftProt), I elucidated 
raft associated mechanisms of malignant transformations and explored a possibility of 
developing a new therapeutic strategies against cancer.  
Collectively, this thesis describes the utility of a systematic bioinformatics approach in 
collection, organisation, and analysis of qualitative and quantitative sub-cellular membrane 
compartment proteomics datasets to gain functional insights of the fascinating cholesterol-
rich membrane microdomains in health and disease. 
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CHAPTER 2 
RAFTPROT: A MAMMALIAN LIPID RAFT 
PROTEOME DATABASE
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2. Chapter 2: RaftProt: A mammalian lipid raft proteome database 
Overview 
Lipid rafts are specialized membrane microdomains enriched in cholesterol and 
sphingolipids thought to act as dynamic signalling and sorting platforms. Given their 
fundamental roles in cellular regulation, there is a plethora of information on the size, 
composition and regulation of these membrane microdomains. Even though a wealth of 
high throughput mass spectrometry studies reported in the literature, the mammalian lipid 
raft proteome is yet to be conclusively identified. To facilitate the mining, analysis and 
integration of lipid raft proteomics studies, I have developed a searchable database 
RaftProt (http://lipid-raft-database.di.uq.edu.au/). RaftProt is the comprehensive inventory 
of mammalian lipid raft associated proteins reported in published lipid raft proteomics 
studies. It has a number of search and browse features to perform queries by protein and 
gene names, searching experiments by cell, tissue, and organisms. Additionally, I have 
implemented several advanced features to facilitate data mining. To address the issue of 
potential bias due to biochemical preparation procedures used, I have captured the lipid 
raft preparation methods and implemented advanced search option for methodology and 
sample treatment conditions, such as cholesterol depletion. Furthermore, I have identified 
a list of high confidence proteins, and enabled searching only from this list of likely bona 
fide lipid raft proteins. Given the apparent biological importance of lipid raft and their 
associated proteins, this database would constitute a key resource for the scientific 
community. A part of this chapter is published in the database issue of the Nucleic Acids 
Research journal (http://nar.oxfordjournals.org/content/43/D1/D335).  
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2.1 Introduction 
Lipid rafts are specialized cholesterol and glycosphingolipid-rich membrane microdomains 
thought to be abundant on most eukaryotic cell surfaces. The concept came into light 
during the study of epithelial cell polarity, where the apical surface was found to be 
enriched with glycosphingolipids5. The physicochemical properties of the lipid raft regions 
resemble to the densely packed liquid order phase (Lo), which is distinct from the loosely 
packed liquid disorder (Ld) phase thought to be represented by the surrounding plasma 
membrane9. Morphologically, these microdomains can be classified as planar rafts or 
flask-shaped invaginations called caveolae and their size and life span found to be varied 
on the plasma membrane. The recent in vivo evidences on the lipid rafts indicate the 
existence of lateral membrane heterogeneity, which eventually led to a notion that these 
are fluctuating nanoscale assemblies. In response to external stimulus or internal events; 
these structures can dynamically stabilized to form specialized platforms to coordinate 
diverse biological processes12. 
Many different roles for these membrane platforms have emerged over the years and 
extensively reviewed in the literature10, 12, 133, 159, 222. The most widely studied function of 
the rafts is compartmentalisation of signalling molecules and receptors and therefore 
regulate downstream pathways8. One potential mechanism for such modulation is the 
coalescing of lipid raft microdomains, bringing into proximity a new repertoire of protein-
protein and protein-lipid interactions223. Moreover, small changes in protein composition of 
lipid raft could lead to initialization and/or amplification of signalling cascades. For 
example, observations from cell signalling studies suggested that raft association is critical 
for receptors and many signalling molecules to perform their function33, 224. The presence 
of several protein transporters as well as drug efflux proteins in lipid raft highlighted roles 
of lipid rafts in the transport of substrates, and exogenous compounds both in and out of 
the cell38-42. Likewise, different pathogens, including viruses and bacteria, use membrane 
lipid raft as a portal to enter the host cell127-128, 225. Growing evidence indicates that lipid 
rafts can act as sorting platforms involved in targeted membrane trafficking of a number of 
proteins. The occurrence of raft-like membranes on secreted extracellular vesicles such as 
exosomes, indicate the involvement of rafts in sorting and release of exosomes from cell 
surface50. Additionally, clathrin-independent endocytic pathways were thought to be 
regulated by caveolae and non-caveolar lipid raft carriers55. 
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Alterations in lipid rafts composition have been observed in many cancers.226 including 
prostate94-95, 227, breast96-97, lung98 and colon cancer99-100. Similarly, these specialized 
membrane domains are also implicated in pathological conditions such as Alzheimer’s121, 
Parkinson’s123, cardiovascular disorders81 and HIV etc.125, 129. As a result, rafts are 
proposed to be a therapeutic target to cure or prevent these disorders.  
Lipid rafts are perhaps the best-studied membrane sub-compartments, although our 
understanding of them is still far from complete. Protein components of these domains 
have a marked impact on their structure, functions and interactions. Identification, 
characterization and quantitation of all or most of the proteins would therefore be critical in 
understanding functional organization of this complex biological system. Due to their 
biological importance, involvement in disease pathologies, and supposed ease of 
purification, lipid rafts have been a very popular target for proteomics studies228. Numerous 
lipid raft proteomics studies capturing both qualitative and quantitative aspects of 
membrane rafts have been published in the past decade with a continuing upwards trend 
as shown in Figure 2.1. These proteomic investigations captured their composition in a 
variety of cell/tissue types, and utilized different biochemical extraction methods to enrich 
membrane raft fraction229. To enable full utilisation of the wealth of published lipid raft 
proteomics datasets, there is a need for a biological database to collate and integrate this 
information. Here I present, for the first time, a dedicated online resource RaftProt, 
comprising of comprehensive collection of searchable lipid raft proteomics studies for the 
researchers. 
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Figure 2.1: Distribution of mammalian lipid raft proteomics studies over the years 
2.2 Materials and Methods 
2.2.1 Literature search, data extraction and processing 
Research publications focused on mass spectrometry based proteomics profiling of lipid 
rafts of mammalian origin was searched using PubMed and Google Scholar. I used 
different search terms like “lipid raft”, “detergent-resistant membrane”, “caveolae” and 
“microdomains”, to query these literature search engines. The protein identifications along 
with their expression values (if mentioned in the article) were recorded and a number of 
experimental parameters were documented. All the proteomics datasets were processed 
by ubiquitous mapping of all the protein identifiers to the UniProtKB accessions using the 
UniProt ID mapping tool or in-house scripts. The annotations about the known subcellular 
localisations of individual proteins were gathered from the UniProtKB (accessed on 
September 20, 2014).  
2.2.2 Development of an online platform 
The online resource is hosted at the Nectar research cloud infrastructure supported by the 
Australian government. The web platform was deployed on the Apache server (version 
2.2.15) using the database built by MySQL 5.1.73. The front end was developed using 
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HTML 5, CSS and the JavaScript framework. The server side scripting was implemented 
in the PHP (version 5.3.3). 
2.3 Results and Discussion 
2.3.1 Data collection and curation 
RaftProt focuses on mammalian raft resident proteins identified through proteomics 
results. These datasets were extracted from published literature where protein information 
mentioned in various sections of the article with a vast majority of the datasets being 
hidden in the supplementary tables. As the published studies used varying protein 
identifiers to report the outcomes, the proteins identified in each study were mapped to 
standard UniProtKB accessions, using UniProtKB ID Mapping tool and customized scripts. 
During the accession mapping, discrepancies were noticed in the accessions within the 
different versions of UniProtKB and therefore the most updated UniProt accession were 
assigned to a given protein. However, the original protein annotation was kept intact, so 
that the user can always trace back the annotation from the original article.  
In RaftProt, a number of different attributes related to lipid raft preparation methods, type 
of proteomics experiment and the abundance of lipid raft proteins (if reported in the original 
article) have been captured. As some research papers reported multiple proteomics 
datasets; each of the dataset was captured as an individual ‘experiment’ in the database. 
Both the qualitative and quantitative aspects were recorded for the given proteomics 
dataset wherever possible and a clear separation is made between these two group of 
studies. For each protein in the quantitative proteomics datasets, I documented the 
expression values and the directionality of its expression change with respect to the 
experimental setup. A detailed description of each of the experimental design and the 
biochemical extraction method was also recorded. A number of different aspects of lipid 
rafts have been captured by the proteomics investigations over the years were catalogued 
in RaftProt. During the data collection, I gathered protein differential expression 
information arising from experiments such as time dependent study or chemical and 
genetic perturbations of the raft domains from various quantitative experiments. I also 
made a note of the studies attempted to explore the post-translational modifications 
observed in the lipid raft proteome. Consequently, some studies explored dynamics 
compartmentalization of proteins into different subcellular organelles in response to 
external stimulus. From those studies only information about lipid raft fraction was 
extracted. Inside the cell, proteins can traffic between multiple sub-cellular compartments. 
Therefore, I have added the associated information about known subcellular localization of 
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each protein to provide the users an intimation about which other organelles these proteins 
are detected.  
2.3.2  Database architecture 
To enable efficient storage and retrieval of the large-scale lipid raft proteomics data and 
related experimental attributes, a series of information connections were established in the 
form of relational database system (Figure 2.2). The basic outline of the RaftProt is shown 
as the Entity Relationship (ER) diagram, describing various experimental attributes 
considered for the database. All the collected data attributes mentioned in the previous 
section were divided into three broad categories: study, experiment and protein. A brief 
information about a research article was stored under study category. While the 
experimental section has detailed information about how a proteomics investigation carried 
out. Finally, the protein category hosts data related to protein including protein name, gene 
name, expression information (if available) and cross-reference to UniProtKB accession. 
The connections between these three broad groups were made using unique identifiers for 
each study and the experiment.  
 
Figure 2.2 Entity relationship diagram of Mammalian Lipid Raft Proteome Database 
The schematic representation of RaftProt architecture is shown in Figure 2.3. The 
database was deployed on the Apache server 2.2.15 (http://www.apache.org). All the data 
points were stored in a relational database schema implemented in the MySQL server 
5.1.73 (http://www.mysql.com). The client-side web interface was built in HTML with the 
help of CSS and the JavaScript. The tabular display of the results output was implemented 
using the JavaScript plug-in DataTables. Besides, the graphical output of summary 
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statistics of the database was implicated with the help of Google Visualization Application 
programming interface (API). The server side logic was implemented using PHP (version 
5.3.3). The user-centred web-interface is functional on major web-browsers including 
Chrome, Firefox and internet explorer and accessible via any operating system. 
 
Figure 2.3: The RaftProt database architecture 
RaftProt is primarily aimed to be used by biologists. In addition, we also envisage RaftProt 
to serve as a data source for other data analysis/mining systems. I have implemented 
RESTful like web-service approach for the transfer of data in JavaScript Object Notation 
(JSON) format. This separation of data from presentation allows the potential for other 
data analysis/mining systems to pull data dynamically from RaftProt. Furthermore, this 
approach also allows RaftProt to be easily extended with addition data post processing 
functionalities. As an open source project, all the source code of "RaftProt" has been made 
available as a github repository that can be accessed here: 
https://github.com/anupshah14/raftprot.  
2.3.3  Placental Mammalian Cell-type Ontology 
A large number of bioinformatics resources were created in the past few decades to 
assists researchers to access, analyse and integrate vast quantities of nucleotide and 
proteomics datasets. Despite the growing amount of available information, it is not always 
represented in describable and computationally manageable format. One of the challenges 
in analysing the massively large datasets, generated by the ‘omics’ technologies, is 
connecting molecular signatures to the phenotypic observations,230 that left biologists with 
massive datasets having lot of hidden information. One way of tackling this problem is 
allowing computers to logically manage the important phenotypic information, such as 
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anatomical hierarchy of cell, tissues and organs, by integrating biological ontologies with 
the relational databases231. Ontologies are control vocabularies which specify how data, 
terminology, concepts and ideas, about a system of interest, are relate to each other232. 
They are formally represented as directed acyclic graphs (Figure. 2.4 A) where nodes are 
represented by term that are linked by different logical relationships. These days, 
ontologies have become an essential part of research, by enabling large-scale 
comparison, integration, and sharing of data233. One of the most well-known ontology is 
Gene Ontology (GO)234, which represents the biological knowledge in three categories (i) 
biological processes (ii) molecular functions (iii) cellular components.  
As lipid raft proteomics studies have little overlap in specific cell type used, we wished to 
enable the search for all experiments that used related cell types in order to derive a 
‘consensus’ raft proteome for specific cell tissue or organ type. To facilitate this search, we 
developed and integrated a novel ontology called placental mammalian cell ontology 
(PMCLO) in the RaftProt. This ontology is represented in standard Open Biological 
Ontology (OBO) format which was visualized and edited using OBO-Edit235. It is a 
controlled vocabulary consisting of graphical representation of relationships among the 
different anatomical structures of the body. The anatomical structures were broadly divided 
into three main subgroups cell type, tissue and organs with each of these three terms 
having their descendants. The descendants themselves can have more than one parent 
terms from above three classes. This tree like structure allows effective computational 
navigation among the terms within this architecture to facilitate streamline retrieval and 
integration of available information in a meaningful way. I implemented this architecture for 
effective organisation of large number of high throughput proteomics datasets present in 
the RaftProt. While developing the ontology we have considered three types of relations: 
(i) “Is a”: where a child term is directly related to its parent. (ii) “Part of” where an entity is a 
part of larger group of a central parent (iii) “Derived from” relationship represent a more 
indirect relations among the child term and its parent. For example, an aggressive prostate 
cancer cell line is categorised as a cancer derived cell line (Is a relationship) which is 
derived from an epithelial tissue of prostate (As shown in Figure 2.4 B). A direct 
application of integration of PMCLO to the relational database is shown in Figure 2.4 C, D. 
Implementation of this architecture allowed users to ask more informed queries including 
organ level search to derive lipid raft proteome from all the cells belonging to particular 
organ type. For instance, RaftProt database has lipid raft proteome from three prostate 
cancer cell lines LNCap, DU145 and PC3, all of which can be fetched by simply searching 
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for prostate as an organ. This search field has an autocomplete feature that gives user 
additional advantage while searching for specific terms. Another important feature of 
PMCLO is division of cell types into primary and experimentally derived cell lines. 
Experimentally derived cells were further divided into perpetual and cancer derived cells to 
clearly differentiate two morphologically different cell states. This separation is particularly 
beneficial in identifying differences in protein constituents of lipid raft assemblies in normal 
perpetual cell lines compared to constantly growing cancer cells.  
 
Figure 2.4: Placental mammalian cell type ontology (PMCLO) describing (A) Directed 
acyclic graph representing the ontology structure (B) the graphical information flow to 
characterise a metastatic prostate cancer PC3 cells. The relationships (arrows) in blue 
shows “Is A” relationship while arrows in grey represents “Derived from” relation. (C and D) 
examples of utility of use of ontology in RaftProt. 
2.3.4  Defining the high confidence lipid raft proteome.  
Numerous mass spectrometry investigations have identified raft localised proteins in the 
purified membrane fractions utilising various biochemical extraction methods. 
Nevertheless, a proportion of these proteins could be co-isolated from other subcellular 
compartments. Therefore, the information gathered from independent lipid raft proteome 
studies was used to build a filter system that assigns a confidence annotation regarding 
bona fide lipid raft residents. We considered two important experimental observations to 
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screen these proteins from the proteome-level data. The first criterion considered to define 
a high confidence protein was their detection in more than one biochemical extraction 
methods. We assume that the likelihood of a protein to be true positive increases with its 
detection in proteomes obtained from multiple lipid raft purification techniques. The two 
widely used categories of membrane raft isolation methods used are: detergent resistant 
membrane fractionation and the detergent free methods. While developing RaftProt, I have 
captured most of the experimental details that enabled us to dissect these raft isolation 
methods; used prior to proteomics investigation via mass-spectrometer. I also observed 
that, over the years numbers of different surfactants were used for lipid raft isolation. 
Pioneer studies from Rabani and colleagues236 and several others229, 237 showed that the 
use of different detergent could detect different profiles of proteins from lipid rafts. 
Therefore, identification of proteins with more than one biochemical purification protocols 
including different detergent information would improve their confidence to be a bona fide 
raft partitioned protein. Detergent resistance is the more widely used lipid raft purification 
method, but as with any biochemical fractionation, this method has an issue of co-isolating 
non-raft contaminations. To overcome this problem, researchers have developed a 
method that uses functional dependence of lipid raft on membrane cholesterol. This 
method includes sensitivity of proteins to the cholesterol modulating agent, methyl-beta-
cyclodextrin (MBCD). The change in expression of the lipid raft protein after the MBCD 
treatment is considered as a gold standard to determine true lipid raft proteins. MBCD 
interacts with membrane cholesterol and disrupts lipid raft assemblies229. There is a loss of 
lipid rafts structural integrity in the cells treated with MBCD before fractionation and the 
proteins were not purified as detergent resistant fraction while contaminants were 
identified in both treated and untreated cell lipid rafts. This technique is quite popular for 
validating protein localisation to lipid raft fractions in targeted studies such as western 
blots. However, only handful of proteomic studies have utilised MBCD treatment during 
quantitative proteomics experiments to determine subset of cholesterol dependent lipid raft 
components and this sensitivity was considered as a second criterion in the filtering. In the 
RaftProt, I have used proteins identification via multiple biochemical extraction and/or their 
sensitivity to cholesterol disruption as a filter to define a subset of high confident lipid raft 
protein components.  
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2.3.5 Database utilities 
RaftProt can be explored through the web interface using variety of ‘search’ and ‘browse’ 
options as illustrated in Figure 2.5. The underlying proteomics data is also made available 
for the download as an individual text files via several ‘downloads’ options.  
 
Figure 2.5: A screenshot of RaftProt database front page detailing various user friendly 
features 
The “Search” page of the RaftProt offers a number of options to retrieve the data from the 
database (Figure 2.6A). It includes a basic search feature to find raft association of an 
individual protein of interest by gene name, protein name, or UniProtKB accession. The 
output of this query output contains the protein information including isoform (if recorded) 
and the number of proteomics experiments it has been detected. Connections have been 
made to get the experimental description, links to the original publication, together with 
entire lipid raft proteome discovered by that experiment. Besides, each protein is cross-
referenced to UniProtKB, which hosts comprehensive information about structure, function 
and localisation of that protein. All other search features in the RaftProt are more complex 
and can be done at complete proteome, only at a subset of high confidence proteins or at 
experimental level. Researchers can retrieve the data by parameters like cell/tissue/organ 
type, species, biochemical methodologies and treatment conditions such as cholesterol 
depletion. After searching for experiments, the user can additionally retrieve a list of 
proteins reported by the output experiments (Figure 2.6D). Most of the databases offer 
searching against single cell line or experiments at a time. But with the integration of 
PMCLO to RaftProt, users can search for tissue or organ specific lipid raft proteome. The 
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use of ontology permits the user to access all the cell lines associated with particular 
tissue or organ for which lipid raft proteomics data is available. Furthermore, proteins and 
experiments identified from primary cells, perpetual cell lines and cancer associated cell 
lines can also be searched separately. An ‘advanced search’ function was offered to 
search multiple fields at the same time. All the result outputs can be visualized on the web 
interface, and can be downloaded in comma separated or pdf format from the same table. 
Here the output reports protein details along with number of experiments the protein is 
found and its confidence to be a bona fide raft resident (Figure 2.6C).  
One of the important features in the RaftProt is the “Analyse” option in the result output 
table. It provides a way to compare all the protein expression reported in the given results, 
across several different experiments. As each experiment used different amounts of 
starting material, sample preparation and mass spectrometry methodology, quantitative 
comparison (e.g. by peptide count) is not meaningful. Hence, a qualitative analysis option 
was provided to compare protein identification across experiments from the search and 
browse output. The user can download a csv file detailing the presence or absence of 
each of the proteins reported in the search result for all experiments in the database. This 
output is a binary matrix where the rows are proteins and the experiments are denoted as 
the columns. The detection status of a protein was modelled Boolean: protein is observed 
in an experiment, a one was set; in case it was absent, a zero was set. 
 
Figure 2.6: The RaftProt associated features. (A) Multiple search options for easy 
retrieval of protein, proteome and experimental level datasets. (B) A browse option 
providing a list of proteins and experimental information. (C) A display output of query 
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regarding lipid raft proteome with highlighted features in RaftProt. (D) User-friendly 
experimental description capturing protein expression change details.  
The data from the RaftProt can also be accessed using the “Browse database” feature that 
provides a list of all proteins and subset of high confidence raft proteins. Again, the 
information like species-specific proteins, experimental details and every publication 
included in the RaftProt can be accessed via this tab (Figure 2.6B). Similar to search 
outputs, the results can also be searched, downloaded and analysed. On the other hand, 
from the “Downloads” option available on the Homepage, the users can directly download 
the list of all proteins, the subset of proteins based on species, the list of unmapped 
proteins, and all experiments in the database. 
2.3.6 Statistics and data analysis 
2.3.6.1 RaftProt 1.0 
The first version of RaftProt (RaftProt 1.0)238 comprised 27773 protein entries from 117 
proteomics experiments reported in 81 scientific publications. I was able to assign 
UniProtKB accession to 7959 unique proteins (~75% of total proteins). The datasets were 
generated from 69 different cell/tissue/organs belonging to six mammalian species. Among 
them T-cells, melanoma cells, fibroblasts, macrophages and brain-tissues are the most 
common. Most of the proteomics investigations were focused on human cell lines and/or 
tissues. Studies demonstrated the use of qualitative and quantitative proteomics 
experiments, along with utilization of chemical or genetic perturbations. Detergent-resistant 
membrane was the most popular method for lipid raft preparation, used in ~80% 
experiments. Lipid raft isolation based on biochemical/biophysical properties may lead to 
co-isolation of contaminant, non-lipid raft proteins. Sensitivity to cholesterol depletion using 
methyl-β-cyclodextrin is an established 'test' for lipid raft presence229, 239, however, only 4 
experiments used this treatment. Therefore, we also considered that co-isolated 
contaminant proteins are likely to be specific to each biochemical isolation method, and 
used identification by more than one biochemical method as a second criterion for 
inclusion in the 'High Confidence' lipid raft protein list. Proteins that fulfil either criteria were 
added to the high confidence list of 2185 proteins (27.5% of total 7959 proteins the 
database).  
2.3.6.2  RaftProt 2.0 
The RaftProt 1.0 has lipid raft proteomics datasets from 2001 to 2013. In August 2015, I 
updated the database with recent proteomics studies (till July 2015). 
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RaftProt 2.0 provides a more comprehensive dataset of experimentally verified lipid raft 
associated proteins identified through mass-spectrometric investigations reported in the 
literature (an updated dataset, "RaftProt_version2.txt", is available at 
https://github.com/anupshah14/raftprot/tree/master/download). After the database upgrade 
with the recent literature, RaftProt 2.0 is now a collection of 8747 lipid raft associated 
proteins across six species. The raft proteomics research published over the span of two 
years consists of eight human, six mouse and four rat experiments derive from eight 
studies. The human studies were focused mainly on blood components240-241, colon cancer 
cells242 and renal cell carcinoma tissue samples from patients243. Apart from that, one 
study looked at caveolae associated proteins from rat ventricular myocytes244 and the 
mouse work include raft proteomics profiling from macrophages245-246 and brain 
samples247. The comparison between two versions of RaftProt is reported in Table 2.1.  
Table 2.1: Comparative analysis of two version of the RaftProt database. 
Parameter RaftProt 2.0 RaftProt 1.0 
Number of proteins 8747 7959 
Number of organism 6 6 
Number of Studies 89 81 
Number of Experiments 135 117 
Number of High confidence proteins 2670 2185 
Number of experiments using Methyl 
beta cyclodextrin (MBCD) treatment 
8 4 
Proteins sensitive to MBCD treatment 824 323 
The updated database has more number of raft proteins both at the proteome level and in 
the subset of high confidence protein list. With the advances in mass spectrometric 
instruments and the raft isolation techniques we were still able to detect novel raft 
associated proteins (represented by blue bars in Figure 2.7A). Similar to the proteins, in 
the RaftProt 2.0 update there is enrichment of lipid raft proteomes from novel cell/tissue or 
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organ types (Figure 2.7B). There was skewness among number of datasets belonging to 
individual species with most of the proteomics experiments derived from lipid rafts of 
human origin (Figure 2.7C). The most notable change was the addition of experiments 
implementing the gold-standard MBCD treatment. In the update version, in just two years 
same number MBCD sensitivity studies were reported in the literature compared to version 
one; identifying 500 more proteins with around two fold enrichment in the protein numbers. 
The high-confidence lipid raft proteins constituted around ~30% (2670) of all lipid raft 
proteins (8747) across all six species reported in RaftProt 2.0. In total, ~27% (2376) of 
proteins were present in proteomic studies that used more than one biochemical lipid raft 
extraction method. On the other hand, only 3% of lipid raft proteins could be found MBCD 
sensitive group. This might be due to less representation of datasets with MBCD treatment 
in RaftProt database. I then performed an overlap of proteins filtered through both of these 
criteria (Figure 2.7D). I found that the 531 lipid raft proteins are common among both 
these filtration criterion.  
 
Figure 2.7: RaftProt summary. (A) Number of unique raft residents detected by MS 
based proteomics studies over the years. The blue colour represents proportion of novel 
raft proteome and green colour represents proportion of raft proteins previously reported in 
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other experiments in the RaftProt. (B) The distribution of the number of unique cell/tissue 
or organ proteomes reported over the years. The blue colour represents proportion of 
known raft proteome and yellow colour represents proportion of novel raft proteomes in the 
RaftProt. (C) The distribution of lipid raft proteomics experiment in the species (D) The 
overlap between high confident lipid raft residents detected via two or more biochemical 
lipid raft purification methods and are sensitive to a gold standard cholesterol disruption 
agent methyl-beta cyclodextrin (MBCD). 
2.4 Conclusions 
RaftProt is a database of mammalian lipid raft associated proteins reported in high 
throughput mass spectrometry studies. This unique resource provides the means to 
systematically analyse existing lipid raft proteomics datasets in an informed manner. 
Critical experimental information is captured in a searchable format. Combined with the 
use of a novel cell ontology, this user-friendly portal will enable biologists to distil useful 
lipid raft proteomics data from the potentially bewildering public datasets. Currently there 
are limited number of studies for most cell types, specific treatments and preparation 
methods. With continued input from the research community, the RaftProt will be able to 
increase our knowledge about the proteomic constituents and dynamic re-arrangement of 
mammalian lipid rafts. 
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CHAPTER 3 
IN SILICO FUNCTIONAL CHARACTERIZATION OF 
THE HUMAN LIPID RAFT PROTEOME
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3. Chapter 3: Computational analysis of human lipid raft proteome 
 Overview 
Cholesterol and sphingolipids in the cellular membranes form functional microdomains that 
serve as a dynamic protein sorting and signaling platforms. These specialized membrane 
regions, also called lipid rafts, regulate numerous cellular events and their dysfunction is 
implicated in multiple diseases. Despite their functional importance, the molecular features 
that facilitate recruitment of proteins to lipid-rafts are poorly understood. According to the 
findings reported in some low-throughput/targeted biophysical investigations, proteins can 
be sorted to the lipid raft via a number of mechanisms such as lipid attachment or binding, 
membrane penetration or protein-protein interactions. To determine the relevance of these 
features, this chapter investigates the representation of these structural determinants in 
RaftProt, a comprehensive human raft proteome dataset of 4898 proteins, derived from 75 
proteomics experiments from 54 different cell and tissue types. Using a detailed 
computational analysis, the human raft proteome was classified into intrinsic, extrinsic and 
raft dependent proteins, based on potential molecular mechanisms of raft partitioning. Of 
all the suggested raft-targeting mechanisms, our meta-analysis indicated that the 
palmitoylated and the cholesterol binding proteins were selectively enriched in the human 
raft proteome compared to the neighboring plasma membrane. Protein-protein interaction 
network analysis of raft proteins showed a high degree of interconnections among lipid raft 
proteins. Furthermore, functional enrichment analysis revealed an over-representation of 
receptors and transporters in the intrinsic raft protein dataset, while cytoskeletal assembly 
was enriched in the extrinsic raft proteome. Collectively, the global integrative analysis 
presented here, will pave the way to more refined representation of human lipid raft 
associated proteins, which will allow better understanding of their function and regulation. 
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3.1 Introduction 
3.1.1 Lipid rafts in health and diseases 
Cholesterol plays a vital role in organizing cellular membranes into distinct regions called 
lipid rafts248 249. The sterol and sphingolipid enriched zones are often observed on the 
surface of living cells as well as synthetic membranes using a high resolution microscopic 
techniques250-251, indicating heterogeneity in the lipid bilayer composition. A characteristic 
cholesterol and sphingolipid arrangements impart unique physicochemical properties to 
the membrane bilayer, which is then utilized by cells as a protein sorting platforms. A 
distinct repertoire of proteins appear to reside at lipid rafts, include receptors, signaling 
molecules, effectors and cytoskeleton machinery252. Lipid raft proteins are reported to 
regulate variety of biological events such as signal transduction253, cell-adhesion77, cellular 
transport254, endocytosis55 and shedding of extracellular vesicles into the surrounding 
environment255. These cellular processes are critical for maintaining normal homeostasis 
of the cell and their disruption may lead to disease226. To this end, alterations in lipid rafts 
have been reported in multiple disease conditions like cancer256 and neurological 
disorders257.  
Over the years, significant efforts have been dedicated to elucidate protein contents of the 
membrane microdomains. High throughput liquid chromatography-coupled mass 
spectrometry approaches have been widely used to characterize the lipid raft proteome 
identifying hundreds of protein species from the detergent resistant membrane (DRM) 
fractions238. These efforts have led to enormous amount of proteomics data of lipid rafts 
being deposited in public domain. Owing to their tight packing and resistance to extraction 
by ionic detergents at low temperatures, lipid rafts are often isolated from cells using a 
simple detergent based density gradient separation techniques144, 258. The validity of such 
extractions is usually checked by western blot methods using raft markers such as 
floatillin259, GM1260 and caveoline-1261. However, the DRM method has been criticized for 
inducing artefactual aggregation262, leading to false positive protein identifications263. 
Additional non-detergent methods143 and affinity-based methods264 have been proposed 
and reported, but are not used routinely in proteomics studies. Despite of proteomics 
efforts, which churned out massive datasets, there is an uncertainty about what protein 
features govern the targeting of protein molecules to the lipid rafts. 
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3.1.2 Determinants of raft localization 
Understanding the mechanisms of protein recruitment to lipid rafts can provide additional 
information that would help in confidently identifying native raft components. In the 
literature, only handful of publications investigated and reported raft targeting features that 
recruit proteins to lipid raft. In a recent review, Levental and colleagues265 attempted to 
provide an overview of the known mechanisms that assist protein sequestering to the lipid 
rafts. As per their opinion, the lipid raft-targeting signals could fall under three main 
categories: post-translational lipid modifications, binding of proteins to the raft specific 
lipids or presence of the transmembrane domain features. Lipid modification is 
characterized by the attachment of fatty acid chain to the proteins, which facilitates sorting 
of proteins to the lipid rafts266. Four types of lipid modifications are known: palmitoylation, 
myristoylation, prenylation and GPI-anchor attachment, based on the type of fatty acid 
attached to the protein. S-palmitoylated proteins (fatty acid attachment through thioester 
bond), with the attachment of the sixteen carbon palmitic acid to the protein C-terminal 
serine, are thought to predominantly been associated with lipid raft domains267-268. For 
instance, palmitoylation is essential for effective functioning of proteins like H-RAS269 and 
tyrosine kinase Lck270 through the raft. Similarly, myristoylated and prenylated proteins 
(FLOT-2271, Rab proteins272-273) have also been reported to be present in lipid rafts274. 
Alternatively, proteins can also be anchored in the extracellular leaflet through 
Glycosylphosphatidylinositol (GPI) molecule attached preferentially at the C-terminal ω-
site of the protein sequence275. A number of complementary strategies, such as western 
blotting and proteomics, have reported GPI-anchored proteins, such as ovarian tumor 
suppressor OPCML119, 276, to selectively partitioned into detergent-resistant membrane 
fractions i.e. lipid rafts26-27, 154, 157.  
In a lipid bilayer, proteins tend to interact with the membrane lipids present in their close 
proximity and a preferential binding to the raft associated lipids could be another way of 
segregation of proteins to the rafts. Specific lipid molecules like cholesterol, sphingolipids 
and ganglioside species such as GM1 are considered as major components of membrane 
rafts277,278. Proteins binding to these sterol and glycolipids molecules are therefore 
postulated to be raft residents. Interestingly, alteration of protein abundance, which are 
predominantly bound to cholesterol by a cholesterol-extracting agent, methyl beta-
cyclodextrin (MBCD), is widely used as a ‘test’ for reliable estimation of raft localized 
proteins279-281. The presence of saturated phospholipids and larger sphingolipids enhance 
thickness of the lipid raft assemblies compared to the rest of the plasma membrane. Due 
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to hydrophobic mismatch between lipid bilayer and transmembrane (TM) region of 
proteins, certain transmembrane proteins tend to preferentially segregate to the rafts282-284. 
For example, alteration in transmembrane peptide length of the raft partitioned protein 
linker for activation of T-cells (LAT) significantly abrogate its surface localization285. Lipid 
rafts are also considered as cellular platform that facilitates protein-protein interactions by 
restricting the lateral diffusion of proteins. Finally, proteins could be drawn to the raft 
domains by preferential interactions with other proteins attached or penetrate in the lipid 
rafts286. However, all these conclusions about the proposed mechanisms of protein 
partitioning to lipid rafts were either derived the physicochemical evidences from various 
model membranes287 or limited number of experimental observations reported while 
studying individual proteins285. Most of the previous studies paid little attention to the 
representation of the sequence features that dictate protein sorting to lipid rafts at the 
proteome level. Therefore, in this study, I performed a detailed bioinformatics analysis, 
combining subcellular proteomics, computational predictions, protein interaction analysis 
and literature evidences. 
3.1.3 Computational predictors 
Computational approaches have widely been used to detect underlined pattern in the 
protein sequences. Here, I present a survey of available in silico prediction methods that 
could assist the investigation of potential lipid raft targeting mechanisms in the proteome-
wide datasets. I specifically looked for the tools developed to predict three broad 
categories of the sequence and structural features namely post translational lipid 
modifications, lipid binding and the presence of alpha helical transmembrane segments. 
Along these lines, I first evaluated a number of computational algorithms that could 
facilitate in silico predictions of four major lipid modifications: palmitoylation, myristoylation, 
prenylation (farnesylation/geranyl-geranylation) and GPI anchoring. Computational tools 
like PalmPred288, SeqPalm289 and CSSpalm 2.0290 were used to predict palmitoylated 
proteins based on specific sequence patterns. PalmPred is a support vector machine 
(SVM) classifier based on a model built with a training set of 132 proteins having 207 
experimentally verified palmitoylated cysteines. CSSpalm on the other hand, implemented 
using a Clustering and Scoring Strategy (CSS) algorithm trained on the non-redundant 
training data and contained 263 palmitoylation sites from 109 distinct proteins. In contrast, 
SeqPalm is a protein S-palmitoylation sites identification tool that considered a series of 16 
key features from protein sequences and the synthetic minority oversampling technique to 
address the unbalance problem between positive and negative samples. Their model was 
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built on 361 palmitoylation sites from 204 proteins. Even though other Palmitoylated 
protein prediction algorithms such as NBA-Palm291, IFS-Palm292 and CKSAAP-Palm293 are 
reported, these were not available during the analysis. Prediction methods for GPI-anchor 
proteins mainly determine C-terminal ω-site. A series of algorithms like BIG-PI294 
(http://mendel.imp.univie.ac.at/sat/gpi/gpi_server.html), Fragachor295, PredGPI296 and GPI-
pred297 (https://github.com/BILAB/Tools) were available in this space. PredGPI, predicts C-
terminal GPI anchor motif based on ω-site from C-terminal found in 340 proteins with 
known ω-site and GPI-sites, using an integrated SVM and a HMM technique. Alternatively, 
GPI-pred is centered on GPI-modification prediction via SVM method. The services (web-
portals) for BIG-PI294 and Fragachor295 were not functional at the time of this analysis. 
Fourteen carbon myristic acid modification on proteins could be predicted by web-servers 
Myristoylator298 (http://web.expasy.org/myristoylator/) and NMT-myristoylation 
(http://mendel.imp.ac.at/myristate/SUPLpredictor.htm). These tools were based on 
prediction models trained on a number of eukaryotic myristoylated proteins. Likewise, 
three types of prenylation namely; CaaX farnesylation, CaaX geranylgeranylation and Rab 
geranylgeranylation could be predicted by a web-based tool PrenPS299 
(http://mendel.imp.ac.at/PrePS/).  
To the best of my knowledge, there is no bioinformatics tool for predicting lipid binding 
proteins at a proteome scale. However, two cholesterol binding motifs Cholesterol 
recognition/interaction amino acid consensus [CRAC] motif300 “[L/V]-X[1,5]-Y-X[1,5]-[R/K]” 
and inverted CRAC/CARC domain22 “[R/K]-X[1,5]-[Y/F]-X[1,5]-[L/V]” were mentioned in the 
literature. Proteins containing one of these two sequence patterns were reported to be a 
binding partners of cholesterol in the cell. In a mature protein, a typical TM domain 
consists of 17-30 hydrophobic amino acid residues that helps in penetration in the lipid 
membrane. Over the years, number of algorithms have been published to predict TM 
region in the protein sequence. According to a recent benchmark study301, two tools 
TMHMM302 and TOPCONS303 outperformed other TMD prediction approaches and are 
popular in the scientific community. TMHMM predictions were based on Hidden Markov 
Model (HMM), which takes into consideration various regions of topologies of membrane 
proteins such as helix cap, middle of the helix, regions close to membrane and globular 
domains. It also discriminates between signal peptide and transmembrane helixes. On the 
other hand, TOPCONS is a HMM based predictor that considered ensemble of results of 
five transmembrane prediction methods namely; Philius304, SCAMPI-multi305, OCTOPUS, 
SPOCTOPUS306 and PolyPhobius304 to generate consensus topological profile. All these 
computational tools and motif analysis would be beneficial to determine the structural 
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enrichment of proteome-wide data consisting of tens of thousands of proteins. These 
structural signatures would then highlight preferential mechanisms of protein partitioning to 
the rafts and probable implications in raft assisted biological processes. To this end, I 
performed a bioinformatics analysis of multiple experimentally annotated datasets to 
characterize relative proportion of putative raft sorting protein features in the human raft 
proteome. I also performed a comparative analysis to investigate the magnitude of these 
signatures in a much larger dataset of the entire human proteome. I then categorize the 
human lipid raft proteins into intrinsic lipid raft, extrinsic lipid raft and raft associated 
proteins and carried out a detailed functional characterization of raft localized proteins to 
determine characteristic protein classes and pathways unique to the rafts.  
3.2 Material and Methods 
3.2.1 Evaluation of proteome-wide datasets 
A total of six datasets were considered for characterizing representation of sequence 
associated features that govern targeting of proteins to the lipid rafts (Table 3.2). These 
datasets are: (i) Human Proteome (20137) (Uniprot SwissProt October 2015 version) (ii) 
Human Lipid Raft Proteome (4898) (iii) High confidence human raft proteins (1797) (iv) 
Proteins changed by cholesterol depletion agent MBCD treatment (732). Furthermore, I 
considered another subset of human proteome, i.e. (v) proteins annotated to be plasma 
membrane associated as a negative set from SwissProt (accessed on 11 January 2016) 
using a keyword search feature of UniprotKB307. Finally, (vi) non-raft plasma protein 
dataset was derived by excluding raft proteins from UniProtKB annotated plasma-
membrane proteome. Three datasets related to the human lipid raft associated proteins 
were obtained from the RaftProt238, that reports 4393 proteins from 67 proteomics 
experiments till year 2013. I also added manually curated information from 15 more lipid 
raft proteome studies till June 2015 (RaftProt 2.0). I then considered a subset of high 
confident human lipid raft proteome, meaning protein derived from more than one 
biochemical extraction method and/or altered by membrane-cholesterol modulating agent 
methyl beta-cyclodextrin (MBCD). Treatment of cells with MBCD prior to lipid raft isolation 
is considered as a gold standard method to represent true lipid raft associated proteins239, 
and was used as a subset in my analysis. FASTA sequences of proteins from each group 
were obtained from the UniProtKB. Proteins sequences of each datasets were then 
analyzed using multiple computational prediction methods that are discussed in following 
sections.  
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Table 3.1: Summary of total number of proteins in the proteome wide datasets used in this 
analysis. 
Proteome Datasets Number of Proteins 
Human Proteome 21037 
Human lipid raft Proteome 
Total raft Proteome 4898 
High confidence lipid raft 
proteins 
1797 
MBCD sensitive proteins 732 
UniProtKB Plasma-membrane 
proteome 
Total plasma membrane 
proteins 
3029 
Non-raft plasma membrane 
proteins 
2234 
3.2.2 Prediction of lipid modifications in the protein sequence 
I considered in silico tools PalmPred288, SeqPalm289 and CSSpalm 2.0290 to predict 
palmitoylated proteins in the raft proteome. Protein sequences from each of the datasets 
(Human proteome, human raft proteome, plasma membrane proteome) were submitted to 
standalone tool for PalmPred and an updated version CSSpalm 4.0 and on web-server for 
SeqPalm. Only reliable and high confidence predictions reported by individual tools were 
considered as positive hit. Two algorithms PredGPI296 and GPI-pred297 were considered to 
predict GPI anchor attachment containing proteins. Similar to palmitoylation prediction, the 
analysis was done on all the protein datasets using standalone (provided by the authors) 
PredGPI and GPI-pred. Attachment of myristoyl group to the proteins from human 
proteome and human raft proteome were predicted by two web-servers Myristoylator298 
and NMT-myristoylation. High confidence N-terminal glycine modified proteins (Score > 
0.95) were considered as myristoylated. For NMT-myristoylation parameters used were: 
eukaryote taxonomy and prediction considering both the N-terminal and internal glycines. 
Only Myristoylation sites predicted as “reliable” were considered for the analysis. Covalent 
attachment of prenyl group to the protein was predicted by a web-based tool PrenPS299. 
Seleno-proteins containing uncommon seleno-cystein (U) residues and the proteins with 
less than 40 amino acids were excluded from the analysis. Except prenylation, a 
consensus (union) of outcomes of all prediction methods was used to assign lipid 
modification signature to a given protein.  
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3.2.3 Lipid binding proteins 
Cholesterol binding proteins were characterized by the presence of two motifs: the CRAC 
motif300 “[L/V]-X[1,5]-Y-X[1,5]-[R/K]” and the inverted CRAC/CARC domain22 “[R/K]-X[1,5]-
[Y/F]-X[1,5]-[L/V]” in the protein sequence. Simultaneously, I searched for the tilted 
peptides pattern that can bind to cholesterol found in Alpha-synuclein 
(GGAVVTGVTAVA)308 and Beta- amyloid (EDVGSNKGAIIGLM)309 proteins. SlimFinder310 
package from SLimSuits version 1.5.2311 was used to find short linear motifs in the 
proteome-wide datasets mentioned above. Proteins containing either of these motifs or 
peptide sequences were considered potential cholesterol binding proteins. Moreover, I 
also looked for the mention of sterol binding motif or sphingolipid or ganglioside binding 
motif in protein motif databases such as Eukaryotic Linear Motif (ELM) database312, 
Minimotif Miner (MnM) version 3.0313, PFAM314 and InterPRo315, but information was not 
available for either of them in all these resources.  
3.2.4 Transmembrane domain (TMD) prediction 
Two programs implementing different algorithms to predict TMD signals in the protein 
sequence namely TMHMM302 and TOPCONS303 were considered for this work. 
Standalone versions of TMHMM and TOPCONS were used to predict TMD containing 
proteins based on sequence features. TOPCONS also provides information about 
occurrence of signal peptide in the sequence that is typically present in first 70 amino acid 
residues of N-terminal of proteins. I only considered prediction results for TMD to be 
positive only if signal peptides were absent in proteins, as it is characteristic of secreted 
proteins. I also calculated the collective frequencies of number of transmembrane domains 
in the individual proteins reported by TMHMM in the human lipid raft and the complete 
human proteome. 
3.2.5 Annotated or experimentally verified datasets  
I considered a dataset of palmitoylated proteins reported by the database, SwissPalm316. 
This curated resource database consists of 1474 human palmitoylated proteins identified 
in 11 proteomics studies. Out of those proteins, I considered 1351 reviewed palmitoylated 
proteins (accessed on October 7 2015) for my analysis. The annotations for Myristoylated, 
prenylated and GPI anchored proteins were extracted from the SwissProt section of the 
UniProtKB database (release April 2016, accessed on 29 April 2016) using the Keyword 
search feature for “Lipidation”. Recently published proteome-wide study that explored 
comprehensive cellular landscape of sterol binding proteins317 was used to derive list of 
cholesterol binding proteins. I then mapped the IPI protein identifiers reported in the 
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publication to SwissProt to make it consistence with rest of this work. Only lipid raft 
associated cholesterol binding proteins were considered for categorizing intrinsic lipid raft 
proteome. 
3.2.6 Protein interaction network analysis 
A human protein-protein interaction network was downloaded from PINA 2.0 (version 
updated on May 21, 2014)318. PINA is a meta-database of protein-protein interactions, 
created by compiling protein interaction data across six publicly available, manually 
curated databases. I first extracted interaction between intrinsic raft proteins (proteins with 
at least one of above structural features) interacting within themselves from human 
interactome obtained from PINA. Secondly, we categorized the lipid raft proteins directly 
interacting with intrinsic raft proteins as extrinsic raft proteins. Cytoscape (version 2.8.2)219 
was used for network visualization and analysis. Network topological properties were 
calculated using network analyzer plugin of Cytoscape to determine properties like degree 
distribution (number of interacting partners) of individual protein.  
3.2.7 Protein class and pathway enrichment analysis 
I used PANTHER (Protein ANalysis THrough Evolutionary Relationships) classification 
system (http://www.pantherdb.org/)319, protein class feature which is based on well curated 
standard PANTHER index terms and is complementary, but not identical, to GO terms and 
PIR keywords. I performed over-representation analysis for protein functional classes in 
the three distinct groups of lipid raft proteome namely: (i) Intrinsic raft proteome (ii) 
extrinsic raft proteome and (iii) raft-dependent proteome considering complete human raft 
proteome as a background to understand enriched protein classes in each of the 
proteome. I also considered protein class enrichment in combined intrinsic and extrinsic 
proteome set against entire human proteome and compared the results with over-
represented classes in complete plasma membrane proteome (excluding lipid raft 
proteins). The functional pathways enrichment analysis was also carried out for a 
combined list of intrinsic & extrinsic lipid raft proteins and non-raft plasma membrane 
proteins against the background of the human proteome. For all over/under representation 
analysis > 2 fold change and the adjusted p-value < 0.05 (Bonferroni correction) obtained 
from the binomial test was considered to determine significantly altered protein classes or 
signaling and metabolic pathways.  
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3.3 Results and Discussion 
3.3.1 Categorization of the human lipid raft proteome 
I analyzed the most comprehensive catalogue of human lipid raft associated proteins to 
date, comprising of 4898 unique human lipid raft associated proteins obtained from an 
updated version of a mammalian lipid raft proteome database, RaftProt238. This extensive 
list of raft proteins was collected from 75 high throughput lipid raft proteomics experiments, 
derived from 54 cells or tissue types of human origin. As shown in Figure 3.1, raft 
localized proteins were classified into three groups: intrinsic, extrinsic and lipid-raft 
dependent proteome. The intrinsic lipid raft proteome was defined based on the presence 
of at least one of the raft sorting features proposed in the literature. These protein 
signatures are: post-translational lipid modifications (GPI-anchor attachment, 
palmitoylation, myristoylation and prenylation); lipid binding domains (Cholesterol, 
Sphingolipid, Ganglioside binding motifs); presence of the TMD with raft specific 
biochemical/physicochemical properties. I reasoned that the protein could also be 
transiently associated to the lipid rafts via binding to the intrinsic proteins. Hence, I 
performed a protein interaction analysis to derive a set of extrinsic protein component of 
the lipid raft. If a remaining raft protein happens to be a direct binding partner of an intrinsic 
raft protein, it was labeled as an extrinsic raft protein. At last, all the remaining proteins that 
did not had any of the above features constitute a raft dependent protein set. 
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Figure 3.1: Proposed lipid raft targeting features in the proteins. (a) Schematic representation of various structural features 
responsible for protein sorting to the liquid-ordered cholesterol-rich microdomains (lipid rafts) compared to non-raft membrane 
counterparts. The direct attachment of proteins to the lipid raft (intrinsic components) occur via mechanisms reported in the blue box, 
while proteins can also be targeted to the rafts by protein-protein interactions (extrinsic components) with membrane attached proteins 
shown in the orange box. (b) Classification of the lipid raft proteome into intrinsic, extrinsic raft proteins and raft dependent proteins 
based on the presence of putative sequence features and experimentally validated protein-protein interactions information.
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A mammalian lipid raft proteome database RaftProt reports around one fourth (4898) of all 
human proteins (20137) to be associated with the rafts in different cell and tissue type at 
multiple time points. This proportion seemed to be notably high, if rafts were to be 
considered as sub-compartment of cell surface. In RaftProt, only protein level evidence, 
reported in published proteomic studies, was considered to assign lipid raft localization. 
However, mass-spectrometry observations are often quite complex and still face some of 
challenges around precise peptide-level identifications, protein parsimony (grouping of 
protein identifications based on shared peptides) and lab to lab variability. Although many 
attempts are still being made to address these issues, they could result in alternative 
experimental outcomes. Furthermore, careful examination of peptide mass-fingerprints by 
multiple peaks-picking algorithms and re-analysing public data using different search 
settings such as adding more variable peptide modifications might identify more peptides 
and proteins. Additionally, DRM fractions were sometimes criticized for capturing 
contaminant proteins from other subcellular organelles. The occurrence of mitochondrial 
and nuclear proteins in raft studies is still debatable and significant efforts have been made 
to avoid these contaminants as much as possible during raft preparation. An inferential 
bias that might arise due to inclusion of such false positives/contaminants in result 
outcomes can be reduced by considering alternative exclusion strategies. Therefore, a 
computational pipeline was developed (Figure 3.2), to systematically classify the lipid raft 
proteome into intrinsic, extrinsic and raft dependent proteins. Firstly, proteins that can 
directly achieve the raft-compartmentalization via post-translational lipid modifications; 
preferential cholesterol binding or having a TMD; were classified into the intrinsic raft 
protein group. While determining presence of transmembrane domain in the proteins, I 
excluded proteins with signal peptides as they might be false positives. Next, I considered 
experimentally validated protein-protein interactions to identify direct interactions of the 
remaining raft proteins with the intrinsic raft counterparts and called them extrinsic 
components of lipid rafts. Lastly, the proteins devoid of any of these features were 
included in the raft dependent list, which might be co-isolated during the raft isolation.  
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Figure 3.2: An overview of the computational workflow used to categorise the human lipid 
raft proteome based on the structural and interaction features. Three broad sequence 
signatures namely, post-translational lipid modification presence of transmembrane 
domain, and protein cholesterol binding were considered as a direct determinants of 
protein sorting at lipid raft. The transient association of proteins to the rafts was 
characterised by investigating raft localised protein-protein interactions. The remaining raft 
proteins were classified as raft dependent proteins. 
3.3.2  Intrinsic raft proteins 
Three types of intrinsic raft targeting mechanisms are evaluated, namely, lipid-
modification, lipid binding and transmembrane domain. A variety of methods were 
evaluated for each classification.  
3.3.2.1  Post-translationally lipid modified proteins  
Lipid modification of proteins has been reported to mediate the targeting of certain cellular 
proteins towards cell surface lipid rafts, which in turn enables their correct and specialized 
functions274, 320-321. As a first approach for annotating the lipid-modified proteins, manually 
curated SwissProt annotation was evaluated for four major classes of lipid modifications: 
palmitoylation, myristoylation, prenylation and GPI anchor attachment. In addition to the 
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human lipid raft dataset, I analyzed prevalence of these modifications in the entire human 
proteome in UniProtKB (accessed on April, 29 2016) for comparison (Figure 3.3a). Of the 
21037 human proteins in SwissProt (the manually curated version of UniProtKB), only 4% 
(794) were annotated to be lipid modified. Palmitoylation accounted for the majority of 
annotated lipid modified proteins (38%) (Figure 3.3a). Surprisingly, of 300 palmitoylated 
proteins annotated in SwissProt, more than half of the annotations were based on 
computational prediction derived mainly from sequence similarity or using palmitoylation 
prediction tools, rather than experimental evidence. The annotation of myristoylation, the 
second largest group of lipid modification in the proteins (193), was slightly better with 65% 
being experimentally derived N-myristoylation sites (Figure 3.3a). Prenylation and GPI 
anchored proteins form an even smaller subset (167 and 134 proteins respectively), again 
with a very high percentage of proteins (65% and 76%) without experimental evidence 
(Figure 3.3a). Collectively, between more than half to thirty percent of the total annotations 
in the entire human proteome from each sub-category were derived from the 
computational predictions.This reflects that a significant proportion of lipid modification 
annotations in SwissProt did not had experimental evidence and using a systematic 
computational approach we can update those annotations.  
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Figure 3.3: Representation of the source of post-translational lipid modification annotation 
of proteins in UniProtKB. Number of proteins annotated based on experimental evidence 
(green) or computational prediction (blue) are shown in the bar plot for (a) all human 
proteins in UniProtKB and (b) human raft proteins. 
Similar to the total human proteome, only a small subset of the lipid raft proteome (7% or 
336) was annotated as lipid modified in SwissProt (Figure 3.3b). Similar to earlier 
observations, between 30 to 75 percent of UniProtKB lipidation annotations were derived 
from computational based predictions. About one third of all cellular palmitoylated proteins 
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(101) were detected in the lipid raft as per the UniProtKB annotations. This is against the 
popular notion that the palmitoylated proteins preferentially segregated in the lipid rafts31. 
Unlike the trend in the human proteome, >60% of palmitoylation annotations have 
experimental evidence backup. Same case was true with the raft partitioned myristoylated 
proteins (79). However, a bulk of annotations for prenylation (84) and GPI-anchored 
proteins (72) were prediction based. Altogether, this analysis indicated that the majority of 
annotations for lipid modifications in SwissProt were based on potentially ambiguous 
computational results. The uncertainty of this result motivated us to systematically predict 
and define lipid modified proteins localized to lipid rafts, using at least two prediction 
algorithms in order to increase confidence of the predictions (Table 3.2 and 3.3). For 
prenylation, only a single prediction algorithm was available, so a consensus outcome 
could not be determined.  
Each of the predictors was used to analyze the human proteome (Table 3.2) and human 
raft proteome (Table 3.3), and the proteins that predicted to be positive by all predictors for 
a given category was classified as ‘Consensus Outcome’. I used this stringent criterion to 
improve the sensitivity of the prediction outcome of individual features for all predictors.  
Table 3.2: Computational predictions of lipid modified proteins in the human proteome 
Lipid Modification 
Individual Predictor 
outcome [# positive hits] 
Consensus Outcome 
Palmitoylation 
PalmPred [495] 
387 SeqPalm [542] 
CssPalm 4.0 [476] 
Myristoylation 
Myristoylator [201] 
125 
NMT [153] 
Prenylation PrenPS [136] 136* 
GPI-anchor# 
PredGPI [209] 
168 
GPI-predictor [282] 
* The results from only one predictor outcome, # Outcome of FragAnchor (mentioned in Table 3.4) 
were not reported here because the web-portal became inaccessible for human proteome analysis.  
Table 3.3 Computational predictions of lipid modified proteins in the human lipid raft 
proteome 
Lipid Modification 
Individual Predictor 
outcomes [# positive hits] 
Consensus Outcome 
Palmitoylation 
PalmPred [193] 
158 
SeqPalm [183] 
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CssPalm 4.0 [211] 
Myristoylation 
Myristoylator [52] 
40 
NMT [67] 
Prenylation PrenPS [57] 57* 
GPI-anchor 
PredGPI [97] 
68 GPI-predictor [114] 
FragAnchor [94] 
* The results from only one predictor outcome 
Compared with the already annotated lipid modified proteins in SwissProt database 
(Figure 3.3a), none of the consensus prediction outcome for the four lipid modifications 
(palmitoylation, myristoylation, prenylation and GPI-anchor attachment) identified 
significantly larger number of proteins to bear post-translational lipid modifications.  
Next, I looked for the prediction outcomes for protein lipidation in a subset of human raft 
proteome dataset (Table 3.3). The consensus prediction outcome showed 323 (40% of all 
predicted lipid modified proteins from human proteome) raft proteins to be lipid modified 
with 158, 40, 57 and 68 proteins having palmitoylation, myristoylation, prenylation and 
GPI-anchor attachment respectively. With an exception of palmitoylation, all other 
predictors failed to identify lipid modified proteins in the raft dataset compared to 
annotations reported in UniProtKB (Figure 3.3b). Additionally, for palmitoylated proteins 
the prediction outcome was not substantially larger. Collectively, computational prediction 
of lipid modifications on both human proteome and lipid raft proteome datasets did not 
outperform the annotated information present in the UniProtKB. The results from this 
analysis signified that all the prediction methods failed to improve existing knowledge 
about the human lipidated proteins. One possibility is that, these predictors were not 
sensitive enough for the proteome wide datasets. To check the sensitivity of the predictors 
I used an external test set of curated lipid modified (palmitoylation, prenylation, 
myristoylation and GPI anchor) proteins mentioned in the UniProtKB (Figure 3.3a). All the 
lipid-modifications prediction methods produced significant number of false negative 
results for an external test set (result not shown). Moreover, the agreement between tools 
predicting the same lipid modification reported even less true positive observations (Table 
3.2 and 3.3). This is partly due to the fact that most of the prediction models were built on 
very small number of proteins in training and test set and was not able to adequately 
capture the feature space require to correctly identify these modifications just based on 
protein sequence. 
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With the failure of UniProtKB and computational prediction tool to accurately classify lipid-
modified proteins, I then looked for experimentally derived datasets. Two databases were 
identified, SwissPalm316 and HumanPRenBASE299 for palmitoylated and prenylated 
proteins, respectively. SwissPalm contained experimentally validated palmitoylated 
proteins from eleven human LC-MS/MS studies, which had 4 fold more numbers of 
proteins (1351) compared to those annotated in the UniProtKB at the time of this study. 
Unfortunately, no such resources were available for myristoylated and GPI anchored 
proteins. Therefore, curated functional annotations (from UniProtKB) for these proteins 
were used to find their representation in the human proteome and the lipid raft proteome. 
Collectively, using this new information, about 9% (1845) of the total human proteins were 
found to be lipid modified (Figure 3.4). A large section of these lipid modified proteins 
(73%) were palmitoylated. Other modifications like myristoylation, prenylation and GPI-
anchor attachments constituted 11% (193), 9% (167) and 7% (134) respectively of all the 
lipid modified proteins. I then calculated the representation of this final lipid modified 
proteins associated with the lipid rafts. A detailed statistical analysis about individual raft 
targeting features is in the section (3.3.4). Out of all human palmitoylated proteins (1351) a 
significantly large part (980) proteins were found to be in the lipid raft dataset. This shows 
the palmitoylated proteins preferentially partitioned to the raft domains. On the other hand, 
41% (79) of all myristoylated proteins were raft localized. The raft associated prenylated 
subset covered exactly half (84) of the total prenylated proteins. It has been estimated that 
the GPI-proteins comprise of about 1-2% of total human proteins322. A proteomic analysis 
of breast cancer cells identified about 93 proteins on the cell surface suggesting a cell type 
specific expression of GPI-anchored proteins323. Although, a number of targeted studies 
claimed that the GPI-anchored proteins to be selectively aggregated in the lipid rafts, my 
results showed that only about 54% (72) of known GPI-anchored proteins were identified 
in proteomics studies. A possible reason could be the limitation of LC-MS/MS techniques 
to detect low abundant proteins in the sample unless selective enrichment strategies being 
implemented.  
  63 
 
 
Figure 3.4 A systematic analysis of post-translational lipid modifications in the human 
proteome along with the relative proportion of four sub-groups of lipid modifications in the 
lipid raft proteins (green) and non-raft human proteins (blue) 
3.3.2.2 Interactions with cholesterol 
Proteins can attach to the lipid rich cell membrane through a wide array of interactions with 
membrane lipids, including raft-enriched lipids such as cholesterol, sphingolipid and 
gangliosides. Unfortunately, there is hardly any data available for proteins binding to 
sphingolipids and gangliosides, therefore I focused on the cholesterol binders. This 
preferential binding would specifically target these proteins to ordered membrane domains. 
For example, the amyloid precursor protein (APP), partitioned to the lipid rafts with the 
help of its cholesterol-binding domain (a GxxxG motif). This motif was previously 
implicated in helix–helix oligomerization324-325. It is possible that the cholesterol binding 
recruits proteins to the raft compartment and assist GxxxG mediated protein–protein 
interactions. Recognition of cholesterol by the GxxxG motif sparked an identification of the 
cholesterol recognition amino acid consensus (CRAC) motif 326-327. CRAC motifs are a 
loosely defined, ubiquitous, pattern of amino acid sequence (L/V-X1–5-Y-X1–5-(R/K)), 
shown to directly interact with cholesterol328. Several proteins with the CRAC motifs have 
been implicated in raft partitioning22, 329-330, suggesting that selective cholesterol binding 
may be one way to ‘lubricate’ a protein for raft compartmentalisation. Likewise, an inverted 
CRAC/CARC domain22 “[R/K]-X[1,5]-[Y/F]-X[1,5]-[L/V]” have been proposed to be a 
cholesterol recognizing signature for some proteins22.  
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To determine if these individual protein-level observations hold true for the proteome-wide 
data, I searched for the CARC and CRAC motifs in the human proteome and lipid raft 
proteome using the short linear motif finding tool SLimSuits311. The results showed that 
98% of the entire human lipid raft proteome is represented by either CRAC or CARC motif. 
Additionally, this bioinformatics analysis also found similar proportion of these two motifs in 
human proteome and human plasma membrane proteins (99% and 96% respectively). 
Based on the results, it was difficult to believe that entire proteome to have a potential to 
bind to cholesterol based on CRAC and CARC motifs. This extraordinarily huge fraction of 
cholesterol recognising proteins in the proteome is practically impossible. Furthermore, a 
close examination of these motifs suggested that these motifs are too general, capturing 
the linear sequences up to 13 amino acids between Leucine (L) and arginine (R) or Lysine 
(K) which are observed abundantly in the human proteome. Collectively, my analysis 
suggested that both CRAC and CARC motifs, reported in the literature, produced very 
large number of false positive largely because their vague nature. Therefore, the use of 
these motifs to determining cholesterol-binding proteins in the proteome-wide analysis was 
not suitable. Therefore, I again turned back to the literature to find experimentally validated 
proteome wide cholesterol binding dataset. Recently, using a quantitative chemo-
proteomic approach, Hulce et al.317 reported global map of cholesterol-protein interactions 
in living cell. This proteomic investigation identified 855 sterol binding proteins in the colon 
cancer cell line. For cholesterol binding proteins, I used this dataset, mapped to 798 
UniProtKB entries, for further analysis. This dataset showed that, about 4% of total human 
proteins have the capacity to preferentially bind the cellular sterols. For the raft associated 
protein list, about 66% (455) of all cholesterol-binding proteins were detected in the lipid 
raft proteomic studies, indicating selective aggregation of proteins to the rafts via 
cholesterol binding.  
3.3.2.3 Lipid raft associated transmembrane proteins 
The final property of intrinsic raft proteome was the presence of transmembrane domain 
(TMD). Lipid membrane provide a hydrophobic environment that is favored by the span of 
hydrophobic amino acid residues present in the alpha helical TMD. I assumed that if a 
protein with a TMD is detected in the lipid raft proteomic experiments, it is highly likely to 
be a native lipid raft protein. Numerous applications are available to predict the presence 
of TMD in protein sequence using a variety of computational algorithms and were recently 
reviewed in a benchmark study301. In this study, I have used two prediction methods 
TMHMM and TOPCONS based on their universal acceptance and high sensitivity and 
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specificity in the TMD prediction. I have collected TMD status predictions from each of the 
predictors and considered a positive transmembrane protein to be the one that both 
methods have agreed upon the prediction. TMHMM predicted 3818 proteins to have TM 
signature, while TOPCONS predicted 5319 transmembrane proteins in the entire human 
proteome. Here I Both TMHMM and TOPCONS showed a strong overlap among the 
predicted TMD containing proteins. It has been estimated that around 20-30% of 
mammalian proteome is comprised of TMD containing proteins331. However, after applying 
the highly stringent cut off for the prediction agreement, my results showed that 16% 
(3483) of all human proteins contained one or more TMDs that help them penetrate the 
lipid bilayer. Of these, 38% (1283) were found in the human raft proteome. The TMD 
proteins represent 26% of the total human lipid raft proteome, making TMD the most 
common mechanism of intrinsic raft targeting.  
However, the computational analysis of TMD has few potential downfalls. Firstly, 
transmembrane domain containing proteins are present ubiquitously throughput the cell. 
Transmembrane proteins not only occur in the plasma membrane but also integral part of 
membranes of other organelles such as mitochondria, endoplasmic reticulum or Golgi 
bodies. For instance, type II transmembrane proteins were reported to be localised in the 
Golgi bodies. Here I considered all the proteins with a transmembrane domain to be raft 
associated, irrespective of further knowledge of their original localization. The field of TMD 
domain prediction is still evolving and there is a space for improvement in tools and/or 
proper computational algorithms for accurate plasma membrane localization and TMD 
length prediction (further discussed in detail in Chapter 5). Therefore, some unexpected 
results from computational analyses must be viewed with caution unless parallel studies 
are undertaken to validate the localization of the identified proteins. A separate analysis 
about relative frequencies of TMDs in individual proteins was reported in Appendix III 
supplementary Figure 7.1. 
During the quest of uncovering intrinsic raft proteome, I observed that the individual 
proteins could have one or more raft sorting features. When I combined the results of all 
the individual features of raft signals in the human proteome, I found a non-redundant list 
of 25% (5165) of all human proteins exhibited three intrinsic signals: TMD, lipid 
modification and lipid binding. At the same time, applying the exact same filtering criteria 
on the complete lipid raft proteome I found that 44% (2183) of human raft proteins could 
be characterised by these sequence determinants as intrinsic lipid raft proteins. This 
suggested compared to complete human proteome, there were about 20% more intrinsic 
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proteins occur in the lipid raft proteome. Collectively, the analysis of direct raft sorting 
features revealed that the 26% of all raft proteins contains TMD. Furthermore, in total 
~25% of all raft lipid-modified proteins have exhibited 20% palmitoylation, 1.6% 
myristoylation, 1.7% prenylation and 1.5% GPI-anchor attachment. Out of all lipid raft 
proteins 10% showed cholesterol binding potential.  
3.3.3 Shared raft partitioning mechanisms among the intrinsic raft proteins 
Next, I investigated how often a protein contains multiple intrinsic raft targeting features. 
For example, flotillin-2 is known to be palmitoylated and myristoylated, both are crucial for 
its raft compartmentalisation271. Therefore, I calculated the frequency of intrinsic raft 
association features present in individual proteins in human proteome (Figure 3.5a) and 
the lipid raft proteome (Figure 3.5b). I observed that the majority of proteins fulfilling the 
intrinsic criteria in the human proteome (85%) and the lipid raft proteome (69%) only 
contain a single feature. For human raft proteins, the intrinsic features co-occur in about 
15% (802) of total proteins. Interestingly, around 31% (685) of intrinsic raft proteins have 
more than one raft-targeting signal in their sequence. I further analyzed the representation 
of individual intrinsic signals in the single feature containing proteins. In both human 
proteome and the human lipid raft proteome, TMD feature usually do not co-occur with 
other the features (Figure 3.5). The same observations holds true for palmitoylation. 
However, most of the cholesterol binding feature containing proteins also has either TMD 
or the lipid modifications (Figure 3.5). This is partly due to the beta-face of the cholesterol 
being easily available for interaction with proteins after its non-covalent bonding with 
sphingolipids inside the lipid rafts. Interestingly, for the lipid raft protein dataset, three 
proteins shared maximum of four features that assist their raft compartmentalization. One 
of these proteins is BST2, a lipid raft associated bone marrow stromal antigen, 
predominantly detected in lipid raft fractions of immune cells115, 332-333, HeLa cells258, breast 
cancer334 and melanoma cell lines335 in mass spectrometric studies using both detergent 
and detergent-free lipid raft extraction methods. BST2 is a protein with an unusual 
topology336 with a N-terminal transmembrane domain and a C-terminal GPI-anchor. 
Moreover, the results for this analysis showed BST2 to be a cholesterol-binding protein 
and contained S-palmitoylation modification.  
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Figure 3.5: Shared intrinsic protein signatures in individual proteins from (a) human 
proteome (b) lipid raft proteins 
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3.3.4 Comparison of human lipid raft and plasma membrane proteome 
Lipid rafts are long considered as sub-compartments of the plasma membrane with distinct 
physicochemical properties. Proteins detected in the lipid rafts would therefore be a subset 
of plasma membrane localized proteins. To determine whether the proposed lipid raft 
targeting mechanisms were only lipid raft specific or can also be seen throughout the cell 
surface, I investigated the entire membrane proteome. Upon an extensive literature 
search, I could not find any dedicated resource (similar to RaftProt for lipid raft proteome) 
for the plasma membrane proteins. Hence, I considered a list of proteins localized to the 
plasma membrane as per the UniProtKB curated annotations. Next, I performed overlap 
analysis of lipid raft proteome with the UniProtKB plasma membrane proteome. My results 
suggested that lipid raft proteins make only a quarter of (795) all plasma membrane 
proteins (3029) based on UniProtKB annotations. About 75% (2234) of all the plasma 
membrane proteins have not been detected in the lipid raft fractions by LC-MS/MS 
techniques. A lack of reliable plasma membrane isolations methods and/or relative low 
abundance of plasma membrane proteins for the detection by mass-spectrometry could be 
the possible reasons for this finding337-338. Looking into lipid raft proteome perspective, I 
noticed that 17% of the lipid raft proteins were found to be associated with the plasma 
membrane. Inside the cell, sub-organelles are wrapped into their own lipid membranes 
that separate them from cytoplasm to perform specific functions. Interestingly, some of the 
latest advances in the microscopic techniques have recently found the raft like domains in 
the other subcellular organelles like endosomes339-340, phagosomes259, intracellular 
vesicles341, trans-Golgi network342 and the mitochondria343-346. Therefore a large proportion 
of raft proteins may derive from subcellular raft compartments. If an integral raft targeting 
mechanisms are specific to the lipid rafts, I hypothesize that their share to be negligible in 
the plasma membrane proteome which is not raft associated (2234). To test this 
hypothesis, I applied the same filtering strategy on the plasma membrane proteome, and 
the non-raft plasma membrane proteome to calculate proportion of each intrinsic raft 
associated sequence feature. I then performed a statistical analysis to compare extent of 
these features in lipid-raft and plasma-membrane proteome against the complete human 
proteome (Figure 3.6). Detailed statistical analysis is provided in Supplementary Table 7.1 
in Appendix III. Compared to the human proteome, features like TMD, GPI-anchor 
attachment, myristoylation and prenylation were significantly higher in both raft proteome 
and plasma membrane proteome. Interestingly, lipid rafts were found to be significantly 
enriched in cholesterol binding and palmitoylated proteins compared to both UniProtKB 
plasma membrane proteome and the non-raft UniProtKB plasma membrane proteins. This 
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suggests both these class of proteins preferably be associated with the lipid raft 
membrane fractions. Palmitoylation, in particular, was statistically enriched in the lipid raft 
and the whole plasma proteome but not the non-raft plasma membrane subset, indicating 
that majority of palmitoylated proteins on the cell surface were lipid raft associated. 
Moreover, cholesterol binding proteins were statistically enriched in the lipid rafts and 
under-represented in the non-raft plasma membrane proteins compared with human 
proteome. On the other hand, plasma membrane is significantly enriched with 
transmembrane proteins, as expected. The rest of the features (myristoylation, prenylation 
and GPI-anchor attachment) were not significantly different in all three datasets (i.e. lipid 
raft proteome, UniProtKB plasma membrane proteome and non-raft UniProtKB plasma 
membrane proteome). 
 
Figure 3.6: Statistical analysis of representation of intrinsic raft localisation features in four 
datasets: lipid raft proteome, high confidence raft proteome, UniProtKB plasma membrane 
proteome and Non-raft plasma membrane proteome. Each feature was compared against 
feature space of entire human proteome. P-values for over-representation analysis were 
calculated using one tailed Fishers-Exact test.  
Where **, p-value < 0.001; ***, p-value < 2.2e-16 and n.s, non significant 
In a complementary analysis, I determined the representation of an individual intrinsic raft 
targeting determinants in the three subsets of human proteome: lipid raft proteome, 
plasma membrane proteome and the non-raft plasma membrane protein list (Figure 3.7), 
with numerical details provided in Appendix III supplementary Table 7.2 of this thesis. 
Cholesterol-binding proteins were highly represented in lipid rafts, 66% (495), with an only 
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minor representation (5%) in the non-raft plasma membrane. All the three datasets have 
similar share of TM proteins ranging from 34% to 40% of all the human TMD containing 
proteins. Palmitoylation, on the other hand, was predominantly enriched in the lipid rafts 
with non-raft proteins representing only 7% of all palmitoylated proteins. Interestingly, 
almost every GPI-anchor protein was present on the cell surface with roughly equal 
distribution (54% and 45%) in the lipid raft and the non-raft plasma membrane 
respectively. Lipid rafts were found to harbour half of all human prenylated proteins. A 
complementary analysis of all membrane proteins revealed that over half of the human 
prenylated proteins were attached to the plasma membrane. Non-raft component of the 
plasma membrane contained 29% of prenylated proteins (out of 58%), indicating other half 
of plasma membrane localised prenylated proteins could be raft residents. The share of 
myristoylated proteins localised to cytoplasmic end of the cell surface was 43%, indicating 
not all myristoylated proteins targeted to the cell membrane. Again, similar to the 
prenylated proteins over half of the plasma membrane associated myristoylated proteins 
were distributed in the raft domains.  
 
Figure 3.7: Bar plot representing relative proportion of all known human lipid modification, 
cholesterol-binding and TMD signatures in the human raft (green) and non-raft plasma 
membrane proteome (blue), as a remaining subset of entire human raft proteome (grey).  
In Chapter 2, I have derived an exclusive subset of high confidence raft proteins. This 
dataset comprise of those detected in proteomic investigations by two or more biochemical 
raft-isolation methods and/or altered by cholesterol modulating agents. To determine 
whether the notion of higher representation of lipid-driven raft-targeting features holds true 
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in this experimentally annotated subset of lipid raft proteins, I performed similar statistical 
analysis (Fishers Exact test), as above, on the subset of high confidence raft proteins 
dataset. Indeed, when compared with entire the human proteome, high confidence 
proteins were selectively enriched (p value < 0.05) with all the raft-targeting features 
investigated above. Interestingly, these results coincide with observation from total raft 
proteome, and further advocate benefits of using multiple raft isolation methods to 
selectively elevate concentration of raft proteins with characteristic molecular features. The 
use of two or more methodologies in parallel to each other could also help to reduce 
potential cross-contaminations arise due to individual isolation procedures, which is a 
common criticism faced by the raft biology field.  
3.3.5 Defining extrinsic protein components of lipid rafts 
Lipid rafts are known to restrict the lateral diffusion of proteins and thereby create a 
favorable environment for proteins to interact. Even though the role of the lipid raft as a 
coordinator of protein-protein interaction has been documented, very little is known about 
the global interaction potential of these microdomains. From my analysis, I found that more 
than half of human lipid raft proteome does not contain an intrinsic membrane raft 
targeting mechanism. If lipid rafts act as a scaffolds to facilitate the protein-protein 
interactions, proteins can also be drawn to the rafts via binding to intrinsic raft proteins, as 
illustrated in Figure 3.1a for cytoskeleton and S-palmitoylated proteins. Proteins indirectly 
recruited to lipid rafts through protein-protein interactions were classified as extrinsic raft 
proteins (Figure 3.8a). To determine the potential extrinsic raft proteins, I carried out 
protein interaction network analysis of the raft proteome. For that I focused my attention to 
the non-intrinsic raft protein fractions. I noticed that, about 65% of intrinsic raft proteins 
(1417) have an experimentally validated known binding partner present in the non-intrinsic 
human raft proteome. This extrinsic class of proteins represents 34% (1685) of complete 
human lipid raft proteome. Similarly, I analyzed protein-protein interactions among intrinsic 
raft proteins. An experimentally annotated interaction information was available for 79% 
(1722) of all the intrinsic raft proteins (2183) indicating a strong interconnections among 
them within the lipid raft compartments (Figure 3.8b). These protein-protein interactions 
(PPI) can further be differentiated into three groups: (i) intrinsic raft proteins binding only to 
other intrinsic proteins (305) (ii) intrinsic raft proteins interacting with other intrinsic proteins 
as well as non-intrinsic raft residents (1263) and (iii) intrinsic raft proteins only exhibit 
binding to the non-intrinsic raft proteins (154).  
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The intrinsic and extrinsic classes of raft proteins together account for 78% (3867) of the 
human lipid raft proteome, leaving the remaining 22% (1031) with unexplained raft 
partitioning mechanism. I called this subset of lipid raft proteins as raft dependent proteins. 
These proteins could be potential contaminants in LC-MS/MS studies or might have a 
novel raft-targeting mechanism which is yet to be determined. I also performed a network 
analysis of combined protein-protein interactions among the raft localized intrinsic and 
extrinsic proteins (3386/60% in total) after removing self-loops and hanging nodes in the 
network. Figure 3.8a highlights the extent of interconnections among intrinsic and extrinsic 
lipid raft proteins. I noticed that these proteins take part in a large number (25680) of 
interactions among them.  
 
Figure 3.8: Human lipid raft associated protein-protein interaction network. (a) 
Protein-protein interaction network of extrinsic and intrinsic human lipid raft proteome. Red 
coloured proteins are intrinsic raft proteins and blue coloured proteins are extrinsic raft 
proteins. (b) Proportion of intrinsic raft protein taking part in PPI interactions. (c) The 
degree distribution of the intrinsic lipid raft proteins fitting the power law (d) The degree 
distribution of the extrinsic component of the lipid raft fitting the power law. 
It is important understand the complex architecture of PPI network within the lipid raft and 
to characterise whether the generated network belongs to real world network having a 
capability to reflect underlined biology. Thus, I performed network analysis to catalogue 
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various topological properties of raft associated PPI network. A number of raft-associated 
binding partners for an individual protein (degree of the protein) was of particular interest 
to us as it dictates the interaction potential of two classes (intrinsic and extrinsic) of human 
lipid raft proteomes. I then individually analysed subnetworks of intrinsic and extrinsic 
proteins and found that both the subnetwork form a small world network. This is based on 
the observation that the degree distribution of both these network followed the power law 
(Figure 3.8c, d). In general, intrinsic proteins either show a large number of 
interconnections with other intrinsic components or attract extrinsic raft components to the 
lipid raft environment. The top ten highly connected intrinsic proteins are: APP, ELAVL1, 
ITGA4, CAND1, YWHAZ, EGFR, RPA1, HSP90AA1, NPM1 and YWHAQ. On the other 
hand, most of the highly interacting extrinsic raft proteins are part of the ubiquitination 
machinery such as CUL3, FBXO6 and CUL5 along with stromal proteins such as FN1, 
CDK2. Other extrinsic proteins showing high degree of connectivity were ILK, GRB1, 
RPA2, TARDBP and ARRB2. 
Until now, in this study all the computational analysis was performed on the complete list 
of human raft associated proteins in an unbiased manner. In my earlier work238, while 
developing the lipid raft proteome database RaftProt, we proposed an experimental 
evidence based filtering criteria to improve the confidence of proteins detected in the lipid 
raft proteomics studies. Our previous method was based on the two observed 
experimental parameters: (i) detection of proteins by two or more biochemical isolation 
methods and/or (ii) sensitivity of a raft protein towards a gold standard MBCD treatment. 
We called proteins fulfilling the above mentioned very conservative criteria as the “bona 
fide” high confidence lipid raft proteins. Next, I wanted to evaluate the extent of overlap 
between the experimentally derived ‘confidence’ levels with the mechanism-based 
‘intrinsic/extrinsic’ classification. Using the highly conservative experimental evidence 
strategies only about one third (1797) of all lipid raft proteins satisfied the bona-fide raft 
protein criteria. I observed that this high confidence dataset mainly comprised of intrinsic 
and extrinsic raft components (1599, 89%). As no raft localization mechanisms were 
detected in the remaining 11% (198) of the high confidence proteins, I initially anticipated 
that these are contaminant proteins. However, a closer examination showed that a 
proportion (55%, 109) of proteins identifiers in this dataset were obsolete, which either 
could be merged to other UniProtKB identifiers or deleted from the database. Interestingly, 
84 of these protein IDs were merged with other identifiers of high confidence proteins and 
another 17 were merged with the proteins from the (low confidence) lipid raft proteome. 
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Taking this intriguing finding into account, the number of raft dependent proteins is 
reduced to 116, or 6% of all high confidence raft proteins. A possible explanation of 
detection of these 6% in multiple lipid raft proteomics experiments could be their indirect 
interaction with mediated by the extrinsic components of lipid raft.  
Table 3.4: The relative proportion of lipid raft targeting mechanisms in experimental based 
raft protein categories 
Human Lipid raft 
proteome 
Intrinsic raft 
Proteome 
Extrinsic raft 
proteome 
Co-isolated lipid 
raft proteins 
Total (4898) 2183 (44%) 1684 (35%) 1031 (21%) 
High confidence 
(1797) 
1144 (64%) 455 (25%) 198 (11%) 
Altered with MBCD 
(732) 
441 (60%) 167 (23%) 124 (17%) 
A cyclic oligosaccharide (MBCD), is widely used in cell biology studies for the controlled 
manipulation membrane cholesterol347. This modulation attributed to the disruption of lipid 
raft domains and associated cellular functions348. Change in expression of raft localized 
proteins upon MBCD treatment was therefore considered as “a test” to determine true 
positive matches for lipid raft association, at molecular level349 and proteome-level157. 
Although MBCD treatment is widely used in the targeted studies such as western blotting, I 
noticed that, this gold-standard test has been under-utilized in the proteomic profiling of 
the lipid raft. While collecting proteomics datasets for the RaftProt database, I could 
identify eight experiments employing cholesterol depletion strategies before LC-MS/MS 
analysis. Collectively, I found 732 proteins (15% of all lipid raft associated proteins) 
showed altered expression upon MBCD treatment. I then calculated the relative fraction of 
intrinsic and extrinsic raft features in this dataset. An intrinsic raft association mechanism 
was found in 60% (441) of MBCD sensitive proteins and other 23% proteins in this dataset 
have known PPI association with intrinsic counterparts. Together these two classes make 
up of 83% of all MBCD sensitive raft protein group which was slightly less than their 
proportion in the high confidence lipid raft protein dataset. Likewise, I also failed to notice 
raft association signals for 17% (124) of MBCD sensitive group of raft proteins. Again this 
could be due to the discrepancies with the protein identifier mapping in the UniProtKB. 
Taken together, my unbiased computational analysis has provided an insight into how 
proteins target to lipid raft membrane microdomains at proteome level. Around half of all 
lipid raft proteins possess one of the three raft sorting features namely: TMD, lipid 
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modification and lipid binding. The share of this class of raft proteins was found to be 
greater (ranging from 60 to 64%) in the high confidence lipid raft proteome derived from a 
very conservative experimental estimates. This suggests that the experimental evidence 
based criteria was able to correctly identify a large proportion of proteins with raft 
partitioning mechanisms. Considering the subset of entire extrinsic component of lipid raft, 
these raft-interacting proteins were found less frequently (around 10% lesser) in the high 
confidence and MBCD sensitive subsets. In contrast, the proportion of co-isolated raft 
proteins was found to be larger in the total raft proteome compared to high confidence 
subset, suggesting the experimental parameters, we proposed earlier, were capable of 
distinguishing the true raft residents over co-isolated raft proteins. This also highlights the 
fact that the chances of detecting co-isolated proteins in the rafts using the combined 
analysis of results from two or more raft isolation methods would be drastically reduced.  
3.3.6 Functional characterization of human lipid raft proteome 
Having classified the human raft proteome based on targeting mechanisms, I went on to 
perform functional characterization, in order to reveal its molecular functions. I reasoned 
that the intrinsic, extrinsic and raft dependent protein categories will represent different 
protein families. To test this, I performed a protein class enrichment analysis of three 
mechanism based subsets of raft proteins against the total raft proteome using the 
PANTHER tool. The statistically significant (Bonferroni corrected p value <0.05) over-
represented or under-represented protein classes in each subset was visualized along 
with the relative proportion of given class in the remaining two groups (Figure 3.9). 
Proteins belonging to cation transporters, ion channels, receptors and SNARE proteins 
were significantly increased in the intrinsic component of lipid rafts by over 2 fold. 
However, these proteins were significantly under-represented (≥ 6 fold) in the extrinsic and 
raft dependent subsets (Figure 3.9). The membrane association/penetration (specifically 
the presence of transmembrane domain) of all these enriched protein families of 
transporter and receptors was very well characterized in the literature350-352. Furthermore, 
their raft association is critical to propagate crucial signals in and out of the cells59, 353-354. 
On the other hand, the extrinsic raft proteome showed statistical enrichment (≥ two fold) of 
kinases, G-protein modulators, cytoskeletal proteins, enzyme modulators, guanyl-
nucleotide exchange factors and non-receptor serine/threonine kinases. These proteins 
are known to be localized near the cytosolic face of the cell membrane and involved in the 
formation of functional complexes with the integral membrane proteins to assist signaling 
cascade. Unexpectedly, the raft dependent dataset showed a strikingly higher (~ 3 to 6 
  76 
 
fold more) representation of nuclear proteins such as KRAB box and zinc finger 
transcription factors and cytoplasmic microtubule binding motor proteins. While these 
proteins could be contaminants co-isolated along with other proteins during the lipid raft 
purification process, their over-representation suggest that these nuclear proteins may be 
binding partners of some cytoskeletal proteins (belonging to the extrinsic raft subclass), 
especially microtubules which are extended from cell surface to the nucleus, and therefore 
drawn to the lipid raft fractions during isolation. This analysis also highlights the top-down 
architecture of the signaling pathways within the lipid rafts, where the cell surface 
receptors, transporters (intrinsic components) senses the stimulus; the scaffolding and 
adaptor proteins then bring together different kinases, enzymes and cytoskeletal proteins 
(extrinsic component) near the cell surface where they propagate the signal to the inner 
core of the cell (possibly via raft dependent proteins).  
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Figure 3.9: Protein class enrichment analysis of three categories of raft proteins, identified 
in the mass spectrometry experiments, using PANTHER over-representation analysis. 
Each protein class is significantly enriched (p-value < 0.05) in at least one out of three 
categories. 
I also extended my analysis to experimental evidence based subgroup of high confidence 
lipid raft protein category to investigate whether the protein class enrichment in the 
mechanism based categories are similar for this class. Here I used the entire high 
confidence lipid raft protein list as my background set. Except, a significant over-
representation of cytoskeletal proteins (1.6 fold with p-value 2.49E-02) of the extrinsic 
fraction of high confidence lipid raft rafts, I failed to see statistical significant enrichment of 
any protein families in the intrinsic and co-isolated fractions. Additionally, I did not see 
enrichment any protein class in the MBCD sensitive raft proteins for any of the mechanism 
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based subsets. I believe it is partly due to implementation of a conservative multiple testing 
Bonferroni correction on a relatively smaller dataset or a high number of proteins (65%) in 
the intrinsic raft protein group of the high confidence raft protein list. It is also possible that 
these intrinsic proteins could represent very diverse families of proteins. However, a 
detailed investigation is needed to evaluate this claim.  
In a cellular context, proteins don’t function alone but rather engage in the one or more 
signaling or metabolic pathways. A detailed analysis of pathways is therefore important to 
interpret cellular events such as signaling, regulation and enzymatic reactions controlled 
by aggregates of protein molecules. To elucidate the system-wide processes regulated by 
the lipid raft proteins, I carried out pathway over-representation analysis. Here, I 
hypothesize that, if intrinsic and extrinsic raft elements has an ability to interact with each 
other, together, they will highly likely to act as regulative components of same pathways. 
Therefore, in contrast to analysis presented so far, here I have used a combined dataset of 
intrinsic and extrinsic raft proteins for pathway analysis. Furthermore, I wanted to dissect 
the pathways specifically partitioned in the lipid rafts but not in the non-raft plasma 
membrane. Hence, I included the UniProtKB non-raft plasma proteome dataset (described 
in Table 3.1), for pathway enrichment analysis. Figure 3.10 describes results of pathway 
enrichment analysis of integral, extrinsic lipid raft proteins and non-raft plasma membrane 
proteins datasets, against the entire human proteome as a background, using PANTHER 
tool after applying a Bonferroni correction (p-value < 0.05). Pathway analysis highlighted 
some of the interesting findings regarding commonalities and differences among raft and 
non-raft proteome. Proteins involved in 5HT1 receptor signaling pathway were present in 
both raft and non-raft proteome, indicating dynamic communications between membrane 
microdomains and rest of the regions on the cell surface. However, stimulation of 5HT2 
and 5HT4 receptors and downstream events selectively occurs in raft domains, suggesting 
involvement of raft proteins in regulating receptor-isoform specific pathways. Similar to 
5HT1 signaling pathway, dopamine and heteromeric G-protein signaling pathways were 
significantly over-represented in raft and non-raft proteome. Importantly, this work also 
revealed pathways predominantly affected or regulated by lipid raft associated proteins. 
Striking enrichment has been observed in proteins engaged in integrin signaling, 
cytoskeleton regulation by Rho GTPase, DNA replication, glycolysis, Parkinson disease 
and T-cell activation in the raft assemblies. Integrin pathway and underlying cytoskeleton 
meshwork are crucial for cell-adhesion355 and motility356. Therefore, disruption of raft could 
influence cellular morphology or phenotype or alter tissue arrangement. On the other 
hand, non-raft components were observed to be over-represented in cadherin signalling, 
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GABA-B receptor signalling, Wnt signalling and glutamate receptor signalling pathways. 
Collectively, this piece of work demonstrated fundamental pathway-level dissimilarities 
between the raft proteins and non-raft plasma membrane proteins. These observations 
suggest involvement of the cholesterol-rich membrane microdomains in controlling raft-
dependent cellular functionalities that are distinct from those regulated by the non-raft 
plasma membrane regions on the cell surface. 
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Figure 3.10: Pathway enrichment analysis of lipid raft proteome (intrinsic plus extrinsic raft (blue) and non-raft plasma proteins (orange) 
compared to complete human proteome. Each pathway is significantly enriched (p-value < 0.05) in at least one out of the three 
categories. (*) is significance in lipid raft dataset and (†) is significance in non-raft plasma membrane dataset
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In summary, I presented, for the first time, a detailed computational analysis of the human 
lipid raft proteome to characterise the raft localised protein landscape. Human lipid raft 
proteins were classified into intrinsic, extrinsic and raft associated protein groups based on 
the structural and protein-binding features. Three possible ways: TMD, cholesterol binding 
and lipid modification for protein to be intrinsically associated with lipid-raft were 
investigated using computational algorithms and data-driven analysis. Statistical analysis 
of lipid raft association features indicated prevalence of palmitoylated and cholesterol 
binding proteins in the lipid raft proteome. Network biology approach was used to 
determine extrinsic protein components and the interaction potential of membrane 
microdomains. Finally, the protein class and pathway enrichment analysis, notably pointed 
the functional differences among different mechanism based categories of raft proteins.  
3.4 Conclusions 
Lipid rafts are integral to cell homeostasis, adhesion, migration and signaling and their 
disruption is implicated in variety of diseases. However, how proteins are sorted to the lipid 
rafts is largely unclear. Here, I described a detailed bioinformatics analysis of the largest 
dataset of human lipid raft proteins, to characterize their mechanisms of raft-association. I 
proposed raft-targeting feature based classification of human lipid raft proteins into 
Intrinsic, extrinsic and raft associated protein components. Comparative analysis of 
different proteome-wide datasets suggests selective partitioning of proteins to the rafts is 
mediated by lipid-driven mechanisms. A complex interplay among the lipid rafts proteins in 
the form of highly interconnected network was seen, indicating lipid rafts as a potential 
interaction platform of the cell. Our enrichment analysis highlights an important and yet 
diverse role of lipid rafts in regulating several cellular processes. We anticipate that the 
refined representation of human lipid raft proteome described here, will improve our 
knowledge the raft domains and make a valuable contribution towards understanding lipid 
rafts in human health and disease. 
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CHAPTER 4 
PAN-CANCER LIPID-RAFT PROTEOME ANALYSIS 
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4. Chapter 4: Pan-cancer lipid raft proteome analysis 
Overview 
Lipid rafts are dynamic membrane micro-domains that orchestrate molecular interactions, 
and are implicated in cancer development. To understand the functions of lipid rafts in 
cancer I performed an integrated analysis of quantitative lipid raft proteomics datasets 
modelling progression in breast cancer, melanoma and renal cell carcinoma. This analysis 
revealed that cancer development is associated with increased membrane raft-
cytoskeleton interactions, with around 40% of elevated lipid raft proteins being cytoskeletal 
components. Previous studies suggest a potential functional role for the raft-cytoskeleton 
in the action of the putative tumor suppressors PTRF/Cavin-1 and Merlin. To extend the 
observation, I examined lipid raft proteome modulation by an unrelated tumor suppressor 
Opioid Binding Protein Cell-adhesion Molecule (OPCML) in ovarian cancer SKOV3 cells. 
In agreement with the other model systems, quantitative proteomics revealed that 39% of 
OPCML-depleted lipid raft proteins are cytoskeletal components, with microfilaments and 
intermediate filaments specifically down-regulated. Furthermore, protein-protein interaction 
network and simulation analysis showed significantly higher interactions among cancer raft 
proteins compared to general human raft proteins. Collectively, these results suggest 
increased cytoskeleton-mediated stabilization of lipid raft domains with greater molecular 
interactions as a common, functional and reversible feature of cancer cells. This chapter is 
accepted to be published as: “Integrative analysis of subcellular proteomics studies 
reveals functional cytoskeleton membrane-lipid raft interactions in tumor progression”, 
Journal of Proteome Research, 2016, DOI: 10.1021/acs.jproteome.5b0103. A link to the 
article has been provided in the Appendix II.
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4.1 Introduction 
All cancers share a list of common ‘hallmarks’102, suggesting a convergence of cellular 
mechanisms of malignant transformation. Similarly, metastatic progression involves 
universal phenotypic changes including epithelial mesenchymal plasticity, anchorage-
independent survival, and the ability to establish pre-metastatic niche357. Common 
properties develop regardless of the causal oncogene or tumor suppressor gene or the 
tissue of origin, implying alteration of fundamental cellular mechanisms. A potential 
unifying mechanism may involve modulation of cholesterol and sphingolipid-rich 
membrane microdomains, commonly referred to as lipid rafts223. Raft localization is known 
to regulate molecular interactions, and hence the function, of signaling proteins involved in 
carcinogenesis, such as RAS, EGFR and HER2224, 358-359. Membrane rafts have been 
implicated in the development and progression of several cancers including prostate94, 
breast96, lung98 and colon cancer360, However, it is unclear whether lipid rafts share cross-
cancer similarities in their protein expression profiles, and how lipid raft alterations promote 
cancer. To this end, I performed an integrative analysis of publicly available quantitative 
proteomics datasets that evaluated the cancer-associated lipid raft proteome from breast 
cancer361, melanoma335 and renal cell carcinoma (RCC)243. Conversely, I also examined 
the lipid raft proteome during the reversal of tumorigenic potential of cells, based on recent 
studies reporting lipid raft proteome alterations associated with tumor suppressors 
Polymerase I and Transcript Release Factor (PTRF)20,15 and Merlin19, 362. Here, I further 
investigated the universality of this phenomenon by applying a quantitative subcellular raft 
proteomics approach to the ovarian cancer tumor suppressor OPCML.  
OPCML is a GPI-anchored protein localized to membrane rafts under normal physiological 
conditions363. A comprehensive loss of heterozygosity analysis of 118 epithelial ovarian 
cancer (EOC) cases has identified inactivation of OPCML at 11q25 either due to CpG 
island methylation or due to allelic loss76. A recent independent TCGA study also confirms 
this finding, where 92% of 489 high-grade serous ovarian cancers reported loss of OPCML 
expression119, 364. OPCML promoter methylation is proposed to be a diagnostic as well as 
prognostic marker in EOC365. OPCML inactivation appears to be crucial for EOC because 
recombinant OPCML therapy demonstrated inhibitory effect on tumor growth in vivo366. As 
a GPI anchored-protein, OPCML is entirely localized on the exo-facial leaflet of the plasma 
membrane, hence it is unable to directly mediate signal transduction. We recently found 
that OPCML negatively regulates a subset of receptor tyrosine kinases (RTKs) by altering 
their recycling and ubiquitin-mediated degradation via sequestration to lipid rafts119. 
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However, the molecular mechanism linking OPCML tumor suppressor expression to 
altered RTK trafficking remains unclear. Here, we performed a quantitative lipid raft 
proteomics study to dissect the raft-mediated mechanism of OPCML regulated tumor 
suppression. We also examined the raft-associated mechanism of OPCML P95R, a 
common mutation resulting in substitution of Proline to Arginine at position 95, mediated 
regulation of adhesion potential of tumors76. Furthermore, to evaluate the connectedness 
of proteins in cancer rafts compared to general raft and total human proteome, I compared 
the topological properties of simulated protein-protein interaction networks.  
4.2 Materials and Methods 
4.2.1 Comparison of lipid raft changes during cancer progression in various cancer types 
To evaluate common changes in the lipid raft proteome during cancer progression, two 
publications reporting changes in lipid raft protein composition in breast cancer361 and 
melanoma335 development were identified from RaftProt238. RaftProt is a mammalian lipid 
raft proteome database which is a comprehensive collection of 117 raft proteomes derived 
from 69 cell and tissue types of 6 mammals238. Specifically, experiments utilizing 
quantitative proteomics strategy to understand raft changes during cancer progression 
were selected. A more recent renal cell carcinoma raft proteomics study243, which was not 
present in the current version of RaftProt was also included in the analysis. Data from 
these three studies were pre-processed for an integrative analysis, including mapping to 
UniProtKB accessions as required, removing single peptide identifications, generating the 
same fold-change characterization (aggressive/less aggressive) and applying the same 
cut-off criteria for significant quantitative changes. Fold change criteria was set to > ± 1.5 
for each of the three datasets. Protein abundance ratios for melanoma and breast cancer 
datasets were reversed to maintain consistency in the directionality of protein expression 
change with RCC raft proteomics dataset. I then carried out an overlap analysis on two 
distinct sets: up-regulated and down-regulated proteins from membrane rafts during 
malignant progression to define a ‘core cancer lipid raft proteome’. 
4.2.2 Cytoskeletal proteins enrichment analysis 
Human proteins with gene ontology annotations for biological process, molecular function 
or cellular compartment having the keyword “Cytoskeleton” in Amigo 2.2.0367 (accessed on 
May 12, 2015) were fetched. To increase the protein coverage, a combination annotations 
based on evidences derived from of experimental, computational and other source were 
used. This yielded a set comprised of 8432 annotations mapping to 4393 unique 
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cytoskeleton associated proteins out of 48293 human UniProtKB entries annotated by GO 
terms (Supplementary Table S4.1-appendix IV). This set was designated “cytoskeleton 
associated proteins” of the human proteome. A subset was created from above dataset by 
filtering lipid raft localized cytoskeletal proteins (684 proteins) mentioned in the 
“RaftProt”.238 The Pearson’s X2-square goodness of fit test was performed to characterize 
enrichment of cytoskeletal elements in our ovarian lipid raft proteomics data and in ovarian 
lipid raft localized protein-protein interaction network (methods described below) against 
above mentioned background sets.  
4.2.3 Cell culture and Stable Isotope Labeling by Amino Acids in Cell Culture (SILAC) 
SKOV3 cells were stably transfected with empty control vector, WT OPCML or P95R 
OPCML as described previously.76 Cells were grown under 5% CO2 at 37°C in RPMI/L-
Glut with 10% fetal calf serum and 125 µg/ml Zeocin. For Stable Isotope Labeling by 
Amino Acids in Cell Culture (SILAC) experiments, cells were grown in media lacking lysine 
and arginine with 10% dialyzed fetal calf serum and supplemented with the following 
amino acids: Control SKOV3 cells, normal isotopic Lys and Arg (“0/0”) designated as 
“Light”; P95R mutant expressing SKOV3 cells, 2H4-Lys and 
13C6
14N4-Arg ("4/6"), 
designated as “Medium” and WT OPCML expressing SKOV3 cells, 13C6
15N2-Lys and 
13C6
15N4-Arg (“8/10”) designated as “Heavy”. Cells were grown for more than 200 
doublings in the SILAC media to achieve >99% label incorporation as confirmed by liquid 
chromatography-tandem mass spectrometry (LC-MS/MS).  
4.2.4 Isolation of lipid raft fraction  
Lipid rafts were prepared using the detergent resistant membrane (DRM) extraction 
method as previously described20, 106, 144, 258, 368-370. Equal amount of DRM proteins 
prepared from each cell line was combined to make a Triplex SILAC mixed sample. Three 
biological replicates were independently prepared using different passage cells. DRM 
proteins (30 µg of mixed sample) were separated by SDS-PAGE to eight fractions and in-
gel tryptic digest was performed using a liquid handler as previously described368.  
4.2.5 LC-MS/MS, Database Searching, SILAC Quantitation and Statistical Analysis 
Digested samples were analyzed using a 1200 Series nano HPLC and Chip-Cube Q-TOF 
6510 (Agilent Technologies). Peptides were separated on a 160 nl (75 mm * 150 μm) high 
capacity C18 reverse phase chip by a 55 min gradient from 0 to 45% acetonitrile with the 
Vcap 1850 V, fragmentor 175 V. Precursor ions were selected in the range of 100–3200 
m/z and fragment ions at 59–3200 m/z; reference ion mix was applied. Triplex SILAC 
  87 
 
samples were analyzed in auto MS/MS mode, with 8 MS and 4 MS/MS per second. Mass 
spectra extraction, database searching, and relative abundance were performed using 
Spectrum Mill software (Agilent, B.04.00) against Human SwissProt database (release-
2014_11 containing 20194 entries). Cysteine carbamidomethylation and SILAC amino 
acids N-Lys, 2H4-Lys, 
13C6
15N2-Lys, N-Arg, 
13C6
14N4-Arg and 
13C6
15N4-Arg were used as 
fixed/mix modifications and oxidized methionine was selected as variable modification. 
Other parameters were: up to 2 missed cleavages for trypsin; minimum of 4 detected 
peaks; ±20 ppm and ±50 ppm threshold for MS and MS/MS measurements respectively. 
Positive identification required a peptide score >10 and >60% scored peak intensity. The 
global peptide level FDR was kept at 0.5% for generating peptide summary from Spectrum 
Mill. Two SILAC ratios namely, L/H and L/M, were considered for peptide quantitation, 
representing protein expression changes upon ectopic expression of WT OPCML (H) and 
P95R OPCML (M), respectively, in the empty vector transfected SKOV3 cells (L).  
Peptides representing known protein contaminants according to common Repository of 
Adventitious Proteins (cRAP version 2012.01.01 from ftp://ftp.thegpm.org/fasta/cRAP 
accessed on August 18, 2014) were manually removed. At the same time, only proteins 
identified by two or more unique peptides were filtered and considered for the downstream 
statistical analysis. I then used this peptide level data against Quantitative Proteomics p-
value Calculator (QPPC)371 server to catalogue the significantly altered proteins in each 
pair-wise comparison. QPPC utilizes peptide level measurements to compute protein 
abundance and statistical significance using the permutation test. We recently 
demonstrated superiority of permutation test over other widely used statistical methods 
because it is not based on data normality assumption372. I selected 10,000 permutations, 
with an outlier removal threshold of 100 for the peptide based SILAC ratios along with two 
cut-off criterion namely, fold change threshold of ±1.5 and p-value < 0.05. Before 
proceeding to calculation of permutation based statistics, QPPC performs additional data 
pre-processing to eliminate (i) peptide ratios that are negative, not numbers or 0s; (ii) 
peptides that are the only single observation of its respective protein; and (iii) peptides that 
have measurements above the outlier threshold. Mean SILAC ratio and standard deviation 
for individual protein was calculated for each of the two pair-wise comparisons namely, 
“Light/Heavy” (L/H) and “Light/Medium” (L/M) separately using QPPC. In order to account 
for experiment-to-experiment variability and to create a baseline for downstream relative 
abundance comparison between L/H and L/M pair-wise comparisons, a mean 
normalization was performed on protein ratios, based on average protein abundance 
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within each pair-wise comparison, during the statistical analysis with QPPC 
(Supplementary Figure S4.1- appendix IV). 
4.2.6 Generation of lipid raft associated protein-protein interaction network  
A human protein-protein interaction network was downloaded from PINA 2.0 (version 
updated on May 21, 2014)373. PINA is a resource of protein-protein interactions, created by 
compiling protein interaction data across six publicly available, manually curated 
databases: HPRD171, IntAct200, BioGRID374, MINT199, DIP375 and MIPS MPact376. As the 
downloaded interactome does not contain all the OPCML binding proteins reported in the 
literature119, I added five interactions to the PINA network (OPCML interacting with each of 
HER2, HER4, FGFR1, FGFR3 and EPHA2)119. I then took the list of all DRM proteins 
identified in our experiment (both those that change abundance, and those that do not), 
and built an “intra-raft” protein interaction network, consisting of only interactions between 
proteins identified in our experiment. Cytoscape 2.8.2 was used for network visualization 
and analysis377.  
Next, protein measurements (abundance and statistical significance of altered expression) 
were overlaid on the ovarian raft associated protein-protein interaction network, together 
with the information about cytoskeleton association in Cytoscape. Three sub networks 
were then created: (a) Interactions among cytoskeleton associated proteins inside the lipid 
raft; (b) Interactions among significantly altered cytoskeleton associated proteins at the 
lipid raft upon WT OPCML expression; (c) Interaction network of first neighbor of 
significantly altered cytoskeletal proteins found in network (b) and analyzed using 
Cytoscape.  
4.2.7 Statistical analysis of protein-protein interaction network topological properties  
Permutation testing was used to determine the statistical significance the network 
properties of cancer raft networks compared with networks derived from the proteome of 
normal human rafts. One thousand protein-protein interaction (PPI) networks were 
generated by fetching experimentally validated interactions between 230 randomly 
sampled proteins (the total number of proteins identified in ovarian raft) from multiple 
datasets: the complete human proteome, human raft proteins (from RaftProt)238 along with 
cancer raft datasets belonging to RCC243 and prostate cancer lipid raft proteome.20 Each of 
the thousand networks was built by retrieving interactions associated with each random 
protein set from the PINA2 human interactome. For each PPI network, I calculated the 
total number of nodes, total number of edges and average degree distribution using the 
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igraph package in R (www.r-project.org)378. The data generated from 1000 networks 
derived from the normal human raft proteome was used to generate a distribution of 
values. I then use a z-test to determine the significance of the properties of networks 
sampled from the human proteome and three cancer raft proteomes (ovarian cancer, 
prostate cancer and RCC).  
4.3 Results  
4.3.1 Comparative analysis of lipid raft alterations during cancer progression 
The potential role of lipid rafts, a platform that coordinates cellular events, in cancer 
development has been well characterized58, 223. However, with the advancements in 
quantitative proteomics techniques, spatiotemporal changes in the protein composition of 
these microdomains have just begun to unfold. Very little is known about the 
commonalities in the lipid raft protein components in different cancer types; understanding 
these shared features is critical to uncover pan-cancer mechanisms. To this end, I carried 
out an integrative analysis of quantitative lipid raft proteomics datasets that compared 
protein levels during tumorigenesis of breast cancer, melanoma and renal cell carcinoma 
(Figure 4.1).  
 
Figure 4.1: Schematic representation of integrative analysis of lipid raft proteomes in 
multiple cancer progression and tumor suppression models to identify pan-cancer lipid raft 
proteomic signatures 
Three quantitative lipid raft proteomics studies were selected for this analysis as outlined 
under methods section. These studies utilized different models and quantitation methods, 
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although all studies used the detergent-resistant membrane method for lipid raft extraction. 
Baruthio et al.335, examined raft associated changes in protein expression during 
melanoma progression using label-free proteomics technique. In this dataset, spectral 
counts from four cell lines of different metastatic potential i.e. MEK representing pre-
malignant cells, SBCL representing primary tumor and SMel93 and WMFG cells 
representing malignant melanoma cells at different time points (for SBCL cell line) were 
pooled together to calculate the relative abundance of lipid raft related proteins. A criterion 
of at-least one observation in comparison between either pre-malignant (SBCL or MEK) or 
malignant cell type (SMel93 and WMFG) was used to characterize proteins altered during 
melanoma progression. Caruso et al.361, carried out proteomic profiling of lipid raft in 
breast cancer model of tumorigenic progression (MCF10A cell lineage) using iTRAQ 
based quantitative proteomics. Although relative quantitation of lipid raft proteins for pre-
malignant cell lines (MCF10AT and MCF10ATG3B) were available, I only considered 
proteins altered in fully malignant MCF10CA1a cell line compared to parent MCF10A cells 
for the purpose of this study. Raimondo and co-workers243 have characterized differential 
raft associated proteins in renal cell carcinoma (RCC) tissue samples compared to 
adjacent normal kidney (ANK) tissues with the help of label free proteomics. Each of the 
study has been replicated thrice, but lack the raw spectral information and/or peptide-level 
inferences.  
Data from these three studies were pre-processed for integrative analysis, generating the 
same fold-change ratio (more aggressive/less aggressive). Taking the fold change cut-off 
of ±1.5, a total of 310 unique differentially regulated raft proteins were identified across the 
three published cancer progression model studies in breast cancer, melanoma and RCC 
(Supplementary Table S4.2- appendix IV). There were 159 unique under-expressed and 
170 over-expressed proteins in aggressive cancer cell or tissues, with some proteins 
showing opposite regulation in different datasets (Figure 4.2). To distil the data into a ‘core 
cancer lipid raft proteome’, proteins consistently altered in at-least two out of three 
datasets were selected (Table 4.1). Out of the 23 altered raft proteins, 19 proteins were 
elevated in malignant lipid rafts, while 4 proteins were reduced during tumor progression 
(Figure 4.2a and 4.2b). This finding suggests that there are similarities in 
association/enrichment of specific repertoire of raft proteins in highly malignant tumours. 
Moreover, 12 of these 23 proteins are structural, regulatory or effector components of 
cytoskeleton (RAC1, AHNAK, GNAI2, GNAI3, GBG12, GAPDH, GELS, STOM, FLOT2, 
ENPL and PLEC). 
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Figure 4.2: Overlap between differentially expressed lipid raft residing proteins during 
cancer progression. (a) Up-regulated proteins in aggressive cancer phenotypes (b) Down-
regulated proteins in aggressive cancer phenotypes identified in breast cancer, renal cell 
carcinoma and melanoma lipid raft proteomics datasets. 
Table 4.1: Lipid raft proteins increased or decreased in more aggressive tumor cells in 
minimum two out of three datasets 
Protein 
Accession 
Gene 
symbol 
Protein name 
Breast 
Cancer 
371 
Melanoma 
348 
Renal Cell 
Carcinoma 
246 
Ovarian 
Cancer 
279 
Proteins enriched in more aggressive tumour derived rafts 
P68363 TBA1B 
Tubulin alpha-
1B chain  
Yes No Yes Yes 
P04899 GNAI2 
Guanine 
nucleotide-
binding protein 
G(i) subunit 
alpha-2  
Yes No Yes Yes 
P07355 ANXA2 
Annexin A2 
(Annexin II) 
Yes No Yes Yes 
P08754 GNAI3 
Guanine 
nucleotide-
binding protein 
G(k) subunit 
Yes No Yes Yes 
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alpha 
P13987 CD59 
CD59 
glycoprotein 
(1F5 antigen)  
Yes No Yes Yes 
Q03135 CAV1 Caveolin-1 Yes No Yes Yes 
Q9UBI6 GBG12 
Guanine 
nucleotide-
binding protein 
G(I)/G(S)/G(O) 
subunit gamma-
12 
Yes No Yes No 
P11142 HSP7C 
Heat shock 
cognate 71 kDa 
protein  
Yes Yes Yes Yes 
P35232 PHB Prohibitin Yes Yes Yes Yes 
P27105 STOM 
Erythrocyte 
band 7 integral 
membrane 
protein  
No Yes Yes Yes 
Q14254 FLOT2 Flotillin-2 No Yes Yes Yes 
P04406 GAPDH 
Glyceraldehyde-
3-phosphate 
dehydrogenase  
No Yes Yes No 
P63000 RAC1 
Ras-related C3 
botulinum toxin 
substrate 1  
No Yes Yes Yes 
P06396 GELS Gelsolin  No Yes Yes No 
P62424 RL7A 60S ribosomal Yes Yes No No 
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protein L7a  
Q09666 AHNAK 
Neuroblast 
differentiation-
associated 
protein AHNAK 
(Desmoyokin) 
Yes Yes No Yes 
Q13488 VPP3 
V-type proton 
ATPase 116 
kDa subunit a 
isoform 3  
Yes Yes No Yes 
Q14126 DSG2 Desmoglein-2  Yes Yes No Yes 
Q99623 PHB2 Prohibitin-2 Yes Yes No Yes 
Proteins depleted from more aggressive tumour derived rafts 
Q15149 PLEC Plectin Yes Yes No Yes 
P15144 AMPN 
Aminopeptidase 
N (plasma 
membrane 
glycoprotein 
CD13)  
No Yes Yes No 
Q9NQ84 GPC5C 
G-protein 
coupled 
receptor family 
C group 5 
member C 
No Yes Yes Yes 
P14625 ENPL 
Endoplasmin 
(Tumor rejection 
antigen 1)  
No Yes Yes Yes 
Proteins in italics are reported to be structural, regulatory or effector components of 
cytoskeleton. 
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To compare the extent of up-regulation of cytoskeletal proteins inside DRM across the 
three proteomics datasets during cancer progression, I further calculated the proportion of 
cytoskeleton associated proteins up-regulated in the lipid raft in each cancer types based 
on the GO annotation. Cytoskeleton proteins represent 36%, 45% and 31% of differentially 
modulated raft proteins in breast cancer, RCC and melanoma respectively during 
malignant progression. These results suggest that altered cytoskeleton assembly at lipid 
rafts is a common phenomenon during cancer progression.  
4.3.2 Ectopic expression of WT and P95R OPCML alters lipid raft proteome of SKOV3 
cells 
The above integrated analysis suggests that increased cytoskeleton assembly at lipid raft 
membranes is a common feature in cancer development and progression regardless of 
tissue of origin. If the cytoskeletal components clustered at lipid raft during malignant 
progression, then ectopic expression of raft associated tumor suppressor should reverse 
this association. We previously reported that expression of PTRF in prostate cancer PC3 
cells reduced the level of the actin cytoskeleton and associated proteins in the lipid raft 
fraction, concomitant with reduced invasive properties20. Furthermore, recent studies using 
live cell imaging379, molecular dynamic simulations380 and in-vitro studies381 strongly 
advocate the role for cytoskeletal dynamics at the lipid raft as a mediator of cellular 
function382. To further evaluate the hypothesis that limiting cytoskeleton assembly at lipid 
rafts is a common mechanism of lipid raft-associated tumor suppressors, we characterized 
the effect of the GPI-anchored tumor suppressor OPCML in ovarian cancer. 
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Figure 4.3: OPCML regulates lipid raft proteome. (a) Triplex SILAC quantitative 
subcellular lipid raft proteomics experiment workflow. (b) Domain architecture of OPCML 
showing three immunoglobulin-like domains along with the location of somatic missense 
P95R mutation on the first immunoglobin (Ig) like domain. (c) 3D homology model of the 
first Ig domain of OPCML with replacement of Proline to Arginine residue at the surface of 
loop between two beta sheets. (d) Volcano plot showing magnitude and significance of the 
lipid raft protein level changes in control SKOV3 cells compared to WT OPCML expressing 
SKOV3 cells. The vertical axis indicates –log(p-value). The horizontal axis indicates 
log(fold change). Proteins satisfy the fold change criteria represented by orange and 
proteins passed the p-value cut-off were shown in blue color. The differentially expressed 
proteins meeting both criteria are shown in magenta color. (e) Volcano plot showing 
magnitude and significance of the lipid raft protein levels in control SKOV3 cells compared 
to P95R OPCML expressing SKOV3 cells. (f) Overlap between WT OPCML and P95R 
OPCML regulated lipid raft proteins in SKOV3 cells. 
The lipid raft proteome of ovarian cancer SKOV3 cells expressing WT OPCML or a 
partially inactive cancer-associated mutant OPCML (P95R) was compared to control 
SKOV3 cells in a triplex SILAC subcellular proteomics experiment (Figure 4.3a). The 
P95R mutation occurs at the first immunoglobulin domain of OPCML (Figure 4.3b and 
4.3c) and results in loss of cell adhesion function of OPCML while retaining growth 
suppression function119. Equal amount of detergent-resistant membrane (DRM) fractions 
from different SILAC-labelled SKOV3 cells stably transfected with empty vector (no 
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OPCML expression), WT OPCML or P95R mutant were combined and then analyzed by 
LC-MS/MS. The protein ratios were calculated from peptide SILAC ratios from the three 
independent experiments (Supplementary Table S4.3-appendix IV). Two pair-wise 
comparison lists were obtained: control (OPCML-negative) SKOV3 cells versus WT 
OPCML SKOV3 cells (L/H); control SKOV3 cells versus P95R OPCML (L/M). Overall, we 
quantified the expression profiles of 218 and 223 DRM proteins in the respective 
comparisons out of the total of 230 non-redundant proteins. Using the criteria of >±1.5 fold 
change with p-value < 0.05, I found 38 and 22 significantly altered DRM proteins by either 
WT OPCML or P95R OPCML, corresponding to 16.5% and 9.5% of total quantified 
proteins (Supplementary Table S4.4-appendix IV, Figure 4.3d and 4.3e). Interestingly, 
WT OPCML and P95R OPCML expression mainly depleted DRM proteins (observed as a 
positive log ratio in the volcano plots Figure 4.3d and 4.3e); suggesting that the tumor 
suppression function of OPCML may be mediated by a reduction in lipid raft proteome 
interactions. The comparative analysis of overlapping altered proteins indicated that 17 
proteins were depleted from DRM by both variants of OPCML (Figure 4.3f). In addition, 
WT OPCML by itself modulated 21 raft proteins, whereas P95R OPCML modulated raft 
association of 5 of total 22 altered proteins on its own (Figure 4.3f). This indicates that the 
P95R mutation affects raft confinement of a subset of protein regulated by WT OPCML, in 
addition to playing a role in altering recruitment of some unique proteins not affected by 
WT OPCML.  
To my knowledge, this is the first study to characterize the lipid raft assembly, on a 
proteome-wide scale, in a system of ovarian origin using mass spectrometry method. To 
determine the similarity of the ovarian lipid raft proteome with known lipid raft associated 
proteins, I compared the ovarian raft proteins to the human lipid raft proteins in the 
RaftProt database238 which currently hosts 67 human lipid raft proteome datasets derived 
from 50 different cell or tissue types. Out of 230 unique ovarian lipid raft proteins, 220 
proteins were present in RaftProt, with 192 (~84%) classified as high confidence bona fide 
lipid raft proteins, meaning they were identified by more than 1 lipid raft isolation method or 
were reported to be sensitive to methyl-β-cyclodextrin extraction. Interestingly, 10 proteins 
were not detected in any of the 67 other high throughput MS based lipid raft proteomics 
experiments in RaftProt. These proteins are AMGO2, AT2C2, DHRS2, ERBB2/HER2, 
FGF2, H11, H2B1A, HS904, LDH6A and VAMP1 (Table 4.2). The presence of 
ERBB2/HER2 in lipid rafts has previously been reported using western blotting and 
microscopic techniques.119 Potential limitations of the present study include the use of 
single raft isolation protocol i.e. sucrose gradient method, unconventional raft-association 
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of histones and lack of information about protein expression profile of non-DRM fractions 
of SKOV3 cells. Considering the dynamic nature of lipid rafts histone molecules might 
shuffle between DRM and non-DRM membrane fractions. Additionally, with the 
controversies surrounding artefactual nature of DRM fractionation methods, claim of raft 
association of histones is difficult to reconcile and interpret. Therefore, the contradictory 
detection of histones in the ovarian lipid-raft fractions should be considered with a caution. 
More dedicated studies like different isolation protocols and super resolution microscopy 
can be used to validate the raft association of histone molecules. Although further studies 
using complementary techniques are needed to confirm the other unique ovarian cancer 
raft proteins, it is likely that these proteins were not identified by mass spectrometry in 
previous proteomics studies due to their low abundance in lipid rafts in other tissues or cell 
types. 
Table 4.2: Novel proteins identified in ovarian cancer lipid raft proteome. 
Protein 
Gene 
symbol 
Protein name 
Fold 
change 
(SKOV3/WT 
OPCML) 
Standard 
deviation 
(SKOV3/WT 
OPCML) 
p-value 
Q86SJ2 AMGO2 Amphoterin-induced protein 2  -1.046 0.350 0.642 
O75185 AT2C2 
Calcium-transporting ATPase 
type 2C member 2 
1.461 0.288 0.110 
Q13268 DHRS2 
Dehydrogenase/reductase 
SDR family member 2 
-1.119 1.036 0.984 
P04626 ERBB2 
Receptor tyrosine-protein 
kinase erbB-2 
1.597 0.448 0.017 
P09038 FGF2 Fibroblast growth factor 2  1.084 1.955 0.462 
Q02539 H11 Histone H1.1 (Histone H1a) 1.460 0.397 0.175 
Q96A08 H2B1A Histone H2B type 1-A 2.864 1.382 9.999E-
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(Histone H2B, testis)  05 
Q58FG1 HS904 
Putative heat shock protein 
HSP 90-alpha A4  
-1.312 0.202 0.845 
Q6ZMR3 LDH6A 
L-lactate dehydrogenase A-
like 6A  
-3.669 0.001 0.480 
P23763 VAMP1 
Vesicle-associated membrane 
protein 1  
-1.602 0.144 0.992 
  
4.3.3 Enrichment of cytoskeletal associated proteins in the lipid rafts of ovarian cancer 
cells.  
Cytoskeleton associated proteins were highly enriched in the ovarian cancer rafts, as this 
class represents 34% of the entire dataset. Of the 23 pan-cancer lipid raft proteins, 19 
were observed in our ovarian raft datasets, including nine cytoskeleton associated proteins 
(Table 4.1). Similar to the findings from three cancer progression quantitative proteomics 
datasets, 39% and 35% of DRM proteins altered by WT and P95R OPCML expression in 
ovarian cancer cells were cytoskeletal associated. To determine the extent of interaction 
between the raft proteins, an ovarian raft protein-protein interaction network was built 
using experimentally validated PPIs (Supplementary Figure S4.2-appendix IV). Around 
80% of the raft proteins interact with each other. Furthermore, 87% of the ovarian raft 
cytoskeletal proteins interact with other raft residents, and tend to have a larger number of 
interactions. This is indicative of higher connectedness of this class of proteins within the 
rigid environment provided by membrane rafts. Statistical analysis showed that both the 
ovarian raft-proteome and the raft associated interaction network were significantly 
enriched with cytoskeleton associated proteins compared to the human lipid raft proteome 
and the whole human proteome (Table 4.3). 
Table 4.3: Enrichment of cytoskeletal associated protein in the ovarian lipid raft proteome 
and ovarian lipid raft associated interactome 
Dataset Background 
# 
Cytoskel
etal 
Total # 
protein
s 
X-
square
d 
p-value* 
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proteins 
Ovarian lipid raft 
proteome 
Human lipid 
raft 
associated 
proteins 
79 230 11.44 0.0007 
Ovarian lipid raft 
associated protein-
protein interactions 
Human lipid 
raft 
associated 
proteins 
69 183 11.78 0.0006 
Ovarian lipid raft 
proteome 
Human 
proteome 
79 230 26.87 2.17 x10-07 
Ovarian lipid raft 
associated protein-
protein interactions 
Human 
proteome 
69 183 25.06 5.55 x10-07 
*Pearson’s X2 goodness of fit test against different background sets 
As the ovarian raft-associated protein interaction network is enriched with cytoskeletal 
proteins, we then asked whether the ectopic expression of OPCML modulates their 
association with membrane-rafts. If I consider only cytoskeleton associated proteins from 
this network, I find a single, dense cluster of 54 interacting proteins (Figure 4.4). I visualize 
the changes in abundance of these interacting proteins under different treatment 
conditions to identify coordinated changes in the cytoskeleton-associated network (Figure 
4.4). A repertoire of cytoskeletal proteins show up-regulation (green), down-regulation 
(magenta) or loss of expression (gray) upon WT OPCML expression (Figure 4.4a). The 
same pattern of protein expression changes was not seen with P95R OPCML (Figure 
4.4b). This result also suggests that the WT and P95R OPCML differentially regulate actin 
filaments, intermediate filaments and cytoskeleton regulatory proteins, but microtubules 
(tubulins) were not significantly altered by WT or P95R OPCML. 
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Figure 4.4: Expression signatures of cytoskeleton associated proteins at ovarian lipid rafts 
upon WT and P95R OPCML expression in SKOV3 cells. Pair-wise comparison between 
(a) Control SKOV3 (OPCML negative) versus WT OPCML (b) Control SKOV3 (OPCML 
negative) versus P95R OPCML. A sub-network of WT OPCML regulated cytoskeleton 
associated proteins is shown in (c), and the effect of P95R OPCML expression on these 
proteins shown in (d). Magenta coloured proteins are down-regulated with fold change ≤-
1.5; up-regulated protein with fold change threshold of ≥ 1.5 represented by green; grey 
coloured proteins for which ratio was not found. Thicker borders indicate significantly 
altered proteins (p-value < 0.05). 
I then focused on the WT OPCML-specific lipid raft cytoskeleton associated proteins, 
reasoning that these proteins may mediate the mechanism of OPCML-induced cell 
adhesion, since P95R OPCML has lost this property. This distinct phenotype of P95R 
OPCML expressed in clonal SKOV-3 cells was demonstrated using an in-vitro cell 
aggregation assay76. The sub-network of WT OPCML-altered cytoskeletal DRM proteins 
comprise of a cluster of six proteins (Figure 4.4c and 4.4d). While actin microfilament 
regulating proteins PLEC, JUP and SPTAN1 were significantly down-regulated by WT and 
P95R OPCML expression, VIM, DES and PRPH were significantly down-regulated by WT 
but not P95R OPCML. These results suggest that the loss of VIM, DES and PRPH from 
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rafts containing WT OPCML may be associated with the inhibition of cell adhesion. VIM 
and DES are intermediate filaments that are well characterized markers of mesenchymal 
phenotype observed among aggressive tumor cells383-384. Depletion of VIM and DES from 
the ovarian rafts upon WT OPCML expression might reverse the epithelial to 
mesenchymal transition of SKOV3 cells.  
To evaluate crosstalk between differentially regulated cytoskeletal components with non-
cytoskeletal proteins, this significantly up-regulated network module (Figure 4.4c) was 
expanded to include neighboring interactions, resulting in a network of 25 proteins with 50 
interactions (Figure 4.5). This expanded network includes other cytoskeleton associated 
proteins ACTB, ATCTA2, MYL6, MYH9, CCT6A, GNAI2 and FYN, as well as integrins 
ITGA6 and B4 and the receptor tyrosine kinase ERBB2. The down-regulation of raft 
localized ERBB2 by OPCML observed in this work corroborates our previous findings119. 
Furthermore, both WT and P95R OPCML expression reduced ERBB2 in DRM (Figure 
4.5a and 4.5b); suggesting ERBB2 removal from lipid rafts may be a mechanism for 
growth suppression by both WT and P95R OPCML, potentially mediated by reducing raft-
actin microfilament interaction. On the other hand, WT but not P95R OPCML increased 
the DRM level of desmoglein-2 (DSG2), a component of intracellular desmosomal 
cadherins385. These results suggest that a web of interacting cytoskeletal components in 
the ovarian cancer rafts might influence the sequestration of proteins to the raft. To 
determine if this property is unique to our ovarian cancer data, or is seen in other types of 
cancer, I next evaluated interaction potential of lipid raft proteomes in two further models of 
cancer development. 
 
Figure 4.5: OPCML altered expression of binding partners of significantly different 
cytoskeletal proteins. Interactions between binding partners of significantly altered 
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cytoskeletal proteins (VIM, PRPH, DES, PLEC, JUP and SPTAN1) by WT OPCML. 
Comparison between (a) Control SKOV3 (OPCML negative) versus WT OPCML (b) 
Control SKOV3 (OPCML negative) versus P95R OPCML. Magenta coloured proteins are 
down-regulated proteins with fold change ≤ -1.5; up-regulated protein with fold change 
threshold of ≥1.5 represented by green; grey coloured proteins found to dissociate from 
ovarian lipid rafts in the respective comparison and the proteins with thicker borders are 
significantly altered proteins (permutation p-value<0.05) in each pair-wise comparison. 
Cytoskeleton associated proteins are represented by diamond shape.  
4.3.4 Cancer lipid rafts: a signalling platform stabilized by protein-protein interactions  
Lipid rafts are known to restrict lateral diffusion of proteins and thereby create a favorable 
environment for proteins to interact286. Cytoskeletal rearrangements can further influence 
raft protein clustering by stabilizing the raft assemblies386. Even though the role of the lipid 
raft as a coordinator of protein-protein interaction has been documented286, 387, very little is 
known about the interaction potential of these microdomains in cancer. Out of the 230 
ovarian lipid raft proteins identified in the dataset of ovarian cancer, 183 proteins (~80%) 
interact with each other in the ovarian raft associated interaction network I described 
above (Supplementary Figure S4.2-appendix IV). To determine if this degree of 
connectivity is characteristic of cancer rafts and different from what might be expected of a 
normal raft proteome, I performed a series of network simulations comparing interactions 
between known raft proteins238 to interactions in the wider human proteome and in three 
cancer lipid raft proteomes: ovarian cancer (this study), prostate cancer and RCC 
(Supplementary Table S4.5-appendix IV). I exclude breast cancer and melanoma raft 
proteomes due to the smaller size of their measured proteomes. The sample size of each 
dataset for network generation was normalized to the number of proteins detected in the 
ovarian lipid raft. Compared to the network properties (number of interacting proteins, 
number of interactions between proteins and average number of neighbor in the network) 
of the normal human raft interactome, the proteins from the complete human proteome 
participate in significantly fewer interactions. Interestingly, all three cancer rafts showed 
significantly larger number of interactions (p-value < 0.05 for every topological measure) 
compared to the interactions between normal raft resident proteins (Table 4.4). These 
findings suggest that the proteins in cancer rafts have higher tendency to engage in 
interactions with the other raft resident proteins.  
  103 
 
Table 4.4: Topological properties of various protein-protein interaction networks 
Topological 
Property 
Human lipid 
raft 
proteins* 
(Total=4243) 
Human 
proteome* 
(Total=20192) 
Ovarian 
cancer 
lipid raft 
proteome 
(Total = 
230) 
Prostate 
cancer lipid 
raft 
proteome* 
(Total=358) 
Renal cell 
carcinoma 
raft 
proteome* 
(Total=330) 
Number of 
Proteins 
80 
34 
p-value= 9.54 
x 10-8 
183 
p-
value=3.3
5 x10-68 
173 
p-value= 
5.29 x10-58 
163 
p-value= 
1.72 x 10-51 
Number of 
Interactions 
97 
30 
p-value= 1.4 x 
10-12 
509 
p-value= 
0.00 
460 
p-value= 
4.67 x 10-14 
378 
p-value= 
4.68 x 10-16 
Average 
Degree 
2.40 
1.71 
p-value= 0.31 
5.56 
p-value= 
7.80 x10-
97 
5.32 
p-value= 
1.93 x 10-12 
4.46 
p-value= 
1.21 x 10-10 
*The value of each topological property is an average value of 1000 networks generated by 
random sampling where the size of each dataset was normalized to number of proteins identified in 
the ovarian cancer lipid raft proteome. 
The p-value is based on one tailed Z-test that compared average topological property of human 
raft protein-protein networks with the protein-protein interaction networks of each respective 
datasets. 
4.4 Discussion 
Mounting evidence supports a key role of lipid rafts in cancer development and 
progression in multiple cancer systems, with diverse molecular mechanisms proposed356. 
Numerous studies have documented the interplay between lipid raft and membrane 
cytoskeleton382, 386, 388, with a potential role in coordinating membrane-associated cellular 
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events relating to tumor progression, such as motility, cell adhesion, signal transduction 
and receptor endocytosis389. Here I used integrative analysis of quantitative lipid raft 
proteomics to identify increasing abundance of raft-associated cytoskeletal proteins as an 
underlying molecular mechanism in cancer progression. In the comparative analysis of 
multiple cancer raft proteomes, I observed that cytoskeletal proteins dynamically partition 
to lipid rafts during cancer development. These cytoskeletal components are considered to 
alter membrane heterogeneity by tethering the membrane raft components to intra-cellular 
structures390, thereby stabilizing raft microdomains.  
If lipid raft-cytoskeleton interactions drive tumor progression, the corollary is that tumor 
suppressors acting on lipid rafts should reduce the cytoskeleton attachment. In a previous 
study, we reported such phenomena for PTRF/cavin-1 in prostate cancer PC3 cells20, 
while an independent report suggest that merlin, the neurofibromatosis-2 gene product 
also acts by disrupting cytoskeleton-lipid raft interaction362, 391. Here I report similar findings 
for an unrelated tumor suppressor, OPCML, in ovarian cancer. Together these results 
indicate that the lipid raft cytoskeleton association is critical for tumor progression. Further, 
ectopic expression or drug induced expression of raft localized tumor suppressor 
molecules might reverse neoplastic transformation through re-organizing cytoskeletal 
components inside membrane microdomains. 
Due to their abundance, cytoskeleton components are commonly observed in lipid raft 
proteomics studies. By quantitatively comparing lipid raft proteome changes induced by 
ectopic expression of WT and P95R OPCML in SKOV3 cells, which led to differing 
adhesive properties76, I identified a potential involvement of intermediate filament-lipid raft 
interaction for tumor adhesion. Expression of either WT or P95R OPCML in SKOV3 cells 
reduces cell proliferation but only WT OPCML imparts cellular adhesion. Intriguingly, both 
cell lines showed reduction of lipid raft actin microfilament regulating proteins (PLEC, JUP 
and SPTAN1), while intermediate filament proteins (VIM and DES) and tetraspanin-22 
(PRPH) were down-regulated by WT but not P95R OPCML. VIM is a well characterized 
marker of epithelial-to-mesenchymal transition (EMT) during cancer progression392. In 
ovarian cancer tissues, VIM expression is significantly associated with primary chemo-
resistance and poor response to chemotherapy at diagnosis393 and it is also abundantly 
expressed in SKOV3 cells representing a mesenchymal phenotype394. A recent finding in 
colorectal cancer395 demonstrated that restored expression of OPCML led to inhibition of 
cell motility and invasiveness via negatively regulating EMT. This reversal of EMT 
phenotype might be mediated by dissociation of VIM from the rafts. VIM is frequently found 
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in lipid rafts, being reported in 34 out of 67 raft proteomes in RaftProt238 including prostate, 
breast cancer, renal cell carcinoma and melanoma rafts. However, further studies are 
required to determine the molecular function of intermediate filaments in lipid rafts, and its 
role in EMT transition. PRPH, also known as tetraspanin-22, is a member of the 
tetraspanin family that play a crucial role in cell adhesion396. Initially identified for its role in 
retinal photoreceptors and involvement in retinitis pigementosa397, PRPH has membrane 
fusion function398. According to the human protein atlas170, PRPH shows tissue selective 
expression, with low/medium protein expression in ovarian tumours but not expressed in 
normal ovary. 
The extent of interconnectivity observed among the raft localized proteins of the ovarian 
cancer, prostate cancer and RCC lipid raft proteome supported the notion of lipid raft 
serving as a protein sorting platform. Biophysical evidence demonstrated a role for 
cholesterol and saturated sphingolipids in the enhancement of lipid raft rigidity399. This 
suggests that the raft compartmentalization of proteins might provide favorable 
environment to facilitate interactions among raft components. Microdomains can act as a 
scaffold to concentrate molecules like receptors, adaptors, scaffolding proteins, effectors, 
kinases and cytoskeletal machinery to trigger complex signaling events in cancer. 
Intriguingly, the network simulation results revealed significantly increased connectivity for 
cancer raft proteome compared to the general human raft proteome. Transmembrane 
proteins anchored to this membrane-skeleton “fence” further influence clustering of lipid 
raft proteins through immobilization and increases tendency of protein-protein interaction 
at cancer rafts, as suggested by Kusumi et al.139 Taken together, my results suggest 
stabilized membrane microdomains, facilitated by increased recruitment of cytoskeletal 
proteins and greater molecular interactions on the lipid raft, are an integral and reversible 
step in cancer development.  
4.5 Conclusions 
Through integrative analysis, I identified pan-cancer molecular signatures common in 
cancer cell lipid rafts. This ‘core cancer lipid raft’ proteome show a high representation of 
cytoskeleton associated proteins. Conversely, tumor suppressors PTRF in PC3 prostate 
cancers and OPCML in SKOV3 ovarian cancer cells act by significantly attenuating 
cytoskeletal components of the lipid raft proteome. Furthermore, I found that cancer raft 
proteome has an increased potential for protein-protein interaction compared to general 
human raft proteome. Taken together, these results suggest that cancer development is 
associated with cytoskeletal rearrangements to stabilize raft platforms and promote raft 
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associated molecular interactions. The fact that two independent tumor suppressors 
(PTRF and OPCML) reduced these interactions suggests disruption of cytoskeleton-lipid 
raft assemblies as a potential anti-cancer strategy. I believe the integrated approach I 
presented here will pave the way to more refined representation of lipid raft dynamics in 
various malignancies.  
Supporting information 
The raw data for quantitative proteomics study focused on ovarian cancer lipid raft domain 
has been deposited in PRIDE repository under accession PXD006078. 
(https://www.ebi.ac.uk/pride/archive/) 
Below are details: 
ProteomeXchange title: Ovarian Cancer Lipid raft proteomics and role of OPCML 
ProteomeXchange accession: PXD006078 
PubMed ID: 27384440 
Project webpage: http://www.ebi.ac.uk/pride/archive/projects/PXD006078 
FTP download: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/03/PXD006078 
A brief overview about individual supporting files is provided in Appendix IV. Moreover, all 
the supplementary material mentioned in this chapter is available online at 
http://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.5b01035 
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5. Chapter 5: Discussion and Future Directions 
This thesis has presented a systematic computational analysis of lipid raft proteomics data 
aiming to provide new avenues towards improving our knowledge about the functions of 
these membrane microdomains in health and disease. The key outcomes from my thesis 
are discussed and summarised below (Figure 5.1). 
5.1 Research outcomes 
 
Figure 5.1: Generalised workflow of the implemented computational approach to uncover 
functions of lipid rafts in health and disease. Detailed information of about the lipid raft 
focused proteomic studies in the literature was collected to develop a dedicated public 
resource “RaftProt”. This database is a comprehensive collection of mammalian lipid raft 
proteome derived from LC-MS/MS experiments. Next, a bioinformatics approach was used 
to characterise systems-wide structural and functional landscapes of the human lipid raft 
proteome. Finally, an integrative analysis of quantitative lipid raft proteomics studies of five 
cancer types was carried out to elucidate lipid-raft associate mechanisms of tumor 
promotion.  
5.1.1 Revisiting thesis aims: 
(i) To create an open source database for mammalian lipid raft proteome. 
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In the chapter 2 of this thesis, I presented a survey of the mammalian lipid raft associated 
proteins identified in large-scale LC-MS/MS investigations focused on the proteomics 
profiling of the membrane microdomains. An extensive list of mammalian raft localised 
proteins from the literature was collected and made available at one place as an online 
resource “RaftProt” to the scientific community. This unique, largest, manually curated and 
user-friendly database of mammalian lipid raft proteome currently hosts the information 
about 7959 lipid raft proteins from 117 proteomic datasets derived from 69 different cell, 
tissue or organ type of six organisms. The web portal of RaftProt assists querying, 
browsing and downloading of these massive datasets with the help of several advanced 
features: semantic search and cross-experiment comparison capabilities along with the 
information about protein expression changes catalogued by the quantitative proteomics 
experiments. Importantly, in this chapter, I proposed a screening criterion to determine 
high-confidence bona-fide lipid raft proteins, using conservative experimental criteria: 
detection by more than one raft purification methods and/or sensitivity to membrane 
cholesterol extraction. RaftProt highlights biological and technical variability in the lipid raft 
proteome and points at context specific reorganisations of proteins at the lipid raft domains 
as response to external and internal perturbations. Since publication, RaftProt has been 
widely used by researchers across the globe in last two years with over 4000 unique 
visitors. According to Google scholar, RaftProt article published in Nucleic acids Research 
was cited 18 times at the time of completing this thesis (accessed March 15 2017). 
Moreover, several raft-associated datasets and cross-experimental analysis results have 
been downloaded 985 times, which highlights the popularity of this resource among 
scientific community. I believe, this first dedicated resource of its kind, will continue to 
provide valuable insights to the research community about the composition and functions 
of dynamic protein landscape of the membrane microdomains. 
(ii) To gain a detailed structural and functional understanding of the human lipid raft 
proteome using an in silico approach. 
After defining a mammalian lipid raft proteome in the Chapter 2, I concentrated on 
characterising human lipid raft proteome in the Chapter 3. This chapter explores, for the 
first time, protein sorting mechanisms, protein interaction potential and the functional 
characteristics of the largest dataset human lipid raft proteome derived from 75 human 
lipid raft proteomics profiling experiments reporting 4898 unique proteins localised to the 
lipid rafts. If the lipid rafts are the sub-compartments of the plasma membrane, it was 
difficult to believe that around quarter of human proteins to be lipid raft associated (more 
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than total membrane proteins). In an effort to reduce the frequency of false-positive 
assignment of raft localisation to these proteins, I proposed an alternative approach to 
investigate how proteins are targeted to the lipid rafts and defined intrinsic and extrinsic 
raft protein elements. Using a detailed computational approach, I examined the potential of 
using existing in silico predictors or annotations of several lipid raft targeting mechanisms 
in a proteome-wide dataset to derive a class of intrinsic lipid raft proteins. Likewise, an 
investigation of raft-confined protein interactions led to the definition a set of peripheral 
lipid raft proteins i.e. extrinsic component of lipid raft. Statistical analysis showed proteins 
were partitioned to the raft via lipid modifications, lipid binding, transmembrane signal and 
attracts other proteins to form functional complexes that regulate downstream cellular 
events. Moreover, functional and pathway characterisation revealed key biological 
processes that require lipid raft proteins. The cell-surface is a highly dynamic place and 
proteins, which are not part of membrane microdomains, can also regulate vital processes 
and thereby assist in maintaining cellular integrity. Indeed, the pathway analysis, 
presented in chapter 3, revealed key cellular processes such as cadherin signalling, Wnt 
signalling, that are predominantly regulated by proteins located outside of lipid rafts. 
Furthermore, events such as clatherine-mediated endocytosis do not depend on functional 
rafts. Altogether, this analysis bring to the fore a notion about membrane microdomains as 
a complex cellular machinery, which undergoes dynamic re-arrangements to form 
functional complexes regulating key biological processes.  
(iii) To uncover lipid raft associated mechanisms during cancer progression by 
performing an integrated analysis of quantitative lipid raft proteomics datasets. 
Under the hypothesis that, unifying alterations occurs at the lipid raft assemblies during 
neoplastic progression, I probed the altered abundance of raft proteins in multiple cancer 
types. An integrated analysis of quantitative lipid raft proteomics datasets modelling 
progression in breast cancer, melanoma and renal cell carcinoma, revealed that cancer 
development is associated with an increased membrane raft-cytoskeleton interactions. An 
attenuation of raft-cytoskeleton interaction was previously observed upon expression of 
the tumour suppressor PTRF20. In this chapter, I extended this analysis to an unrelated 
tumour suppressor, OPCML in an ovarian cancer cell system. The results showed that the 
presence of the tumor suppressors in the lipid raft compartment leads to depletion 
cytoskeletal components, implying a functional requirement of cytoskeleton-raft interaction 
for tumour progression. Furthermore, protein-protein interaction network and simulation 
analysis showed significantly higher interactions among cancer raft proteins compared to 
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general human raft proteins. Taken together, these results suggest increased 
cytoskeleton-mediated stabilization of lipid raft domains with greater molecular interactions 
as a common, functional and reversible feature of cancer cells. Chapter 4 demonstrates 
the utility of the integrative computational analysis of proteomics studies to reveal protein 
expression signatures in the lipid raft common across different cancer. Moreover, this work 
may represent a possible link between cholesterol and cancer progression via alteration of 
membrane microdomain composition.  
Now, in next sections I would like to discuss some key perspectives came out of this 
thesis, linking findings from individual chapters that were not presented in details in each 
chapter.  
5.2 Obesity, Cancer, Cholesterol and Lipid rafts: From proteomics perspective 
Alterations in a pool of body cholesterol have been well documented in the number of 
pathophysiological conditions. Elevated serum cholesterol levels were reported in the 
people with obesity, who are at increased risk of developing many chronic health 
conditions like coronary heart disease87, high blood pressure400, stroke86, type II diabetes 
mellitus401, osteoarthritis402, sleep apnoea403, gallstones404 and reproductive problems405, 
compared to healthy or normal weight individuals406. Interestingly, most of these conditions 
reported elevated levels of free serum cholesterol and LDL particles (rich in cholesterol 
molecules). More recently, epidemiological studies associated obesity with an increased 
risk for several cancer types: colorectal407, breast408, and endometrial cancers409. A 
seminal work by Bhaskaran et al.410, published in the Lancet, investigated the association 
of body mass index (BMI) of 5.24 million UK adults with the risk of most-common 22 site 
specific cancers. This large scale population-based cohort study presented results based 
on seven years of patient follow up. They found association of BMI with 17 out of 22 
cancer types. Higher BMI was linked with increased risk for subsequent development of 10 
cancers: uterus, gallbladder, kidney, cervix, thyroid, leukaemia, liver, colon, ovarian, and 
breast cancers. In these cancer types, each 5kg/m2 rise in BMI increased the chance of 
developing disease with varying degree ranging from 64% to 5%, indicating complex 
relationship between excess weight and individual cancers. In contrast, an inverse 
association of BMI was observed in prostate, premenopausal breast cancer, stomach, lung 
and oral malignancy risks, which might be attributed to patients smoking status as its effect 
diminished in the non-smoker cohort. Similarly, links of obesity with cancer was also 
highlighted in an independent meta-analysis of 221 datasets, involving 282,137 
incidences. Here, researcher found increased BMI associated with an increased risk of 
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developing oesophageal adenocarcinoma, melanoma, leukaemia, thyroid, colon, 
endometrial, pancreatic cancers in both men and women411. Collectively, these large scale 
epidemiological studies, underscored an inclination of obese individuals towards 
developing cancers in their lifetime. At the same time, these studies have been criticized 
for their retrospective focus103, as several other studies412-414 have suggested very low or 
no benefits of lowering patient cholesterol levels, by medications like statins, in cancer. 
Owing to these contradictory findings, instead of serum cholesterol, recent studies were 
focused towards elucidating the role of intracellular cholesterol in cancer progression and 
metastasis.  
Elevated levels of cholesterol have been reported in tumor tissues415 and cancer cells416-
417 but mechanisms linking this cholesterol accumulation and the tumorigenicity is still 
largely unclear. The normal cholesterol homeostasis at the cellular level is a result of fine-
tuning of two main mechanisms namely cholesterol biosynthesis via mevalonate pathway 
and its import/export by the specialised receptors and transporters. Circulating cholesterol 
in the form of LDL or VLDL particles is taken up by the cells with the help of internalisation 
of LDL bound receptor complex. In contrast, the specialised exporters, eliminates excess 
of cholesterol in the form of HDL particles out in the circulation. However, in the cancer cell 
this crucial balance of demand and supply is impaired (Figure 5.2). To meet the demand 
of rapidly proliferating cells, there is excessive reprogramming of cellular metabolism, 
called Warburg effect, one of the hallmarks in cancer102. One of the consequences, of the 
array of metabolic transformations in the cancer, is disturbed cholesterol metabolism with 
abnormally high concentrations cellular cholesterol417. At the same time, cancer cells show 
up regulation of LDL receptors418 which further enhances intracellular cholesterol level. 
This excess of cholesterol is either catabolised by the cancer cells to meet the energy 
demand or in most cases accumulated in the lipid particles and at the specific regions of 
the cell membrane, i.e. lipid rafts.  
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Figure 5.2: Altered lipid metabolism in cancer cells. Lipid metabolism pathways (blue) 
including de novo lipid synthesis via lipogenesis and cholesterol synthesis along with lipid 
transport (import/export) and lipid catabolic pathways by fatty acid oxidation (FAO). 
Cellular citrate is synthesized from glucose- and/or glutamine obtained from diet through 
increased glycolysis and/or glutaminolysis (orange). It acts as common precursor of 
lipogenesis and cholesterol synthesis. Cancer cells can also uptake circulating cholesterol, 
transported by Low density lipoproteins (LDL) and very-low-density lipoproteins (VLDL), to 
meet their cholesterol requirement. The excess cholesterol, phospholipids and 
triglycerides eliminated from the cell as high-density lipoproteins (HDLs) or locally stored 
into lipid droplets (LDs). Being an essential membrane lipid, cholesterol also accumulated 
in the special membrane compartments i.e. lipid rafts that serve as protein sorting platform 
to promote processes like cell adhesion, migration and cancer associated signalling. TCA 
cycle: tricarboxylic acid cycle, αKG: α-Ketoglutarate. (Modified from Beloribi-Djefaflia et 
al.419) 
Malignant cells are known to have more concentration of lipid rafts279 which in turn 
positively contribute towards cancer cell signalling, adhesion and migration phenotype420. 
Elevated concentration of cellular cholesterol increases density and potentially size of 
membrane lipid raft domains. This in turn, facilitates recruitment of signalling molecules 
and formation of functional protein complexes that regulate multiple processes in tumor 
cells. To determine how this increased cholesterol contents in the cancer cells might 
impact the protein landscape of the lipid raft I referred back to the quantitative lipid raft 
proteomic datasets of cancer cells, I presented in chapter 4. For five cancer types: RCC, 
melanoma, breast, ovarian and prostate cancer raft proteome profiles analysed; together I 
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observed 372 unique altered proteins. Out of these differentially expressed proteins, an 
equal number of proteins change their expression in both directionalities, reflecting the 
similar proportion of proteins attached (236) and depleted (174) from the lipid rafts during 
cancer progression. If the cholesterol has a role in the altered abundance of proteins on 
the lipid raft, then this group of proteins could be sensitive to cholesterol modulation or are 
cholesterol binding proteins. Indeed, upon closer examination of the altered protein 
dataset, I noticed almost half (117) of the common up-regulated proteins (236), during 
malignant transformation, to be either MBCD sensitive or known cholesterol binding 
proteins. This suggests that the higher concentration of cholesterol at the lipid raft could be 
the driver for compartmentalise more number of proteins to the lipid rafts in cancer cells. 
Furthermore, about two third of (147) of commonly upregulated proteins are intrinsic 
components of lipid raft with one or more raft penetrance signals. It is likely that, once 
these proteins establish themselves in the highly stable lipid raft environment, they could 
then attract more proteins to the raft scaffold to further regulate the cancer cell signalling. 
In fact, I observed upregulated intrinsic raft proteins recruiting further 39 of non-intrinsic 
raft proteins to the rafts via directly engaging in protein-protein interactions. As many 
biological processes are mediated by protein complexes involving more than two proteins, 
this observation highlights special property of the lipid rafts, where the concentration of a 
distinct group of proteins collectively increased in the rafts during in cancer, contributing 
towards aggressive phenotype. This interesting cooperative behaviour is jointly catalysed 
by the seeding of proteins to lipid rafts with the help of protein-lipid interactions and the 
binding potential of the raft-recruited proteins to favour protein-protein interactions. In total, 
I found 67 extrinsic raft proteins to be highly expressed in the cancer rafts. The remaining 
28 up-regulated extrinsic proteins might interact with other intrinsic proteins whose 
expression is unchanged in the cancer rafts during progression, suggesting the existence 
of common scaffolding or adhesion proteins in less aggressive and more aggressive 
cancer cells.  
Another finding emerged through analysis of cancer raft proteomes that I would like to 
point out here is lipid raft heterogeneity. For instance, there was an extreme disparity 
between protein content of lipid raft of individual cancer types (Figure 4.2). Even though 
four out of five solid cancers (RCC, breast, ovarian and prostate cancers) studied in 
chapter 4 were of epithelial origin, they differ in their genetic makeup, protein expression 
profiles and each has a distinct site-specific extracellular environment. It raises a 
possibility of presence of unique raft mechanisms or processes for each cancer type, 
catalysed by selective expression proteins in the rafts of specific cancer cells. Additional 
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experimental investigations are needed to clarify these observations. A study from Li et 
al279 demonstrated that malignant cells, in general, have higher levels of raft like platforms, 
partly due to elevated concentration of cholesterol. Since then, other in vitro421-422 and in 
vivo studies423-424 have produced similar results. These amplified lipid raft regions have 
been shown to affect the cell morphology425 by only handful of reports. New studies should 
therefore focus on investigating the correlation between levels of lipid rafts on the cell 
surface and tumorigenic potential. Overall observations from the research work presented 
in this thesis hints at cell type variability in lipid raft proteome. Both genetic and 
environmental factors dictate the type and amount of protein localised to lipid rafts. In the 
context of raft-targeting mechanisms, alterations in lipid modifying enzymes have been 
shown to affect the lipid raft compositions321, 426. It would be interesting to characterise the 
influence of lipid-modifying enzyme expression patterns on lipid raft protein profile and 
thereby raft-regulated functions. Still, this thesis has presented some interesting findings 
that further require validation by techniques other than proteomics like microscopy, 
western blotting, functional or morphological characterisation following genetic/chemical 
perturbation of a cellular system. 
5.3 Crosstalk between lipid raft and cytoskeleton 
Evidence has emerged over the past few years that the cytoskeletal proteins stabilises 
lipid rafts by tethering to integral membrane proteins at the cytoplasmic face of the cell 
membrane and formed the basis for conceptualised of ‘picket fence model’ of raft 
formation138-139, 154. Yet, to the best of my knowledge, the contribution this broad family of 
proteins have largely been underestimated in the lipid raft proteomic studies. Thus, I 
revisited the results obtained in this thesis to examine the prevalence of this key 
component of lipid rafts in the context of entire lipid raft proteome and their involvement in 
the raft associated tumor proliferation. To achieve that, I used the human cytoskeletal 
protein dataset, extracted from Amigo, mentioned in the chapter 4. Even though 
cytoskeletal proteins are ubiquitous in the cell and create a highly inter-connected 
meshwork under the cell surface, only one-fifth all human cytoskeletal proteins (18%, 794) 
were detected in the lipid rafts by LC-MS/MS methods. From the lipid raft proteome 
perspective, cytoskeletal components contribute a relatively similar (16%) fraction. Having 
said that, at this moment there is not much information about their relative abundance and 
confinement to the rafts. The majority of raft associated cytoskeletal proteins (54%, 425) 
interact with intrinsic raft proteins. Interestingly, around 37% of raft localised cytoskeleton 
components reportedly possess lipid modification and/or lipid binding signals, indicating an 
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alternate lipid-driven mechanism of their raft compartmentalisation. However, there was 
not preferential attachment of any of the three cytoskeletal protein subclasses, i.e. actin-
filaments, microtubules and intermediate filaments, to the cholesterol-rich membrane 
microdomains.  
The role of cytoskeletal proteins in the cancer development has emerged to be quite 
crucial356, 382, 427-428. The expression of certain cytoskeletal components and associated 
fragments (cytokeratin) has even been used clinically as a pan-cancer diagnostic 
biomarker to pin down cancer staging429-431. Moreover, an intermediate filament protein 
vimentin is considered as a classical molecular marker of epithelial to mesenchymal 
transition (EMT) during metastatic progression432. Functionally, in the malignant cells, 
cytoskeleton is a key player in coordinating membrane-associated cellular events relating 
to tumor growth, migration, cell adhesion, invasion, signal transduction and receptor 
endocytosis. Compared to the whole human lipid raft proteome (chapter 3), the proportion 
of cytoskeletal proteins was strikingly higher (more than two fold or ~40%) in the lipid rafts 
of multiple aggressive cancer cells (chapter 4). The amplified presence of cytoskeleton at 
lipid raft domains would further stabilise raft assemblies by engaging in more molecular 
interactions. This raft-cytoskeleton interplay could be a common, functional and reversible 
feature of cell during malignant transformations. One argument always arise from the 
highly focused subcellular proteomics analysis is whether the protein alterations are 
specific to the compartment of interest or are the consequence of global protein 
expression changes within the entire proteome. Unfortunately, the 5 cancer types, 
interrogated in chapter 4,lack the whole cell proteomics data. In an effort to address this 
question, I analysed the m-RNA expression levels of cytoskeleton associated core-cancer 
raft proteins in patient samples of these five cancer types, reported by RNA-Seq technique 
in The Cancer Genome Atlas (TCGA) database. I used the cBioPortal433 to analyse and 
visualise the expression profiles of gene transcripts of the twelve cytoskeletal proteins 
commonly elevated in the cancer rafts in the patient samples of RCC, melanoma, breast, 
ovarian and prostate cancer. Interestingly, the expression of all 12 cancer raft associated 
cytoskeleton associated proteins (TUBA1B, GNAI2, GNAI3, GBG12, STOM, FLOT2, 
GAPDH, RAC1, GSL, AHNAK, HSP90B1 and PLEC) were found to be significantly higher 
in tumor samples compared to adjacent normal tissue (described in Figure 7.2 of the 
Appendix V). Although, the correlation between transcript and protein abundance is 
considered to be moderate or poor, this observation suggested that transcripts were 
elevated for these 12 cytoskeletal genes, that possibly be recruited to lipid rafts to promote 
tumor progression. This independent analysis of clinical datasets presumably reflects the 
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involvement of cytoskeleton protein in the wide range of malignancies. Alternatively, a 
possible off target or side effect of widely used chemotherapeutic agents of anti-
microtubule category from taxane family including docetaxel and vinca alkaloid such as 
vincristine and vinblastine might arise from affecting the raft assembly by targeting 
underlined cytoskeleton in normal cells. 
5.4 Challenges in the field 
Inside the cell, protein molecules sometimes occur in more than one sub cellular 
compartments. Depending on the context, a given protein can have same function in 
multiple locations or alternatively perform site-specific function. One possible caveat of the 
analysis presented in the chapter 3 and 4 is retrospective focus towards only lipid raft 
domains. So far, my analysis has been limited to protein profiling of single sub-
compartment. A simultaneous qualitative or quantitative proteomic characterisation of 
multiple sub-cellular organelles like nucleus, cytoplasm, mitochondria, Golgi apparatus, 
endoplasmic reticulum, endosomes and complete membrane proteins would better reflect 
dynamic protein behaviour of underline biology of cell both in normal and 
pathophysiological state. 
In most of my research, each protein identified in lipid raft proteomic experiment was 
uniformly cross-referenced either with SwissProt accession numbers, a manually curated 
version of UniProtKB or computationally derived section TrEMBL, if the SwissProt 
information is not available. One of the issues during my analysis is standardisation of 
protein identifiers from different data sources. Currently we have lipid raft protein 
information from LC-MS/MS methods for the last fifteen years (2001-2015). In this 
intervening period, most of the primary protein sequence sources like UniProtKB, IPI and 
RefSeq have undergone a series of updates that sometimes led to deletion of protein entry 
from the database. Importantly, support for IPI database has been withdrawn by EBI but 
the older versions of this database are still being used to report protein constituents. 
Similarly, each new release of UniProtKB (monthly release) is associated with addition or 
removal of protein entries from the database. However, removal or reassignment of protein 
accession is not always associated with erroneous entry which is rightly pointed down by 
the recent investigation of effect of stability of protein accessions on Gene Ontology 
annotations within InterPro database434. During the collection and analysis of various 
proteomics datasets presented in this thesis, I referred to the most updated version of 
UniProtKB available at that time but there still remain minor challenges with precise 
mapping of protein identifiers that might result in loss of information. To capture all original 
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data, I have created a section of unmapped protein entries under the "Download" segment 
of RaftProt for which I could not find reliable protein accession in UniProtKB. As mentioned 
in the methods section (4.2.2), the dataset of cytoskeleton associated proteins was based 
on GO annotations consisting evidences derived from multiple sources. With relative 
paucity of experimental observations, other sources (computational inference, author 
statement and curator statement) were used to increase the coverage of cytoskeleton 
proteins in human proteome. However, there is a possibility of introducing a bias that could 
lead to over-estimation of results.  
In chapter 3, I interrogated a number of computational prediction tools to annotate lipid 
modified proteins in the proteome-wide datasets. While none of the predictors for each of 
the four lipid modifications (palmitoylation, myristoylation, prenylation and GPI anchor 
attachment) significantly improved the existing annotations in the UniProtKB, I proposed 
an alternative approach of data mining to gather experimentally validated datasets. I used 
a dedicated lipid modification resource SwissPalm for protein palmitoylation has 
contributed to over four fold increase in number of known palmitoylated proteins. This 
could be one of the possible reasons for significant enrichment of palmitoylated proteins 
observed in lipid rafts in Chapter 3. However, I believe the public data for other lipid 
modifications like myristoylation, prenylation and GPI anchor are not yet sufficiently 
complete to confidently comment on their existence and enrichment status in the lipid rafts. 
If such data resources or proteome wide datasets become available it will be possible to 
pin down the representation of these three class of lipid modifications with greater 
confidence to define intrinsic protein component of lipid rafts. In chapter 3, I considered all 
the proteins with a transmembrane domain to be raft associated. Transmembrane proteins 
are not only reside in the plasma membrane but also found in the membrane of other 
organelles such as Golgi, endoplasmic reticulum or mitochondria. For example, type II 
transmembrane proteins known to be localised in the Golgi apparatus435-436. While some of 
the literature suggests only proteins with a long transmembrane domain might be recruited 
to the thicker lipid bilayer of lipid rafts, the TMD prediction tool algorithms of TMHMM302 
and TOPCONS303 have implemented very conservative sliding window of size 20 or 21 of 
amino acid residues, for estimating the span of hydrophobic residues. Thus, even though 
there exists some proteins like CAV-1 with a very large transmembrane domain span of 40 
hydrophobic amino acid residues437, both the TMD predictors were unable to capture the 
accurate length of the alpha helix. Similarly, other tools such as MeMo438, Memstat439 or 
DAS440 with no such window size restrictions failed to give reliable estimate of the helix 
length. In future, a special consideration should be given to accurately capturing entire 
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hydrophobic amino acid residue span in the protein sequence while developing an 
algorithm. Computationally, there also a possibility for development of sequence based 
lipid raft localisation predictor. So far, from the analysis in chapter 3, none of the potential 
lipid raft localisation features was found to be uniquely associated to the lipid rafts. But 
with further research in determining selective lipid raft feature might provide the possibility 
for development of a prediction tool for characterising probable lipid raft localization of 
unknown protein.  
Compared to massive population scale datasets in genomic or transcriptomic studies, the 
proteomics experiment I collected were fairly limited in their sample size. This issue was 
profound during the integrative analysis of cancer raft datasets where some experimental 
outcomes, for example colon cancer raft study441, were statistically underpowered because 
of lack of reliable replicate datasets for quantitative analysis. Normalisation of protein 
expression data was also a challenging step with some studies as the published studies 
did not provide raw mass spectrometric data with the publication nor did the data been 
uploaded in the public repositories like PRIDE. The research in subcellular proteomics field 
would therefore be greatly benefit if more raw data being available in public domain. At the 
same time, the Triplex SILAC proteomics data (peptide identification and the ratios of pair-
wise comparison) of lipid rafts derived from ovarian cancer SKOV3 cells (chapter 4) was 
generated by the Spectrum Mill search protein engine which was the only available option 
to analyse encrypted vender specific mass fingerprints generated on the Agilent 
instrument. While collecting the proteomic datasets from the literature I noticed that 
majority of datasets from RaftProt were based on profiling of cancer derived cell lines with 
very few studies dedicated towards investigating rafts from normal or primary cell or tissue 
types. Therefore, work characterising differences between primary and cancerous cells 
from same tissue or organ would highlight the underlying differences in normal and cancer 
rafts.  
5.5 Future Directions  
Cancer is a disease characterise by significantly large number genetic alterations giving 
rise to synonymous or non-synonymous mutations. A protein with even a single alteration 
in the amino acid sequence could undergo misfolding, degradation or functional changes. 
Even though the mutations occur in genes, it is a protein that is localised to the rafts. Thus 
there is need for performing a proteogenomic analysis442 of the lipid raft compartments to 
determine possible somatic alterations in the oncogenes, receptors or signalling molecules 
associated with the lipid rafts. As described in chapter 3, multiple post-translational 
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modifications dictate the recruitment of proteins to the lipid rafts. However, only a handful 
of studies have focused in characterising PTM occur at the raft domains. It is extremely 
challenging to capture and analyse lipid modifications by proteomics techniques, and the 
limited amount of proteins in lipid raft preparations further adds to the technical difficulty 
level. In future, specialised bio-analytical methods and computational algorithms for 
creating a proteome wide landscape of lipid modified proteins would be highly beneficial to 
catalyse the field of lipid raft research. Another exciting avenue is the advancements in the 
field of lipidomics443. Inside lipid raft assemblies, proteins do not occur alone, rather there 
exists a hostile environment to promote strong intercommunication between protein and 
lipid species. However, until recently, the lipid components of the cholesterol-rich 
microdomains have largely been uncharacterised. Recent, advancements in the lipidomics 
methods would present a refined knowledge about the structure, complexities and function 
of these fascinating cholesterol rich regions of the membrane.  
In summary, this thesis describes different attempts to explore the diversity of mammalian 
proteins localised to the cholesterol rich membrane microdomains by combining 
experimental data with computational analysis. The development of RaftProt created the 
roadmap for subsequent functional characterisation of lipid raft proteome of human and 
unravelling raft associated pan-cancer protein signatures during cancer development. 
Specifically, I developed experimental evidence based or protein signature based criteria 
to improve the likelihood of determining true lipid raft proteins from proteomics outcomes. 
The bioinformatics approach presented in this thesis highlighted both static and dynamic 
nature of lipid rafts localised proteins combining data from different sources like structure, 
sequence and function to gain systems-level understanding of this complex system. I 
believe, the findings from this thesis could be used to develop new therapeutic strategies 
against cancer and offer important perspectives for understanding the lipid raft proteome 
as a dynamic system.  
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7. Chapter 7: Appendices 
7.1 Appendix I: Research article entitled “RaftProt: mammalian lipid raft proteome 
database” 
As per the University of Queensland policy PPL 4.60.07, journal formatting is not accepted 
in the main thesis or the appendices. Therefore, in this appendix I am providing the 
hyperlink to this research article, partially included as chapter 2 of this thesis. 
The RaftProt database (version 1) has been published as an open access article in the 
database issue of the Nucleic Acids Research and can be accessed here 
http://nar.oxfordjournals.org/content/43/D1/D335.long.  
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7.2 Appendix II: Research article entitled “Integrative analysis of subcellular 
quantitative proteomics studies reveals functional cytoskeleton 
membrane−lipid raft interactions in cancer” 
This peer reviewed article, presented as the Chapter 4 of my thesis, has been published 
in the Journal of Proteome Research which can be accessed here 
http://pubs.acs.org/doi/abs/10.1021/acs.jproteome.5b01035 
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7.3 Appendix III: Supporting information for Chapter 3 
Transmembrane-domain frequency 
The number of TMDs in the individual proteins estimated to range from single TMD up to 
as high as 31 TMD containing protein (PIEZ1) in the human proteome. Protein families 
such as tetraspannins and G-proteins coupled receptors (GPCRs) harbor a defined 
number of four and seven TM helices in their protein structures. Next, I calculated the 
frequencies of the number of TMDs present in the individual TMD containing human 
proteins and the raft associated protein subset (Figure 7.1 a, b). The majority of 
transmembrane proteins, predicted through TMHMM, from the human proteome (45%) 
and the raft associated subset (54%) are single pass proteins, containing only one TM 
helix in their folded state. In the human proteome second largest subset (14%) comprise of 
proteins of GPCR family. However, this subgroup represents a relatively small proportion 
(4%) of all transmembrane proteins detected in the lipid rafts. The share of tetraspannins 
i.e. proteins containing four TMDs, were similar in both all human TM proteins (7.5%) and 
raft localised TM proteins (8%). Similarly, the distribution of all other TMD containing 
proteins is relatively equal in both the datasets.   
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Figure 7.1: The frequency distribution of the number of TMDs in the (a) human proteome 
and (b) human lipid raft proteins. 
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Table 7.1: Proportion of lipid-driven raft targeting features in proteins from different 
datasets 
Feature 
Human 
Proteome 
(21037) 
Human Lipid 
raft 
Proteome 
(4898) 
 UniProtKB 
Plasma 
membrane 
Proteome 
(3029) 
Non-raft 
UniProtKB 
plasma 
membrane 
proteome 
(2234) 
High 
confidence 
lipid raft 
Proteins 
(1797) 
Cholesterol 
binding proteins 
755 
(3.6%) 
495 (10%) 
p-value< 
2.2e-16 
117 (4%) 
p-value= 
0.24 
36 (1.6%) 
p-
value=5.7e-
08* 
348 (19%) 
p-value< 
2.2e-16 
Transmembrane 
Domain 
3428 
(16%) 
1286 (26%) 
p-
value=<2.2e-
16 
1359 (44%) 
p-value=< 
2.2e-16 
1146 (51%) 
p-value = 
<2.2e-16 
574 (32%) 
p-value< 
2.2e-16 
Palmitoylation 
1351 
(6%) 
980 (20%) 
p-
value<2.2e-
16 
319 (11%) 
p-
value=2.5e-
15 
101 (4.5%) 
p-value=0.99 
649 (36%) 
p-value< 
2.2e-16 
GPI-anchor 
134 
(0.66%) 
72 (1.5%) 
p-value= 
3.5e-08 
129 (4.2%) 
p-
value=<2.2e-
16 
60 (2.6%) 
p-
value=<2.2e-
16 
34 (1.9%) 
p-
value=5.02E-
13 
Prenylation 
167 
(0.79%) 
84 (1.7%) 
p-
value=2.6e-
08 
97 (3.2%) 
p-
value=<2.2e-
16 
48 (2.1%) 
p-
value=2.2e-
08 
59 (3.3%) 
p-
value=<2.2e-
16 
Myristylation 193 79 (1.6%) 82 (2.7%) 41 (1.8%) 53 (2.9%) 
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(0.92%) p-value= 
3.01e-05 
p-value= 
2.5e-14 
p-value= 
0.001 
p-value 
<2.2e-16 
p-value for over-representation analysis is calculated by using one tailed Fisher’s Exact 
test comparing each feature present in three different dataset with entire human proteome.  
*Under-representation analysis of non-raft plasma membrane proteins compared to human 
proteome  
 
Table 7.2: Relative proportion of all known human lipid modification, binding and TMD 
signatures in the human raft and UniProtKB plasma membrane proteome. 
Proteome 
Sterol 
binding 
proteins 
TMD 
(3428) 
Palmitoylation 
(1351) 
GPI-
anchor 
(134) 
Prenylation 
(167) 
Myristylation 
(193) 
Human 
Proteome 
755 
(100%) 
3428 
(100%) 
1351 (100%) 
134 
(100%) 
167 (100%) 193 (100%) 
Human Raft 
Proteome 
(4898) 
495 (66%) 
1286 
(38%) 
980 (73%) 72 (54%) 84 (50%) 79 (41%) 
UniProtKB 
Plasma 
Proteome 
(3029) 
117 (16%) 
1359 
(40%) 
319 (24%) 
129 
(96%) 
97 (58%) 82 (43%) 
Non-raft 
UniProtKB 
plasma 
proteome 
(2232) 
36 (5%) 
1146 
(34%) 
101 (7%) 60 (45%) 48 (29%) 41 (21%) 
 
7.4 Appendix IV: Supporting information for chapter 4 
All the supplementary material mentioned in this chapter is available online at 
http://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.5b01035 
Here, I am providing a brief information about individual supporting material mentioned in 
the chapter.  
Table S4.1: Human cytoskeletal associated proteins along with their GO annotations used 
for enrichment analysis 
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Table S4.2: Altered protein list from published cancer lipid raft proteome datasets used for 
the comparative analysis 
Table S4.3: Raw peptide summary document of quantitative proteomics analysis of 
ovarian cancer lipid raft upon wild type and mutant OPCML over-expression 
Table S4.4: Protein expression profiles in ovarian cancer lipid raft upon wild type and 
mutant OPCML over-expression along with a list of unique DRM proteins identified in the 
ovarian lipid raft. 
Table S4.5: Topological properties of networks generated using random sampling. 
Figure S4.1: Normalization of SILAC ratios of proteins.  
Figure S4.2: Protein-protein interaction network of ovarian lipid raft associated proteins. 
The nodes represent individual protein (183) and the lines connecting the nodes are 
physical interaction among them 
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7.5 Appendix V: Expression profiles of cytoskeleton associated proteins 
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Figure 7.2 : Transcript levels of upregulated cytoskeleton associated proteins in the cancer lipid rafts from TCGA tumor samples 
identified through RNA-Seq experiments from 1100 breast cancer, 471 melanoma, 307 ovarian cancer, 498 prostate cancer and 534 
RCC patient tumor samples.
  175 
 
7.6 Appendix VI: Additional co-authored publications during the PhD candidature 
not contributing to the thesis 
Here, I would like to mention two additional co-authored research articles, in which I have 
contributed during my PhD candidature. 
I was a co-author in the Research article entitled “Online Quantitative Proteomics p‐Value 
Calculator for permutation-based statistical testing of peptide ratios” the Journal of 
Proteome Research http://pubs.acs.org/doi/abs/10.1021/pr500525e during my PhD 
candidature. This additional work, performed during candidature, did not directly contribute 
to this thesis, but the web-server (http://qppc.di.uq.edu.au/) was used to analyse SILAC 
proteomic dataset of Chapter 4. The publication describes a web-server assisting LC-
MS/MS-platform independent analysis of quantitative proteomics datasets based on the 
permutation test on the peptide ratios. I contributed to a part of web-server development 
and extensive testing along with analysed MEF cell line dataset for the performance 
evaluation of different parameters. 
A peer reviewed article entitled “Diet-induced hypercholesterolemia promotes androgen-
independent prostate cancer metastasis via IQGAP1 and caveolin-1” published in the 
Oncotarget 
(http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&o
p=view&path%5B%5D=3476&path%5B%5D=6882) in which I shared an authorship. This 
article demonstrates the link between dietary cholesterol in the prostate cancer metastasis 
using in vitro and in vivo mouse model. In this article, I characterised the association of 
IQGAP-1 with the lipid rafts analysing multiple lipid-raft proteomics datasets.  
